Gene Symbol | Gene ID | Gene Info |
---|---|---|
Plagl1
|
ENSMUSG00000019817.12 | pleiomorphic adenoma gene-like 1 |
CRE | Gene | Distance | Association probability | Pearson corr. coef. | P-value | Plot |
---|---|---|---|---|---|---|
chr10_13114904_13115115 | Plagl1 | 1355 | 0.466914 | 0.37 | 3.3e-03 | Click! |
chr10_13114669_13114820 | Plagl1 | 1279 | 0.487428 | 0.33 | 9.9e-03 | Click! |
chr10_13060623_13061509 | Plagl1 | 562 | 0.761716 | 0.31 | 1.5e-02 | Click! |
chr10_13093078_13094452 | Plagl1 | 2752 | 0.287698 | -0.28 | 3.2e-02 | Click! |
chr10_13095567_13095718 | Plagl1 | 4629 | 0.234717 | -0.26 | 4.9e-02 | Click! |
Move your cursor over a bar to see sample name and corresponding Z-value.
Cis Regulatory Element (CRE) | Target Score | Top associated gene | Gene Info | Distance of CRE to TSS | CRE/Gene association probability |
---|---|---|---|---|---|
chr5_120433178_120434996 | 5.48 |
Gm27199 |
predicted gene 27199 |
2320 |
0.19 |
chrX_101301762_101302890 | 4.72 |
Nlgn3 |
neuroligin 3 |
1852 |
0.2 |
chr13_34128849_34129198 | 4.33 |
Tubb2b |
tubulin, beta 2B class IIB |
1331 |
0.28 |
chr12_29533001_29533958 | 4.10 |
Myt1l |
myelin transcription factor 1-like |
94 |
0.96 |
chr15_99673865_99674141 | 3.92 |
Asic1 |
acid-sensing (proton-gated) ion channel 1 |
1336 |
0.24 |
chr8_70119024_70120981 | 3.84 |
Ncan |
neurocan |
871 |
0.35 |
chr2_74737192_74739622 | 3.76 |
Hoxd3 |
homeobox D3 |
1212 |
0.2 |
chr7_73376866_73377306 | 3.42 |
A730056A06Rik |
RIKEN cDNA A730056A06 gene |
1312 |
0.3 |
chr11_96308497_96309471 | 3.42 |
Hoxb5os |
homeobox B5 and homeobox B6, opposite strand |
2074 |
0.12 |
chr14_67236008_67239452 | 3.41 |
Ebf2 |
early B cell factor 2 |
3086 |
0.21 |
chr1_172025134_172025920 | 3.33 |
Vangl2 |
VANGL planar cell polarity 2 |
1184 |
0.38 |
chr6_8949544_8950237 | 3.30 |
Nxph1 |
neurexophilin 1 |
214 |
0.97 |
chr11_96306504_96308444 | 3.27 |
Hoxb5os |
homeobox B5 and homeobox B6, opposite strand |
564 |
0.48 |
chr12_108000728_108001440 | 3.21 |
Bcl11b |
B cell leukemia/lymphoma 11B |
2330 |
0.41 |
chr2_158614356_158617139 | 3.20 |
Gm14205 |
predicted gene 14205 |
3927 |
0.13 |
chr14_64592253_64592626 | 3.20 |
Mir3078 |
microRNA 3078 |
1254 |
0.34 |
chr14_122478089_122479067 | 3.20 |
Zic2 |
zinc finger protein of the cerebellum 2 |
478 |
0.68 |
chr5_135077129_135077753 | 3.16 |
Vps37d |
vacuolar protein sorting 37D |
825 |
0.4 |
chr8_123410787_123412789 | 3.16 |
Tubb3 |
tubulin, beta 3 class III |
198 |
0.84 |
chr10_81229656_81230911 | 3.15 |
Atcay |
ataxia, cerebellar, Cayman type |
502 |
0.53 |
chr2_181768465_181769553 | 3.14 |
Myt1 |
myelin transcription factor 1 |
1497 |
0.33 |
chr6_103513044_103513373 | 3.09 |
Chl1 |
cell adhesion molecule L1-like |
1878 |
0.31 |
chr7_87586513_87587584 | 3.09 |
Grm5 |
glutamate receptor, metabotropic 5 |
2650 |
0.4 |
chr19_6499251_6500132 | 3.07 |
Nrxn2 |
neurexin II |
1856 |
0.23 |
chr2_85197983_85199004 | 2.95 |
Lrrc55 |
leucine rich repeat containing 55 |
1296 |
0.28 |
chr6_134886811_134888239 | 2.95 |
Gpr19 |
G protein-coupled receptor 19 |
243 |
0.87 |
chr19_45230983_45235468 | 2.91 |
Lbx1 |
ladybird homeobox 1 |
2587 |
0.27 |
chr7_49915184_49916836 | 2.87 |
Slc6a5 |
solute carrier family 6 (neurotransmitter transporter, glycine), member 5 |
4310 |
0.29 |
chr6_83179353_83180686 | 2.86 |
Dctn1 |
dynactin 1 |
406 |
0.67 |
chr3_88211471_88212561 | 2.83 |
Gm3764 |
predicted gene 3764 |
2469 |
0.11 |
chr19_7420029_7420661 | 2.72 |
2700081O15Rik |
RIKEN cDNA 2700081O15 gene |
64 |
0.95 |
chr5_135806693_135807939 | 2.69 |
Srrm3 |
serine/arginine repetitive matrix 3 |
419 |
0.73 |
chr7_90886512_90887836 | 2.62 |
Gm45159 |
predicted gene 45159 |
102 |
0.88 |
chr15_102972226_102973378 | 2.62 |
Mir196a-2 |
microRNA 196a-2 |
548 |
0.53 |
chr18_60925301_60926809 | 2.61 |
Camk2a |
calcium/calmodulin-dependent protein kinase II alpha |
330 |
0.84 |
chr11_96335758_96336467 | 2.59 |
Hoxb3 |
homeobox B3 |
4833 |
0.08 |
chr2_178141581_178143125 | 2.52 |
Phactr3 |
phosphatase and actin regulator 3 |
420 |
0.88 |
chr8_94997776_94998724 | 2.51 |
Adgrg1 |
adhesion G protein-coupled receptor G1 |
2589 |
0.18 |
chr13_40727690_40728914 | 2.48 |
Gm26688 |
predicted gene, 26688 |
494 |
0.48 |
chr6_137253502_137253687 | 2.48 |
Ptpro |
protein tyrosine phosphatase, receptor type, O |
1129 |
0.6 |
chrX_105390628_105392456 | 2.47 |
5330434G04Rik |
RIKEN cDNA 5330434G04 gene |
212 |
0.93 |
chr11_96291690_96292512 | 2.44 |
Hoxb6 |
homeobox B6 |
375 |
0.66 |
chr11_96325013_96326405 | 2.44 |
Hoxb3 |
homeobox B3 |
2353 |
0.11 |
chr17_56474107_56476457 | 2.44 |
Ptprs |
protein tyrosine phosphatase, receptor type, S |
655 |
0.65 |
chr7_25153391_25155013 | 2.42 |
D930028M14Rik |
RIKEN cDNA D930028M14 gene |
867 |
0.45 |
chr5_139545650_139546069 | 2.39 |
Uncx |
UNC homeobox |
1961 |
0.3 |
chr18_43686487_43688415 | 2.39 |
Jakmip2 |
janus kinase and microtubule interacting protein 2 |
174 |
0.96 |
chr7_48960076_48960785 | 2.38 |
Nav2 |
neuron navigator 2 |
1333 |
0.41 |
chr3_8509825_8511666 | 2.36 |
Stmn2 |
stathmin-like 2 |
1159 |
0.54 |
chr11_96251471_96253106 | 2.33 |
Gm53 |
predicted gene 53 |
244 |
0.82 |
chr17_52602081_52603198 | 2.31 |
Gm27217 |
predicted gene 27217 |
21 |
0.54 |
chr11_80479429_80480178 | 2.28 |
Cdk5r1 |
cyclin-dependent kinase 5, regulatory subunit 1 (p35) |
2747 |
0.26 |
chr4_45824847_45825701 | 2.27 |
Igfbpl1 |
insulin-like growth factor binding protein-like 1 |
1649 |
0.31 |
chr2_25264308_25268001 | 2.27 |
Tprn |
taperin |
1410 |
0.14 |
chr2_24473566_24475385 | 2.26 |
Pax8 |
paired box 8 |
622 |
0.64 |
chr7_19175632_19177533 | 2.25 |
Eml2 |
echinoderm microtubule associated protein like 2 |
161 |
0.88 |
chrX_140279357_140279690 | 2.21 |
Gm15046 |
predicted gene 15046 |
1661 |
0.41 |
chr3_68573207_68574269 | 2.21 |
Schip1 |
schwannomin interacting protein 1 |
1493 |
0.45 |
chr11_69835948_69836218 | 2.20 |
Nlgn2 |
neuroligin 2 |
1234 |
0.17 |
chr12_86989498_86990698 | 2.20 |
Zdhhc22 |
zinc finger, DHHC-type containing 22 |
332 |
0.85 |
chr12_88724244_88724446 | 2.18 |
Nrxn3 |
neurexin III |
664 |
0.75 |
chr15_99704098_99705242 | 2.17 |
Gm34939 |
predicted gene, 34939 |
694 |
0.3 |
chr11_93098807_93100169 | 2.15 |
Car10 |
carbonic anhydrase 10 |
198 |
0.97 |
chr17_91093132_91093621 | 2.15 |
Nrxn1 |
neurexin I |
305 |
0.87 |
chr2_74725879_74728683 | 2.15 |
Hoxd4 |
homeobox D4 |
207 |
0.67 |
chr11_96334278_96335532 | 2.13 |
Hoxb3 |
homeobox B3 |
6040 |
0.08 |
chr16_77421091_77421970 | 2.12 |
9430053O09Rik |
RIKEN cDNA 9430053O09 gene |
290 |
0.84 |
chr11_116919762_116920015 | 2.11 |
Mgat5b |
mannoside acetylglucosaminyltransferase 5, isoenzyme B |
1025 |
0.48 |
chr5_111424407_111425623 | 2.09 |
Gm43119 |
predicted gene 43119 |
1426 |
0.38 |
chr7_141428600_141429722 | 2.09 |
Cend1 |
cell cycle exit and neuronal differentiation 1 |
190 |
0.82 |
chr2_113757445_113759087 | 2.09 |
Grem1 |
gremlin 1, DAN family BMP antagonist |
380 |
0.87 |
chr3_66977838_66980287 | 2.09 |
Shox2 |
short stature homeobox 2 |
251 |
0.9 |
chr11_96294128_96295421 | 2.05 |
Hoxb6 |
homeobox B6 |
2298 |
0.11 |
chr13_20472048_20472724 | 2.05 |
Elmo1 |
engulfment and cell motility 1 |
340 |
0.8 |
chr3_88458101_88459325 | 2.04 |
Sema4a |
sema domain, immunoglobulin domain (Ig), transmembrane domain (TM) and short cytoplasmic domain, (semaphorin) 4A |
163 |
0.88 |
chr13_78187943_78188977 | 2.03 |
Nr2f1 |
nuclear receptor subfamily 2, group F, member 1 |
1983 |
0.23 |
chr11_84519480_84520865 | 2.03 |
Lhx1 |
LIM homeobox protein 1 |
1895 |
0.32 |
chr12_117153278_117156362 | 2.02 |
Gm10421 |
predicted gene 10421 |
3169 |
0.37 |
chr3_34652462_34653573 | 2.02 |
Sox2 |
SRY (sex determining region Y)-box 2 |
2612 |
0.16 |
chr2_152081612_152083149 | 2.02 |
Scrt2 |
scratch family zinc finger 2 |
851 |
0.52 |
chr11_93100564_93101210 | 2.01 |
Car10 |
carbonic anhydrase 10 |
1597 |
0.56 |
chr4_151127830_151127981 | 2.01 |
Camta1 |
calmodulin binding transcription activator 1 |
1590 |
0.42 |
chr8_83902724_83903561 | 1.99 |
Adgrl1 |
adhesion G protein-coupled receptor L1 |
2407 |
0.18 |
chr3_5220585_5221267 | 1.99 |
2700069I18Rik |
RIKEN cDNA 2700069I18 gene |
85 |
0.9 |
chr18_43390784_43391261 | 1.97 |
Dpysl3 |
dihydropyrimidinase-like 3 |
2355 |
0.34 |
chr11_96309485_96310411 | 1.97 |
Hoxb5os |
homeobox B5 and homeobox B6, opposite strand |
3038 |
0.09 |
chr7_25152042_25153378 | 1.97 |
D930028M14Rik |
RIKEN cDNA D930028M14 gene |
253 |
0.87 |
chrX_143930842_143933141 | 1.96 |
Dcx |
doublecortin |
1059 |
0.64 |
chr4_91372863_91373225 | 1.96 |
Elavl2 |
ELAV like RNA binding protein 1 |
14 |
0.83 |
chr6_52160071_52161455 | 1.96 |
Hotairm1 |
Hoxa transcript antisense RNA, myeloid-specific 1 |
2239 |
0.09 |
chr2_70564530_70567543 | 1.95 |
Gad1 |
glutamate decarboxylase 1 |
341 |
0.83 |
chr10_80179768_80180422 | 1.94 |
Efna2 |
ephrin A2 |
613 |
0.51 |
chr15_82277282_82277951 | 1.92 |
Septin3 |
septin 3 |
2216 |
0.14 |
chr6_90781027_90782541 | 1.90 |
Iqsec1 |
IQ motif and Sec7 domain 1 |
188 |
0.94 |
chr10_106469534_106470969 | 1.90 |
Ppfia2 |
protein tyrosine phosphatase, receptor type, f polypeptide (PTPRF), interacting protein (liprin), alpha 2 |
88 |
0.97 |
chr11_96324031_96324564 | 1.89 |
Hoxb3 |
homeobox B3 |
971 |
0.28 |
chr18_64890376_64890890 | 1.88 |
Nedd4l |
neural precursor cell expressed, developmentally down-regulated gene 4-like |
140 |
0.95 |
chr11_55606213_55606456 | 1.87 |
Glra1 |
glycine receptor, alpha 1 subunit |
1399 |
0.46 |
chr1_5018491_5020565 | 1.87 |
Rgs20 |
regulator of G-protein signaling 20 |
11 |
0.98 |
chr7_64501626_64502920 | 1.86 |
Apba2 |
amyloid beta (A4) precursor protein-binding, family A, member 2 |
135 |
0.96 |
chrX_23283125_23283785 | 1.86 |
Klhl13 |
kelch-like 13 |
1374 |
0.57 |
chr15_79159930_79161178 | 1.86 |
Sox10 |
SRY (sex determining region Y)-box 10 |
3920 |
0.11 |
chr2_151966993_151968089 | 1.84 |
Mir1953 |
microRNA 1953 |
76 |
0.96 |
chr14_84446983_84448692 | 1.83 |
Pcdh17 |
protocadherin 17 |
670 |
0.76 |
chr2_65565600_65566271 | 1.83 |
Scn3a |
sodium channel, voltage-gated, type III, alpha |
1557 |
0.45 |
chr9_58197310_58202560 | 1.83 |
Islr2 |
immunoglobulin superfamily containing leucine-rich repeat 2 |
637 |
0.54 |
chr1_132541040_132543287 | 1.83 |
Cntn2 |
contactin 2 |
702 |
0.64 |
chr7_45366021_45366296 | 1.82 |
Mtag2 |
metastasis associated gene 2 |
5 |
0.86 |
chr5_134101487_134102203 | 1.80 |
Castor2 |
cytosolic arginine sensor for mTORC1 subunit 2 |
1840 |
0.26 |
chr10_34299043_34301066 | 1.78 |
Tspyl4 |
TSPY-like 4 |
798 |
0.4 |
chr4_22479026_22480517 | 1.78 |
Pou3f2 |
POU domain, class 3, transcription factor 2 |
8595 |
0.17 |
chr9_108573133_108575666 | 1.78 |
Dalrd3 |
DALR anticodon binding domain containing 3 |
2007 |
0.1 |
chr15_103029865_103030648 | 1.77 |
Hoxc4 |
homeobox C4 |
4139 |
0.1 |
chr14_122461803_122462503 | 1.77 |
Zic5 |
zinc finger protein of the cerebellum 5 |
2132 |
0.2 |
chr9_74864280_74865379 | 1.77 |
Onecut1 |
one cut domain, family member 1 |
1655 |
0.3 |
chr8_106336310_106337932 | 1.75 |
Smpd3 |
sphingomyelin phosphodiesterase 3, neutral |
867 |
0.61 |
chr17_32808952_32809925 | 1.75 |
Zfp811 |
zinc finger protein 811 |
404 |
0.53 |
chr1_92847884_92848981 | 1.73 |
Gm29480 |
predicted gene 29480 |
339 |
0.76 |
chr7_45785390_45787192 | 1.73 |
Lmtk3 |
lemur tyrosine kinase 3 |
266 |
0.77 |
chr9_99357344_99358705 | 1.73 |
Esyt3 |
extended synaptotagmin-like protein 3 |
494 |
0.71 |
chr5_114090086_114090237 | 1.72 |
Svop |
SV2 related protein |
1206 |
0.33 |
chr4_139832357_139834219 | 1.72 |
Pax7 |
paired box 7 |
240 |
0.94 |
chr11_96331807_96334248 | 1.72 |
Hoxb3 |
homeobox B3 |
4965 |
0.08 |
chr11_97842036_97842206 | 1.72 |
B230217C12Rik |
RIKEN cDNA B230217C12 gene |
802 |
0.44 |
chr10_33623738_33624906 | 1.71 |
Gm15939 |
predicted gene 15939 |
76 |
0.56 |
chr5_139548537_139550176 | 1.70 |
Uncx |
UNC homeobox |
5458 |
0.19 |
chr8_107549386_107550336 | 1.69 |
Wwp2 |
WW domain containing E3 ubiquitin protein ligase 2 |
1034 |
0.42 |
chr1_25226679_25227199 | 1.68 |
Adgrb3 |
adhesion G protein-coupled receptor B3 |
1887 |
0.26 |
chr8_92362973_92364962 | 1.68 |
Irx5 |
Iroquois homeobox 5 |
6218 |
0.19 |
chr2_157561445_157562129 | 1.67 |
Gm23134 |
predicted gene, 23134 |
660 |
0.4 |
chr1_120607630_120608287 | 1.67 |
En1 |
engrailed 1 |
5540 |
0.23 |
chr2_159002562_159003405 | 1.67 |
Gm44319 |
predicted gene, 44319 |
66880 |
0.12 |
chr13_99443316_99444666 | 1.67 |
Map1b |
microtubule-associated protein 1B |
47 |
0.98 |
chr11_69835212_69835923 | 1.66 |
Nlgn2 |
neuroligin 2 |
718 |
0.33 |
chr18_82405647_82407688 | 1.66 |
Galr1 |
galanin receptor 1 |
110 |
0.96 |
chr17_37048176_37048677 | 1.66 |
Gabbr1 |
gamma-aminobutyric acid (GABA) B receptor, 1 |
152 |
0.9 |
chr7_29306041_29306691 | 1.65 |
Dpf1 |
D4, zinc and double PHD fingers family 1 |
1558 |
0.24 |
chr19_48205901_48206676 | 1.65 |
Sorcs3 |
sortilin-related VPS10 domain containing receptor 3 |
263 |
0.94 |
chr7_49914124_49915124 | 1.65 |
Slc6a5 |
solute carrier family 6 (neurotransmitter transporter, glycine), member 5 |
2924 |
0.34 |
chr10_89256685_89257951 | 1.63 |
Ano4 |
anoctamin 4 |
18 |
0.99 |
chr12_105453821_105454975 | 1.63 |
D430019H16Rik |
RIKEN cDNA D430019H16 gene |
542 |
0.76 |
chr7_79501250_79502506 | 1.63 |
Mir9-3hg |
Mir9-3 host gene |
1757 |
0.18 |
chr10_19354370_19355680 | 1.63 |
Olig3 |
oligodendrocyte transcription factor 3 |
1508 |
0.47 |
chr6_51848684_51849648 | 1.62 |
Skap2 |
src family associated phosphoprotein 2 |
22763 |
0.22 |
chr6_52233543_52234485 | 1.61 |
Hoxa10 |
homeobox A10 |
690 |
0.34 |
chr4_140244024_140245271 | 1.60 |
Igsf21 |
immunoglobulin superfamily, member 21 |
2137 |
0.36 |
chr8_64691882_64692436 | 1.60 |
Cpe |
carboxypeptidase E |
895 |
0.57 |
chr13_97245763_97246942 | 1.60 |
Enc1 |
ectodermal-neural cortex 1 |
5247 |
0.18 |
chr7_25004827_25006284 | 1.57 |
Atp1a3 |
ATPase, Na+/K+ transporting, alpha 3 polypeptide |
340 |
0.79 |
chr9_121403057_121404479 | 1.57 |
Trak1 |
trafficking protein, kinesin binding 1 |
290 |
0.91 |
chr2_33641457_33645822 | 1.56 |
C130021I20Rik |
Riken cDNA C130021I20 gene |
2308 |
0.22 |
chr12_85150310_85151505 | 1.56 |
Rps6kl1 |
ribosomal protein S6 kinase-like 1 |
329 |
0.81 |
chr1_132740444_132742155 | 1.54 |
Nfasc |
neurofascin |
458 |
0.83 |
chr15_103166833_103167683 | 1.54 |
Smug1 |
single-strand selective monofunctional uracil DNA glycosylase |
166 |
0.92 |
chr4_122997127_122997278 | 1.54 |
Mycl |
v-myc avian myelocytomatosis viral oncogene lung carcinoma derived |
1103 |
0.42 |
chr5_120435079_120435805 | 1.53 |
Gm27199 |
predicted gene 27199 |
3675 |
0.15 |
chr7_99272446_99273539 | 1.53 |
Map6 |
microtubule-associated protein 6 |
3860 |
0.15 |
chr4_43044880_43045893 | 1.53 |
Fam214b |
family with sequence similarity 214, member B |
373 |
0.57 |
chrX_135210129_135210918 | 1.52 |
Tceal6 |
transcription elongation factor A (SII)-like 6 |
164 |
0.93 |
chr1_194623571_194625393 | 1.52 |
Plxna2 |
plexin A2 |
4657 |
0.21 |
chr13_40731940_40732438 | 1.52 |
Tfap2a |
transcription factor AP-2, alpha |
582 |
0.59 |
chr10_81014285_81014919 | 1.52 |
Gng7 |
guanine nucleotide binding protein (G protein), gamma 7 |
311 |
0.78 |
chr2_169636158_169637469 | 1.52 |
Tshz2 |
teashirt zinc finger family member 2 |
3137 |
0.27 |
chr6_103510606_103512502 | 1.51 |
Chl1 |
cell adhesion molecule L1-like |
224 |
0.93 |
chr13_55962186_55963636 | 1.50 |
Gm47071 |
predicted gene, 47071 |
39354 |
0.14 |
chr5_30104769_30106082 | 1.49 |
3110082J24Rik |
RIKEN cDNA 3110082J24 gene |
66 |
0.75 |
chr4_41693576_41694021 | 1.49 |
Cntfr |
ciliary neurotrophic factor receptor |
1644 |
0.21 |
chr5_120437495_120438815 | 1.49 |
Gm27199 |
predicted gene 27199 |
6388 |
0.13 |
chr4_139825879_139826333 | 1.49 |
Pax7 |
paired box 7 |
6901 |
0.23 |
chr7_78577179_78577473 | 1.48 |
Ntrk3 |
neurotrophic tyrosine kinase, receptor, type 3 |
457 |
0.73 |
chr11_55607331_55608633 | 1.48 |
Glra1 |
glycine receptor, alpha 1 subunit |
161 |
0.96 |
chr5_120426818_120428597 | 1.48 |
Lhx5 |
LIM homeobox protein 5 |
3992 |
0.15 |
chr7_3391394_3391714 | 1.48 |
Cacng8 |
calcium channel, voltage-dependent, gamma subunit 8 |
871 |
0.34 |
chr19_44747536_44748066 | 1.47 |
Gm35610 |
predicted gene, 35610 |
6448 |
0.15 |
chr5_115431565_115432258 | 1.47 |
Msi1 |
musashi RNA-binding protein 1 |
1306 |
0.22 |
chr2_32428080_32429746 | 1.47 |
Slc25a25 |
solute carrier family 25 (mitochondrial carrier, phosphate carrier), member 25 |
1839 |
0.19 |
chr18_35966869_35967020 | 1.47 |
Psd2 |
pleckstrin and Sec7 domain containing 2 |
1839 |
0.27 |
chr6_37299209_37299387 | 1.47 |
Dgki |
diacylglycerol kinase, iota |
339 |
0.92 |
chr9_54764594_54766122 | 1.47 |
Crabp1 |
cellular retinoic acid binding protein I |
610 |
0.69 |
chr9_107401822_107402928 | 1.47 |
Cacna2d2 |
calcium channel, voltage-dependent, alpha 2/delta subunit 2 |
2306 |
0.19 |
chr5_24454355_24456254 | 1.46 |
Agap3 |
ArfGAP with GTPase domain, ankyrin repeat and PH domain 3 |
2970 |
0.1 |
chr11_119229202_119229418 | 1.46 |
Ccdc40 |
coiled-coil domain containing 40 |
181 |
0.85 |
chr5_116587782_116587933 | 1.46 |
Srrm4 |
serine/arginine repetitive matrix 4 |
3960 |
0.21 |
chr11_44621018_44621458 | 1.46 |
Ebf1 |
early B cell factor 1 |
523 |
0.75 |
chr5_150261018_150262108 | 1.45 |
Fry |
FRY microtubule binding protein |
1796 |
0.34 |
chr8_17532221_17533470 | 1.45 |
Csmd1 |
CUB and Sushi multiple domains 1 |
2436 |
0.46 |
chr2_33639069_33641423 | 1.45 |
Lmx1b |
LIM homeobox transcription factor 1 beta |
234 |
0.85 |
chr5_37245879_37246957 | 1.45 |
Crmp1 |
collapsin response mediator protein 1 |
573 |
0.76 |
chr3_88529609_88530041 | 1.44 |
Gm37584 |
predicted gene, 37584 |
2470 |
0.11 |
chr11_59312061_59312212 | 1.44 |
Wnt9a |
wingless-type MMTV integration site family, member 9A |
5206 |
0.14 |
chr1_135579927_135581701 | 1.43 |
Gm4793 |
predicted gene 4793 |
3959 |
0.2 |
chr3_134236641_134237783 | 1.43 |
Cxxc4 |
CXXC finger 4 |
392 |
0.78 |
chr2_180888498_180889012 | 1.43 |
Gm14342 |
predicted gene 14342 |
905 |
0.38 |
chr5_116589538_116590511 | 1.42 |
Srrm4 |
serine/arginine repetitive matrix 4 |
1793 |
0.34 |
chr7_34651302_34651863 | 1.41 |
Kctd15 |
potassium channel tetramerisation domain containing 15 |
1255 |
0.32 |
chr11_96298885_96301196 | 1.41 |
Hoxb6 |
homeobox B6 |
869 |
0.31 |
chr3_141470082_141470233 | 1.41 |
Unc5c |
unc-5 netrin receptor C |
4486 |
0.26 |
chr19_6418703_6419936 | 1.40 |
Nrxn2 |
neurexin II |
554 |
0.44 |
chr17_66443636_66444700 | 1.40 |
Mtcl1 |
microtubule crosslinking factor 1 |
4201 |
0.18 |
chr15_30457692_30458387 | 1.40 |
Ctnnd2 |
catenin (cadherin associated protein), delta 2 |
251 |
0.94 |
Log-likelihood per target | Total log-likelihood | Term | Description |
---|---|---|---|
1.4 | 4.3 | GO:0021570 | rhombomere 4 development(GO:0021570) |
1.3 | 5.4 | GO:0021615 | glossopharyngeal nerve morphogenesis(GO:0021615) |
1.1 | 3.4 | GO:1904059 | regulation of locomotor rhythm(GO:1904059) |
1.1 | 3.4 | GO:0072240 | distal convoluted tubule development(GO:0072025) DCT cell differentiation(GO:0072069) metanephric distal convoluted tubule development(GO:0072221) metanephric distal tubule development(GO:0072235) metanephric DCT cell differentiation(GO:0072240) |
1.0 | 13.5 | GO:0071625 | vocalization behavior(GO:0071625) |
1.0 | 3.1 | GO:0061205 | paramesonephric duct development(GO:0061205) |
1.0 | 2.9 | GO:0090027 | negative regulation of monocyte chemotaxis(GO:0090027) |
0.9 | 2.8 | GO:0021603 | cranial nerve formation(GO:0021603) |
0.9 | 2.7 | GO:0071205 | protein localization to juxtaparanode region of axon(GO:0071205) |
0.9 | 3.5 | GO:0098795 | mRNA cleavage involved in gene silencing by miRNA(GO:0035279) mRNA cleavage involved in gene silencing(GO:0098795) |
0.9 | 2.6 | GO:0002930 | trabecular meshwork development(GO:0002930) |
0.7 | 3.0 | GO:0033602 | negative regulation of dopamine secretion(GO:0033602) |
0.7 | 2.2 | GO:0097107 | postsynaptic density organization(GO:0097106) postsynaptic density assembly(GO:0097107) |
0.7 | 2.2 | GO:0021986 | epithalamus development(GO:0021538) habenula development(GO:0021986) |
0.7 | 13.7 | GO:0021516 | dorsal spinal cord development(GO:0021516) |
0.7 | 2.1 | GO:0009449 | gamma-aminobutyric acid biosynthetic process(GO:0009449) |
0.7 | 2.6 | GO:0016103 | diterpenoid catabolic process(GO:0016103) retinoic acid catabolic process(GO:0034653) |
0.6 | 1.3 | GO:0021773 | striatal medium spiny neuron differentiation(GO:0021773) |
0.6 | 2.5 | GO:2000382 | positive regulation of mesoderm development(GO:2000382) |
0.6 | 1.8 | GO:2000211 | regulation of glutamate metabolic process(GO:2000211) |
0.6 | 1.8 | GO:2000807 | regulation of synaptic vesicle clustering(GO:2000807) |
0.6 | 1.2 | GO:0097476 | motor neuron migration(GO:0097475) spinal cord motor neuron migration(GO:0097476) |
0.6 | 1.8 | GO:0061346 | non-canonical Wnt signaling pathway involved in heart development(GO:0061341) planar cell polarity pathway involved in heart morphogenesis(GO:0061346) |
0.6 | 1.7 | GO:2000302 | positive regulation of synaptic vesicle exocytosis(GO:2000302) |
0.5 | 1.6 | GO:1901536 | regulation of DNA demethylation(GO:1901535) negative regulation of DNA demethylation(GO:1901536) |
0.5 | 1.6 | GO:0009786 | regulation of asymmetric cell division(GO:0009786) |
0.5 | 2.0 | GO:0072307 | metanephric nephron tubule epithelial cell differentiation(GO:0072257) regulation of metanephric nephron tubule epithelial cell differentiation(GO:0072307) |
0.5 | 1.5 | GO:0021699 | cerebellar cortex maturation(GO:0021699) |
0.5 | 1.5 | GO:2000297 | negative regulation of synapse maturation(GO:2000297) |
0.5 | 4.4 | GO:0060012 | synaptic transmission, glycinergic(GO:0060012) |
0.5 | 1.9 | GO:2000741 | positive regulation of mesenchymal stem cell differentiation(GO:2000741) |
0.5 | 1.4 | GO:0046959 | habituation(GO:0046959) |
0.5 | 5.8 | GO:0007216 | G-protein coupled glutamate receptor signaling pathway(GO:0007216) |
0.5 | 0.5 | GO:0021559 | trigeminal nerve development(GO:0021559) |
0.5 | 1.4 | GO:0033693 | neurofilament bundle assembly(GO:0033693) |
0.5 | 1.4 | GO:1902513 | regulation of organelle transport along microtubule(GO:1902513) |
0.5 | 2.7 | GO:0090091 | positive regulation of extracellular matrix disassembly(GO:0090091) |
0.4 | 1.8 | GO:0031117 | positive regulation of microtubule depolymerization(GO:0031117) |
0.4 | 1.3 | GO:2000586 | regulation of platelet-derived growth factor receptor-beta signaling pathway(GO:2000586) negative regulation of platelet-derived growth factor receptor-beta signaling pathway(GO:2000587) |
0.4 | 1.3 | GO:0021586 | pons maturation(GO:0021586) |
0.4 | 1.3 | GO:0045608 | negative regulation of auditory receptor cell differentiation(GO:0045608) |
0.4 | 1.7 | GO:0061589 | calcium activated phosphatidylserine scrambling(GO:0061589) |
0.4 | 2.1 | GO:0001957 | intramembranous ossification(GO:0001957) direct ossification(GO:0036072) |
0.4 | 1.2 | GO:0048682 | axon extension involved in regeneration(GO:0048677) sprouting of injured axon(GO:0048682) |
0.4 | 0.8 | GO:0060061 | Spemann organizer formation(GO:0060061) |
0.4 | 1.6 | GO:0051464 | positive regulation of cortisol secretion(GO:0051464) |
0.4 | 1.6 | GO:0061743 | motor learning(GO:0061743) |
0.4 | 0.8 | GO:0060160 | negative regulation of dopamine receptor signaling pathway(GO:0060160) |
0.4 | 2.0 | GO:0021869 | forebrain ventricular zone progenitor cell division(GO:0021869) |
0.4 | 1.6 | GO:0071286 | cellular response to magnesium ion(GO:0071286) |
0.4 | 3.1 | GO:0097120 | receptor localization to synapse(GO:0097120) |
0.4 | 2.3 | GO:2000172 | regulation of branching morphogenesis of a nerve(GO:2000172) |
0.4 | 0.8 | GO:0050923 | regulation of negative chemotaxis(GO:0050923) |
0.4 | 1.9 | GO:0035469 | determination of pancreatic left/right asymmetry(GO:0035469) |
0.4 | 1.1 | GO:0090154 | positive regulation of sphingolipid biosynthetic process(GO:0090154) positive regulation of ceramide biosynthetic process(GO:2000304) |
0.4 | 1.1 | GO:0060535 | trachea cartilage morphogenesis(GO:0060535) |
0.4 | 1.1 | GO:0097503 | sialylation(GO:0097503) |
0.3 | 0.7 | GO:1904339 | negative regulation of dopaminergic neuron differentiation(GO:1904339) |
0.3 | 0.7 | GO:0003219 | cardiac right ventricle formation(GO:0003219) |
0.3 | 2.1 | GO:0048539 | bone marrow development(GO:0048539) |
0.3 | 1.4 | GO:0071698 | olfactory placode formation(GO:0030910) olfactory placode development(GO:0071698) olfactory placode morphogenesis(GO:0071699) |
0.3 | 3.8 | GO:1902287 | semaphorin-plexin signaling pathway involved in axon guidance(GO:1902287) |
0.3 | 1.0 | GO:0007208 | phospholipase C-activating serotonin receptor signaling pathway(GO:0007208) |
0.3 | 1.0 | GO:1902897 | regulation of postsynaptic density protein 95 clustering(GO:1902897) |
0.3 | 1.0 | GO:0046684 | response to pyrethroid(GO:0046684) |
0.3 | 1.0 | GO:0060596 | mammary placode formation(GO:0060596) |
0.3 | 0.3 | GO:1904861 | excitatory synapse assembly(GO:1904861) |
0.3 | 3.8 | GO:0035235 | ionotropic glutamate receptor signaling pathway(GO:0035235) |
0.3 | 0.6 | GO:0021912 | regulation of transcription from RNA polymerase II promoter involved in spinal cord motor neuron fate specification(GO:0021912) |
0.3 | 0.3 | GO:0061588 | calcium activated phospholipid scrambling(GO:0061588) calcium activated phosphatidylcholine scrambling(GO:0061590) calcium activated galactosylceramide scrambling(GO:0061591) |
0.3 | 1.2 | GO:0007258 | JUN phosphorylation(GO:0007258) |
0.3 | 0.3 | GO:0051795 | positive regulation of catagen(GO:0051795) |
0.3 | 0.9 | GO:0071879 | positive regulation of adrenergic receptor signaling pathway(GO:0071879) |
0.3 | 1.2 | GO:0060159 | regulation of dopamine receptor signaling pathway(GO:0060159) |
0.3 | 0.9 | GO:1902075 | cellular response to salt(GO:1902075) |
0.3 | 0.3 | GO:0072309 | mesenchymal stem cell maintenance involved in metanephric nephron morphogenesis(GO:0072309) |
0.3 | 1.5 | GO:0090244 | Wnt signaling pathway involved in somitogenesis(GO:0090244) |
0.3 | 1.5 | GO:0000160 | phosphorelay signal transduction system(GO:0000160) |
0.3 | 5.0 | GO:0001964 | startle response(GO:0001964) |
0.3 | 0.9 | GO:1901386 | negative regulation of voltage-gated calcium channel activity(GO:1901386) |
0.3 | 0.9 | GO:0032289 | central nervous system myelin formation(GO:0032289) |
0.3 | 0.6 | GO:0044340 | canonical Wnt signaling pathway involved in regulation of cell proliferation(GO:0044340) |
0.3 | 0.6 | GO:0061626 | pharyngeal arch artery morphogenesis(GO:0061626) |
0.3 | 0.9 | GO:1901843 | positive regulation of high voltage-gated calcium channel activity(GO:1901843) |
0.3 | 0.8 | GO:0002121 | inter-male aggressive behavior(GO:0002121) |
0.3 | 0.8 | GO:0090135 | actin filament branching(GO:0090135) |
0.3 | 3.1 | GO:0060080 | inhibitory postsynaptic potential(GO:0060080) |
0.3 | 1.4 | GO:2001023 | regulation of response to drug(GO:2001023) |
0.3 | 0.6 | GO:0071898 | regulation of estrogen receptor binding(GO:0071898) negative regulation of estrogen receptor binding(GO:0071899) |
0.3 | 1.6 | GO:0051823 | regulation of synapse structural plasticity(GO:0051823) |
0.3 | 1.1 | GO:0060385 | axonogenesis involved in innervation(GO:0060385) |
0.3 | 1.3 | GO:0050915 | sensory perception of sour taste(GO:0050915) |
0.3 | 14.6 | GO:0051965 | positive regulation of synapse assembly(GO:0051965) |
0.3 | 0.5 | GO:2000987 | regulation of fear response(GO:1903365) positive regulation of fear response(GO:1903367) regulation of behavioral fear response(GO:2000822) positive regulation of behavioral fear response(GO:2000987) |
0.3 | 0.3 | GO:0099558 | maintenance of synapse structure(GO:0099558) |
0.3 | 0.3 | GO:0021913 | regulation of transcription from RNA polymerase II promoter involved in ventral spinal cord interneuron specification(GO:0021913) |
0.3 | 0.8 | GO:1905098 | negative regulation of guanyl-nucleotide exchange factor activity(GO:1905098) |
0.3 | 1.8 | GO:0070571 | negative regulation of neuron projection regeneration(GO:0070571) |
0.3 | 1.3 | GO:0034047 | regulation of protein phosphatase type 2A activity(GO:0034047) |
0.3 | 1.3 | GO:0021860 | pyramidal neuron development(GO:0021860) |
0.3 | 0.8 | GO:0043985 | histone H4-R3 methylation(GO:0043985) |
0.3 | 0.8 | GO:0060023 | soft palate development(GO:0060023) |
0.2 | 3.2 | GO:0035640 | exploration behavior(GO:0035640) |
0.2 | 0.5 | GO:2001055 | positive regulation of mesenchymal cell apoptotic process(GO:2001055) |
0.2 | 0.7 | GO:0042126 | nitrate metabolic process(GO:0042126) |
0.2 | 0.5 | GO:0032097 | positive regulation of response to food(GO:0032097) positive regulation of appetite(GO:0032100) |
0.2 | 0.5 | GO:0060221 | retinal rod cell differentiation(GO:0060221) |
0.2 | 2.4 | GO:0031115 | negative regulation of microtubule polymerization(GO:0031115) |
0.2 | 0.2 | GO:0097119 | postsynaptic density protein 95 clustering(GO:0097119) |
0.2 | 0.2 | GO:0035524 | proline transmembrane transport(GO:0035524) |
0.2 | 0.9 | GO:0060179 | male mating behavior(GO:0060179) |
0.2 | 0.9 | GO:0035093 | spermatogenesis, exchange of chromosomal proteins(GO:0035093) |
0.2 | 0.5 | GO:1902805 | positive regulation of synaptic vesicle transport(GO:1902805) |
0.2 | 0.5 | GO:0010360 | negative regulation of anion channel activity(GO:0010360) |
0.2 | 0.5 | GO:0009448 | gamma-aminobutyric acid metabolic process(GO:0009448) |
0.2 | 0.5 | GO:0014722 | regulation of skeletal muscle contraction by calcium ion signaling(GO:0014722) |
0.2 | 0.7 | GO:0033122 | negative regulation of purine nucleotide catabolic process(GO:0033122) |
0.2 | 2.3 | GO:0047497 | establishment of mitochondrion localization, microtubule-mediated(GO:0034643) mitochondrion transport along microtubule(GO:0047497) |
0.2 | 0.5 | GO:0014053 | negative regulation of gamma-aminobutyric acid secretion(GO:0014053) |
0.2 | 0.9 | GO:0016198 | axon choice point recognition(GO:0016198) |
0.2 | 0.7 | GO:0060084 | synaptic transmission involved in micturition(GO:0060084) |
0.2 | 3.8 | GO:0048843 | negative regulation of axon extension involved in axon guidance(GO:0048843) negative regulation of axon guidance(GO:1902668) |
0.2 | 0.4 | GO:0060748 | tertiary branching involved in mammary gland duct morphogenesis(GO:0060748) |
0.2 | 0.4 | GO:0021698 | cerebellar cortex structural organization(GO:0021698) |
0.2 | 2.6 | GO:0022038 | corpus callosum development(GO:0022038) |
0.2 | 0.4 | GO:0021898 | commitment of multipotent stem cells to neuronal lineage in forebrain(GO:0021898) |
0.2 | 0.9 | GO:0010288 | response to lead ion(GO:0010288) |
0.2 | 0.9 | GO:0043587 | tongue morphogenesis(GO:0043587) |
0.2 | 0.6 | GO:0010499 | proteasomal ubiquitin-independent protein catabolic process(GO:0010499) |
0.2 | 16.6 | GO:0048704 | embryonic skeletal system morphogenesis(GO:0048704) |
0.2 | 1.7 | GO:0035881 | amacrine cell differentiation(GO:0035881) |
0.2 | 0.4 | GO:0051611 | negative regulation of neurotransmitter uptake(GO:0051581) regulation of serotonin uptake(GO:0051611) negative regulation of serotonin uptake(GO:0051612) |
0.2 | 0.2 | GO:0046532 | regulation of photoreceptor cell differentiation(GO:0046532) |
0.2 | 0.4 | GO:0071873 | response to norepinephrine(GO:0071873) |
0.2 | 0.4 | GO:2000705 | regulation of dense core granule biogenesis(GO:2000705) |
0.2 | 0.6 | GO:0070649 | formin-nucleated actin cable assembly(GO:0070649) |
0.2 | 1.9 | GO:0014051 | gamma-aminobutyric acid secretion(GO:0014051) |
0.2 | 1.2 | GO:0070092 | regulation of glucagon secretion(GO:0070092) |
0.2 | 0.6 | GO:0060279 | positive regulation of ovulation(GO:0060279) |
0.2 | 1.0 | GO:0060371 | regulation of atrial cardiac muscle cell membrane depolarization(GO:0060371) |
0.2 | 0.2 | GO:0048880 | sensory system development(GO:0048880) |
0.2 | 0.4 | GO:0071502 | cellular response to temperature stimulus(GO:0071502) |
0.2 | 0.2 | GO:0032079 | positive regulation of endodeoxyribonuclease activity(GO:0032079) |
0.2 | 0.6 | GO:0071895 | odontoblast differentiation(GO:0071895) |
0.2 | 0.6 | GO:0071651 | positive regulation of chemokine (C-C motif) ligand 5 production(GO:0071651) |
0.2 | 0.6 | GO:1990034 | calcium ion export from cell(GO:1990034) |
0.2 | 0.4 | GO:1904468 | negative regulation of tumor necrosis factor secretion(GO:1904468) |
0.2 | 1.1 | GO:2000650 | negative regulation of sodium ion transmembrane transporter activity(GO:2000650) |
0.2 | 0.4 | GO:0035262 | gonad morphogenesis(GO:0035262) |
0.2 | 0.7 | GO:0090394 | negative regulation of excitatory postsynaptic potential(GO:0090394) |
0.2 | 0.4 | GO:2001170 | negative regulation of ATP biosynthetic process(GO:2001170) |
0.2 | 2.0 | GO:0001504 | neurotransmitter uptake(GO:0001504) |
0.2 | 0.5 | GO:0048069 | eye pigmentation(GO:0048069) |
0.2 | 0.5 | GO:0021979 | hypothalamus cell differentiation(GO:0021979) |
0.2 | 0.4 | GO:2001137 | positive regulation of endocytic recycling(GO:2001137) |
0.2 | 0.5 | GO:0030167 | proteoglycan catabolic process(GO:0030167) |
0.2 | 0.9 | GO:0060040 | retinal bipolar neuron differentiation(GO:0060040) |
0.2 | 0.5 | GO:0060478 | acrosomal vesicle exocytosis(GO:0060478) |
0.2 | 0.3 | GO:0060687 | regulation of branching involved in prostate gland morphogenesis(GO:0060687) |
0.2 | 0.5 | GO:0045048 | protein insertion into ER membrane(GO:0045048) tail-anchored membrane protein insertion into ER membrane(GO:0071816) |
0.2 | 0.9 | GO:0034638 | phosphatidylcholine catabolic process(GO:0034638) |
0.2 | 0.3 | GO:2000821 | regulation of grooming behavior(GO:2000821) |
0.2 | 0.3 | GO:0002175 | protein localization to paranode region of axon(GO:0002175) |
0.2 | 0.3 | GO:0046958 | nonassociative learning(GO:0046958) |
0.2 | 0.5 | GO:0033278 | cell proliferation in midbrain(GO:0033278) |
0.2 | 1.9 | GO:0071526 | semaphorin-plexin signaling pathway(GO:0071526) |
0.2 | 0.7 | GO:2000767 | positive regulation of cytoplasmic translation(GO:2000767) |
0.2 | 0.2 | GO:0009756 | carbohydrate mediated signaling(GO:0009756) hexose mediated signaling(GO:0009757) sugar mediated signaling pathway(GO:0010182) glucose mediated signaling pathway(GO:0010255) |
0.2 | 0.7 | GO:0061302 | smooth muscle cell-matrix adhesion(GO:0061302) |
0.2 | 0.3 | GO:0061113 | pancreas morphogenesis(GO:0061113) |
0.2 | 1.0 | GO:0090527 | actin filament reorganization(GO:0090527) |
0.2 | 1.0 | GO:0042118 | endothelial cell activation(GO:0042118) |
0.2 | 0.5 | GO:0032474 | otolith morphogenesis(GO:0032474) |
0.2 | 0.3 | GO:0018197 | peptidyl-aspartic acid modification(GO:0018197) |
0.2 | 0.5 | GO:0000087 | mitotic M phase(GO:0000087) |
0.2 | 0.5 | GO:0009629 | response to gravity(GO:0009629) |
0.2 | 0.3 | GO:0042706 | eye photoreceptor cell fate commitment(GO:0042706) photoreceptor cell fate commitment(GO:0046552) |
0.2 | 1.3 | GO:0019800 | peptide cross-linking via chondroitin 4-sulfate glycosaminoglycan(GO:0019800) |
0.2 | 0.3 | GO:0000720 | pyrimidine dimer repair by nucleotide-excision repair(GO:0000720) |
0.2 | 0.3 | GO:0035359 | negative regulation of peroxisome proliferator activated receptor signaling pathway(GO:0035359) |
0.2 | 0.5 | GO:0035021 | negative regulation of Rac protein signal transduction(GO:0035021) |
0.2 | 0.3 | GO:0035095 | behavioral response to nicotine(GO:0035095) |
0.2 | 0.3 | GO:0030421 | defecation(GO:0030421) |
0.2 | 0.5 | GO:0060024 | rhythmic synaptic transmission(GO:0060024) |
0.2 | 0.5 | GO:0030916 | otic vesicle formation(GO:0030916) |
0.2 | 1.7 | GO:2000193 | positive regulation of fatty acid transport(GO:2000193) |
0.2 | 1.7 | GO:2000311 | regulation of alpha-amino-3-hydroxy-5-methyl-4-isoxazole propionate selective glutamate receptor activity(GO:2000311) |
0.2 | 0.2 | GO:1904338 | regulation of dopaminergic neuron differentiation(GO:1904338) |
0.2 | 0.9 | GO:0030432 | peristalsis(GO:0030432) |
0.2 | 0.5 | GO:0021555 | midbrain-hindbrain boundary morphogenesis(GO:0021555) |
0.2 | 0.6 | GO:0033504 | floor plate development(GO:0033504) |
0.2 | 0.5 | GO:0060573 | ventral spinal cord interneuron specification(GO:0021521) cell fate specification involved in pattern specification(GO:0060573) |
0.2 | 1.4 | GO:0042983 | amyloid precursor protein biosynthetic process(GO:0042983) regulation of amyloid precursor protein biosynthetic process(GO:0042984) |
0.2 | 0.3 | GO:0035461 | vitamin transmembrane transport(GO:0035461) |
0.1 | 0.3 | GO:0021937 | cerebellar Purkinje cell-granule cell precursor cell signaling involved in regulation of granule cell precursor cell proliferation(GO:0021937) |
0.1 | 3.4 | GO:0048706 | embryonic skeletal system development(GO:0048706) |
0.1 | 0.7 | GO:0031915 | positive regulation of synaptic plasticity(GO:0031915) |
0.1 | 0.7 | GO:0033564 | anterior/posterior axon guidance(GO:0033564) |
0.1 | 2.0 | GO:0016486 | peptide hormone processing(GO:0016486) |
0.1 | 0.3 | GO:0016259 | selenocysteine metabolic process(GO:0016259) |
0.1 | 0.4 | GO:1903026 | negative regulation of RNA polymerase II regulatory region sequence-specific DNA binding(GO:1903026) |
0.1 | 2.0 | GO:0032012 | ARF protein signal transduction(GO:0032011) regulation of ARF protein signal transduction(GO:0032012) |
0.1 | 0.1 | GO:1902308 | regulation of peptidyl-serine dephosphorylation(GO:1902308) |
0.1 | 0.4 | GO:2000354 | regulation of ovarian follicle development(GO:2000354) |
0.1 | 0.3 | GO:0032831 | positive regulation of CD4-positive, CD25-positive, alpha-beta regulatory T cell differentiation(GO:0032831) |
0.1 | 0.4 | GO:1901844 | regulation of cell communication by electrical coupling involved in cardiac conduction(GO:1901844) |
0.1 | 0.8 | GO:0015816 | glycine transport(GO:0015816) |
0.1 | 0.1 | GO:0098902 | regulation of membrane depolarization during action potential(GO:0098902) |
0.1 | 0.5 | GO:2001258 | negative regulation of cation channel activity(GO:2001258) |
0.1 | 0.3 | GO:0030917 | midbrain-hindbrain boundary development(GO:0030917) |
0.1 | 0.3 | GO:1902498 | regulation of protein autoubiquitination(GO:1902498) |
0.1 | 0.4 | GO:0031585 | regulation of inositol 1,4,5-trisphosphate-sensitive calcium-release channel activity(GO:0031585) |
0.1 | 0.5 | GO:2000463 | positive regulation of excitatory postsynaptic potential(GO:2000463) |
0.1 | 0.5 | GO:0033689 | negative regulation of osteoblast proliferation(GO:0033689) |
0.1 | 0.4 | GO:0002087 | regulation of respiratory gaseous exchange by neurological system process(GO:0002087) |
0.1 | 0.4 | GO:0034729 | histone H3-K79 methylation(GO:0034729) |
0.1 | 0.4 | GO:1904222 | regulation of CDP-diacylglycerol-serine O-phosphatidyltransferase activity(GO:1904217) positive regulation of CDP-diacylglycerol-serine O-phosphatidyltransferase activity(GO:1904219) regulation of serine C-palmitoyltransferase activity(GO:1904220) positive regulation of serine C-palmitoyltransferase activity(GO:1904222) |
0.1 | 0.4 | GO:0010046 | response to mycotoxin(GO:0010046) |
0.1 | 0.4 | GO:0051388 | positive regulation of neurotrophin TRK receptor signaling pathway(GO:0051388) |
0.1 | 0.1 | GO:0045794 | negative regulation of cell volume(GO:0045794) |
0.1 | 0.8 | GO:0043951 | negative regulation of cAMP-mediated signaling(GO:0043951) |
0.1 | 0.4 | GO:0015747 | urate transport(GO:0015747) |
0.1 | 0.1 | GO:0045632 | negative regulation of mechanoreceptor differentiation(GO:0045632) negative regulation of inner ear receptor cell differentiation(GO:2000981) |
0.1 | 0.3 | GO:0048934 | peripheral nervous system neuron differentiation(GO:0048934) peripheral nervous system neuron development(GO:0048935) |
0.1 | 0.3 | GO:0010520 | regulation of reciprocal meiotic recombination(GO:0010520) |
0.1 | 0.3 | GO:2000574 | regulation of microtubule motor activity(GO:2000574) |
0.1 | 1.3 | GO:0060065 | uterus development(GO:0060065) |
0.1 | 0.5 | GO:0051365 | cellular response to potassium ion starvation(GO:0051365) |
0.1 | 0.4 | GO:1900368 | regulation of RNA interference(GO:1900368) |
0.1 | 0.5 | GO:0046600 | negative regulation of centriole replication(GO:0046600) |
0.1 | 0.4 | GO:0006438 | valyl-tRNA aminoacylation(GO:0006438) |
0.1 | 1.8 | GO:0048026 | positive regulation of mRNA splicing, via spliceosome(GO:0048026) |
0.1 | 2.0 | GO:0071475 | cellular hyperosmotic salinity response(GO:0071475) |
0.1 | 0.5 | GO:2000504 | positive regulation of blood vessel remodeling(GO:2000504) |
0.1 | 0.6 | GO:0048672 | positive regulation of collateral sprouting(GO:0048672) |
0.1 | 0.2 | GO:0042713 | sperm ejaculation(GO:0042713) |
0.1 | 2.0 | GO:0007214 | gamma-aminobutyric acid signaling pathway(GO:0007214) |
0.1 | 0.5 | GO:0050812 | regulation of acetyl-CoA biosynthetic process from pyruvate(GO:0010510) regulation of acyl-CoA biosynthetic process(GO:0050812) |
0.1 | 0.5 | GO:0008635 | activation of cysteine-type endopeptidase activity involved in apoptotic process by cytochrome c(GO:0008635) |
0.1 | 0.6 | GO:0060836 | lymphatic endothelial cell differentiation(GO:0060836) |
0.1 | 0.1 | GO:0061043 | regulation of vascular wound healing(GO:0061043) |
0.1 | 0.1 | GO:0097029 | mature conventional dendritic cell differentiation(GO:0097029) |
0.1 | 0.7 | GO:0042866 | pyruvate biosynthetic process(GO:0042866) |
0.1 | 0.3 | GO:2000474 | regulation of opioid receptor signaling pathway(GO:2000474) |
0.1 | 0.5 | GO:1903361 | protein localization to basolateral plasma membrane(GO:1903361) |
0.1 | 0.5 | GO:0015015 | heparan sulfate proteoglycan biosynthetic process, enzymatic modification(GO:0015015) |
0.1 | 1.8 | GO:0035335 | peptidyl-tyrosine dephosphorylation(GO:0035335) |
0.1 | 0.7 | GO:0016339 | calcium-dependent cell-cell adhesion via plasma membrane cell adhesion molecules(GO:0016339) |
0.1 | 0.7 | GO:0031937 | positive regulation of chromatin silencing(GO:0031937) |
0.1 | 0.9 | GO:0007168 | receptor guanylyl cyclase signaling pathway(GO:0007168) |
0.1 | 0.2 | GO:0072092 | ureteric bud invasion(GO:0072092) |
0.1 | 0.1 | GO:0060842 | arterial endothelial cell differentiation(GO:0060842) |
0.1 | 0.6 | GO:0021520 | spinal cord motor neuron cell fate specification(GO:0021520) |
0.1 | 0.4 | GO:0032202 | telomere assembly(GO:0032202) |
0.1 | 0.3 | GO:0072429 | response to intra-S DNA damage checkpoint signaling(GO:0072429) |
0.1 | 1.9 | GO:0060219 | camera-type eye photoreceptor cell differentiation(GO:0060219) |
0.1 | 0.1 | GO:0072497 | mesenchymal stem cell differentiation(GO:0072497) |
0.1 | 0.2 | GO:0060672 | epithelial cell differentiation involved in embryonic placenta development(GO:0060671) epithelial cell morphogenesis involved in placental branching(GO:0060672) |
0.1 | 0.4 | GO:0097500 | receptor localization to nonmotile primary cilium(GO:0097500) |
0.1 | 0.4 | GO:0035090 | maintenance of apical/basal cell polarity(GO:0035090) |
0.1 | 0.2 | GO:0060648 | mammary gland bud morphogenesis(GO:0060648) |
0.1 | 2.3 | GO:0021680 | cerebellar Purkinje cell layer development(GO:0021680) |
0.1 | 0.3 | GO:0072318 | clathrin coat disassembly(GO:0072318) |
0.1 | 0.3 | GO:0038030 | non-canonical Wnt signaling pathway via MAPK cascade(GO:0038030) |
0.1 | 0.5 | GO:0015884 | folic acid transport(GO:0015884) |
0.1 | 0.5 | GO:0070314 | G1 to G0 transition(GO:0070314) |
0.1 | 0.1 | GO:2000852 | corticosterone secretion(GO:0035934) regulation of corticosterone secretion(GO:2000852) |
0.1 | 1.1 | GO:0060384 | innervation(GO:0060384) |
0.1 | 1.1 | GO:0090103 | cochlea morphogenesis(GO:0090103) |
0.1 | 0.3 | GO:0060743 | epithelial cell maturation involved in prostate gland development(GO:0060743) |
0.1 | 0.3 | GO:0042160 | plasma lipoprotein particle oxidation(GO:0034441) lipoprotein modification(GO:0042160) lipoprotein oxidation(GO:0042161) |
0.1 | 0.3 | GO:0006420 | arginyl-tRNA aminoacylation(GO:0006420) |
0.1 | 0.1 | GO:1904948 | midbrain dopaminergic neuron differentiation(GO:1904948) |
0.1 | 0.7 | GO:1902018 | negative regulation of cilium assembly(GO:1902018) |
0.1 | 0.3 | GO:0021891 | olfactory bulb interneuron development(GO:0021891) |
0.1 | 0.3 | GO:1902268 | negative regulation of polyamine transmembrane transport(GO:1902268) |
0.1 | 0.4 | GO:0061668 | mitochondrial ribosome assembly(GO:0061668) |
0.1 | 0.5 | GO:0098908 | regulation of neuronal action potential(GO:0098908) |
0.1 | 0.2 | GO:0042414 | epinephrine metabolic process(GO:0042414) |
0.1 | 0.4 | GO:0070120 | ciliary neurotrophic factor-mediated signaling pathway(GO:0070120) |
0.1 | 0.4 | GO:1900109 | regulation of histone H3-K9 dimethylation(GO:1900109) |
0.1 | 0.2 | GO:0014734 | skeletal muscle hypertrophy(GO:0014734) |
0.1 | 0.6 | GO:0048251 | elastic fiber assembly(GO:0048251) |
0.1 | 1.7 | GO:0036465 | synaptic vesicle recycling(GO:0036465) |
0.1 | 0.7 | GO:0019732 | antifungal humoral response(GO:0019732) |
0.1 | 0.2 | GO:0051654 | establishment of mitochondrion localization(GO:0051654) |
0.1 | 1.1 | GO:0050884 | neuromuscular process controlling posture(GO:0050884) |
0.1 | 0.3 | GO:1900452 | regulation of long term synaptic depression(GO:1900452) |
0.1 | 0.4 | GO:0071316 | cellular response to nicotine(GO:0071316) |
0.1 | 0.7 | GO:0030903 | notochord development(GO:0030903) |
0.1 | 0.1 | GO:1900019 | regulation of protein kinase C activity(GO:1900019) positive regulation of protein kinase C activity(GO:1900020) |
0.1 | 0.5 | GO:0048715 | negative regulation of oligodendrocyte differentiation(GO:0048715) |
0.1 | 2.1 | GO:0048013 | ephrin receptor signaling pathway(GO:0048013) |
0.1 | 0.3 | GO:0070634 | transepithelial ammonium transport(GO:0070634) |
0.1 | 0.3 | GO:0048254 | snoRNA localization(GO:0048254) |
0.1 | 0.4 | GO:0006551 | leucine metabolic process(GO:0006551) |
0.1 | 0.3 | GO:0060363 | cranial suture morphogenesis(GO:0060363) |
0.1 | 0.5 | GO:0042769 | DNA damage response, detection of DNA damage(GO:0042769) |
0.1 | 0.5 | GO:0097264 | self proteolysis(GO:0097264) |
0.1 | 0.6 | GO:0071557 | histone H3-K27 demethylation(GO:0071557) |
0.1 | 0.2 | GO:0002051 | osteoblast fate commitment(GO:0002051) |
0.1 | 1.9 | GO:0060997 | dendritic spine morphogenesis(GO:0060997) |
0.1 | 0.2 | GO:0010535 | positive regulation of activation of JAK2 kinase activity(GO:0010535) |
0.1 | 0.1 | GO:0044062 | regulation of excretion(GO:0044062) |
0.1 | 0.4 | GO:0090273 | regulation of somatostatin secretion(GO:0090273) |
0.1 | 0.6 | GO:0007191 | adenylate cyclase-activating dopamine receptor signaling pathway(GO:0007191) |
0.1 | 0.2 | GO:0070317 | negative regulation of G0 to G1 transition(GO:0070317) |
0.1 | 0.8 | GO:0080182 | histone H3-K4 trimethylation(GO:0080182) |
0.1 | 0.7 | GO:0070417 | cellular response to cold(GO:0070417) |
0.1 | 0.1 | GO:1903336 | negative regulation of vacuolar transport(GO:1903336) |
0.1 | 0.1 | GO:0071907 | determination of digestive tract left/right asymmetry(GO:0071907) |
0.1 | 0.4 | GO:0045908 | negative regulation of vasodilation(GO:0045908) |
0.1 | 0.3 | GO:0032066 | nucleolus to nucleoplasm transport(GO:0032066) |
0.1 | 0.3 | GO:0061623 | galactose catabolic process via UDP-galactose(GO:0033499) glycolytic process from galactose(GO:0061623) |
0.1 | 0.2 | GO:1903215 | negative regulation of protein targeting to mitochondrion(GO:1903215) |
0.1 | 0.1 | GO:0048669 | collateral sprouting in absence of injury(GO:0048669) |
0.1 | 2.5 | GO:0000381 | regulation of alternative mRNA splicing, via spliceosome(GO:0000381) |
0.1 | 0.4 | GO:0032512 | regulation of protein phosphatase type 2B activity(GO:0032512) |
0.1 | 0.2 | GO:1900620 | acetylcholine biosynthetic process(GO:0008292) acetate ester biosynthetic process(GO:1900620) |
0.1 | 0.2 | GO:0015888 | thiamine transport(GO:0015888) |
0.1 | 0.2 | GO:1902019 | regulation of cilium movement involved in cell motility(GO:0060295) regulation of cilium beat frequency involved in ciliary motility(GO:0060296) regulation of cilium-dependent cell motility(GO:1902019) |
0.1 | 0.1 | GO:0008065 | establishment of blood-nerve barrier(GO:0008065) |
0.1 | 0.3 | GO:2000535 | entry of bacterium into host cell(GO:0035635) regulation of entry of bacterium into host cell(GO:2000535) |
0.1 | 1.2 | GO:0048025 | negative regulation of mRNA splicing, via spliceosome(GO:0048025) |
0.1 | 0.3 | GO:0001983 | baroreceptor response to increased systemic arterial blood pressure(GO:0001983) |
0.1 | 0.9 | GO:0035563 | positive regulation of chromatin binding(GO:0035563) |
0.1 | 0.3 | GO:0042891 | antibiotic transport(GO:0042891) |
0.1 | 0.2 | GO:0060129 | thyroid-stimulating hormone-secreting cell differentiation(GO:0060129) |
0.1 | 0.4 | GO:0070163 | adiponectin secretion(GO:0070162) regulation of adiponectin secretion(GO:0070163) |
0.1 | 0.1 | GO:0016479 | negative regulation of transcription from RNA polymerase I promoter(GO:0016479) |
0.1 | 0.7 | GO:0071243 | cellular response to arsenic-containing substance(GO:0071243) |
0.1 | 0.2 | GO:1903377 | negative regulation of oxidative stress-induced neuron intrinsic apoptotic signaling pathway(GO:1903377) |
0.1 | 0.1 | GO:1990035 | calcium ion import into cell(GO:1990035) |
0.1 | 0.2 | GO:0060406 | positive regulation of penile erection(GO:0060406) |
0.1 | 1.8 | GO:0045687 | positive regulation of glial cell differentiation(GO:0045687) |
0.1 | 0.2 | GO:0090102 | cochlea development(GO:0090102) |
0.1 | 0.2 | GO:0046951 | ketone body biosynthetic process(GO:0046951) |
0.1 | 0.7 | GO:0046069 | cGMP catabolic process(GO:0046069) |
0.1 | 0.1 | GO:0055075 | potassium ion homeostasis(GO:0055075) |
0.1 | 0.1 | GO:0060591 | chondroblast differentiation(GO:0060591) |
0.1 | 0.2 | GO:1902309 | negative regulation of peptidyl-serine dephosphorylation(GO:1902309) |
0.1 | 0.2 | GO:0072051 | juxtaglomerular apparatus development(GO:0072051) |
0.1 | 0.2 | GO:0060112 | generation of ovulation cycle rhythm(GO:0060112) |
0.1 | 0.3 | GO:0035280 | miRNA loading onto RISC involved in gene silencing by miRNA(GO:0035280) |
0.1 | 0.2 | GO:1900112 | regulation of histone H3-K9 trimethylation(GO:1900112) |
0.1 | 0.2 | GO:0015820 | branched-chain amino acid transport(GO:0015803) leucine transport(GO:0015820) |
0.1 | 0.7 | GO:0070050 | neuron cellular homeostasis(GO:0070050) |
0.1 | 0.9 | GO:0015813 | L-glutamate transport(GO:0015813) |
0.1 | 0.2 | GO:0019747 | regulation of isoprenoid metabolic process(GO:0019747) |
0.1 | 0.1 | GO:0031943 | regulation of glucocorticoid metabolic process(GO:0031943) |
0.1 | 1.3 | GO:0032094 | response to food(GO:0032094) |
0.1 | 0.2 | GO:0035434 | copper ion transmembrane transport(GO:0035434) |
0.1 | 0.1 | GO:0006701 | progesterone biosynthetic process(GO:0006701) |
0.1 | 0.2 | GO:0097105 | presynaptic membrane assembly(GO:0097105) |
0.1 | 0.3 | GO:0046618 | drug export(GO:0046618) |
0.1 | 0.5 | GO:0045176 | apical protein localization(GO:0045176) |
0.1 | 0.2 | GO:0007158 | neuron cell-cell adhesion(GO:0007158) |
0.1 | 0.2 | GO:0015744 | succinate transport(GO:0015744) |
0.1 | 0.1 | GO:0007386 | compartment pattern specification(GO:0007386) |
0.1 | 0.3 | GO:0010587 | miRNA catabolic process(GO:0010587) |
0.1 | 0.7 | GO:0019372 | lipoxygenase pathway(GO:0019372) |
0.1 | 0.4 | GO:0072610 | interleukin-12 secretion(GO:0072610) |
0.1 | 0.1 | GO:0071692 | protein localization to extracellular region(GO:0071692) maintenance of protein location in extracellular region(GO:0071694) |
0.1 | 0.1 | GO:0030908 | intein-mediated protein splicing(GO:0016539) protein splicing(GO:0030908) |
0.1 | 0.1 | GO:0035747 | natural killer cell chemotaxis(GO:0035747) regulation of natural killer cell chemotaxis(GO:2000501) positive regulation of natural killer cell chemotaxis(GO:2000503) |
0.1 | 0.1 | GO:0042524 | negative regulation of tyrosine phosphorylation of Stat5 protein(GO:0042524) |
0.1 | 0.2 | GO:0010982 | regulation of high-density lipoprotein particle clearance(GO:0010982) |
0.1 | 0.1 | GO:0021999 | neural plate anterior/posterior regionalization(GO:0021999) |
0.1 | 0.4 | GO:0042796 | snRNA transcription from RNA polymerase III promoter(GO:0042796) |
0.1 | 0.2 | GO:1901491 | negative regulation of lymphangiogenesis(GO:1901491) |
0.1 | 0.2 | GO:0001777 | T cell homeostatic proliferation(GO:0001777) regulation of T cell homeostatic proliferation(GO:0046013) |
0.1 | 0.6 | GO:0048169 | regulation of long-term neuronal synaptic plasticity(GO:0048169) |
0.1 | 1.9 | GO:0030514 | negative regulation of BMP signaling pathway(GO:0030514) |
0.1 | 0.1 | GO:0010446 | response to alkaline pH(GO:0010446) |
0.1 | 0.3 | GO:0002636 | positive regulation of germinal center formation(GO:0002636) |
0.1 | 0.3 | GO:0048003 | antigen processing and presentation of lipid antigen via MHC class Ib(GO:0048003) antigen processing and presentation, exogenous lipid antigen via MHC class Ib(GO:0048007) |
0.1 | 0.1 | GO:1905097 | regulation of guanyl-nucleotide exchange factor activity(GO:1905097) |
0.1 | 0.3 | GO:0045542 | positive regulation of cholesterol biosynthetic process(GO:0045542) positive regulation of cholesterol metabolic process(GO:0090205) |
0.1 | 0.8 | GO:0097320 | membrane tubulation(GO:0097320) |
0.1 | 0.1 | GO:0043553 | negative regulation of phosphatidylinositol 3-kinase activity(GO:0043553) |
0.1 | 0.3 | GO:1900016 | negative regulation of cytokine production involved in inflammatory response(GO:1900016) |
0.1 | 1.2 | GO:0006921 | cellular component disassembly involved in execution phase of apoptosis(GO:0006921) apoptotic nuclear changes(GO:0030262) |
0.1 | 0.3 | GO:0010745 | negative regulation of macrophage derived foam cell differentiation(GO:0010745) |
0.1 | 0.3 | GO:0036159 | inner dynein arm assembly(GO:0036159) |
0.1 | 0.4 | GO:0090308 | regulation of methylation-dependent chromatin silencing(GO:0090308) |
0.1 | 0.5 | GO:0006108 | malate metabolic process(GO:0006108) |
0.1 | 0.8 | GO:0043248 | proteasome assembly(GO:0043248) |
0.1 | 0.4 | GO:0006337 | nucleosome disassembly(GO:0006337) protein-DNA complex disassembly(GO:0032986) |
0.1 | 0.3 | GO:1901621 | negative regulation of smoothened signaling pathway involved in dorsal/ventral neural tube patterning(GO:1901621) |
0.1 | 0.4 | GO:0060732 | positive regulation of inositol phosphate biosynthetic process(GO:0060732) |
0.1 | 0.2 | GO:0006177 | GMP biosynthetic process(GO:0006177) |
0.1 | 0.2 | GO:0071332 | cellular response to fructose stimulus(GO:0071332) |
0.1 | 0.1 | GO:1902606 | regulation of large conductance calcium-activated potassium channel activity(GO:1902606) positive regulation of large conductance calcium-activated potassium channel activity(GO:1902608) |
0.1 | 0.3 | GO:0060768 | epithelial cell proliferation involved in prostate gland development(GO:0060767) regulation of epithelial cell proliferation involved in prostate gland development(GO:0060768) |
0.1 | 0.2 | GO:0090290 | positive regulation of osteoclast proliferation(GO:0090290) |
0.1 | 0.1 | GO:0072553 | terminal button organization(GO:0072553) |
0.1 | 0.3 | GO:0000012 | single strand break repair(GO:0000012) |
0.1 | 0.2 | GO:1902894 | negative regulation of pri-miRNA transcription from RNA polymerase II promoter(GO:1902894) |
0.1 | 0.1 | GO:0038128 | ERBB2 signaling pathway(GO:0038128) |
0.1 | 0.6 | GO:0033523 | histone H2B ubiquitination(GO:0033523) |
0.1 | 0.2 | GO:0038044 | transforming growth factor-beta secretion(GO:0038044) regulation of transforming growth factor-beta secretion(GO:2001201) |
0.1 | 0.2 | GO:0032808 | lacrimal gland development(GO:0032808) |
0.1 | 0.3 | GO:0006654 | phosphatidic acid biosynthetic process(GO:0006654) |
0.1 | 0.1 | GO:0033578 | protein glycosylation in Golgi(GO:0033578) |
0.1 | 0.1 | GO:1900186 | negative regulation of clathrin-mediated endocytosis(GO:1900186) |
0.1 | 0.1 | GO:1903849 | regulation of aorta morphogenesis(GO:1903847) positive regulation of aorta morphogenesis(GO:1903849) |
0.1 | 0.1 | GO:0033603 | positive regulation of dopamine secretion(GO:0033603) |
0.1 | 0.6 | GO:0031507 | heterochromatin assembly(GO:0031507) |
0.1 | 0.2 | GO:0060020 | Bergmann glial cell differentiation(GO:0060020) |
0.1 | 0.1 | GO:0039534 | negative regulation of MDA-5 signaling pathway(GO:0039534) |
0.1 | 0.5 | GO:1990403 | embryonic brain development(GO:1990403) |
0.1 | 0.2 | GO:0006477 | protein sulfation(GO:0006477) |
0.1 | 0.8 | GO:0030204 | chondroitin sulfate metabolic process(GO:0030204) |
0.1 | 0.3 | GO:0007614 | short-term memory(GO:0007614) |
0.1 | 0.2 | GO:0043578 | nuclear matrix organization(GO:0043578) nuclear matrix anchoring at nuclear membrane(GO:0090292) |
0.1 | 0.1 | GO:0090271 | positive regulation of fibroblast growth factor production(GO:0090271) |
0.1 | 0.1 | GO:2000847 | negative regulation of steroid hormone secretion(GO:2000832) negative regulation of corticosteroid hormone secretion(GO:2000847) negative regulation of glucocorticoid secretion(GO:2000850) |
0.1 | 2.6 | GO:1901379 | regulation of potassium ion transmembrane transport(GO:1901379) |
0.1 | 0.1 | GO:0007442 | hindgut morphogenesis(GO:0007442) |
0.1 | 1.2 | GO:0046928 | regulation of neurotransmitter secretion(GO:0046928) |
0.1 | 0.3 | GO:0035810 | positive regulation of urine volume(GO:0035810) |
0.1 | 0.3 | GO:0075525 | viral translational termination-reinitiation(GO:0075525) |
0.1 | 0.2 | GO:0002326 | B cell lineage commitment(GO:0002326) |
0.1 | 0.3 | GO:0046836 | glycolipid transport(GO:0046836) |
0.1 | 0.1 | GO:0060700 | regulation of ribonuclease activity(GO:0060700) |
0.1 | 0.1 | GO:0032025 | response to cobalt ion(GO:0032025) |
0.1 | 0.1 | GO:0014901 | regulation of satellite cell activation involved in skeletal muscle regeneration(GO:0014717) satellite cell activation involved in skeletal muscle regeneration(GO:0014901) |
0.1 | 0.8 | GO:0030322 | stabilization of membrane potential(GO:0030322) |
0.1 | 0.2 | GO:0045955 | negative regulation of calcium ion-dependent exocytosis(GO:0045955) |
0.1 | 0.1 | GO:1902809 | regulation of skeletal muscle fiber differentiation(GO:1902809) |
0.1 | 0.6 | GO:0016082 | synaptic vesicle priming(GO:0016082) |
0.1 | 0.2 | GO:1902284 | axon extension involved in axon guidance(GO:0048846) neuron projection extension involved in neuron projection guidance(GO:1902284) |
0.1 | 0.2 | GO:1900086 | positive regulation of peptidyl-tyrosine autophosphorylation(GO:1900086) |
0.1 | 0.4 | GO:0006020 | inositol metabolic process(GO:0006020) |
0.1 | 0.2 | GO:0060339 | negative regulation of type I interferon-mediated signaling pathway(GO:0060339) |
0.1 | 0.1 | GO:0050689 | negative regulation of defense response to virus by host(GO:0050689) |
0.1 | 0.2 | GO:0071420 | cellular response to histamine(GO:0071420) |
0.1 | 0.4 | GO:2000010 | positive regulation of protein localization to cell surface(GO:2000010) |
0.1 | 0.1 | GO:0021859 | pyramidal neuron differentiation(GO:0021859) |
0.1 | 0.6 | GO:0045879 | negative regulation of smoothened signaling pathway(GO:0045879) |
0.1 | 0.1 | GO:0002025 | vasodilation by norepinephrine-epinephrine involved in regulation of systemic arterial blood pressure(GO:0002025) |
0.1 | 1.2 | GO:0018345 | protein palmitoylation(GO:0018345) |
0.1 | 0.1 | GO:0098532 | histone H3-K27 trimethylation(GO:0098532) |
0.1 | 0.2 | GO:0035521 | monoubiquitinated histone deubiquitination(GO:0035521) monoubiquitinated histone H2A deubiquitination(GO:0035522) |
0.1 | 0.4 | GO:0031290 | retinal ganglion cell axon guidance(GO:0031290) |
0.1 | 0.1 | GO:0042321 | negative regulation of circadian sleep/wake cycle, sleep(GO:0042321) |
0.1 | 0.3 | GO:0032410 | negative regulation of transporter activity(GO:0032410) |
0.1 | 0.1 | GO:0051105 | regulation of DNA ligation(GO:0051105) positive regulation of DNA ligation(GO:0051106) |
0.1 | 0.1 | GO:0014016 | neuroblast differentiation(GO:0014016) |
0.1 | 0.3 | GO:0035414 | negative regulation of catenin import into nucleus(GO:0035414) |
0.1 | 0.2 | GO:0045074 | interleukin-10 biosynthetic process(GO:0042091) regulation of interleukin-10 biosynthetic process(GO:0045074) |
0.1 | 3.7 | GO:0007156 | homophilic cell adhesion via plasma membrane adhesion molecules(GO:0007156) |
0.1 | 0.3 | GO:0036289 | peptidyl-serine autophosphorylation(GO:0036289) |
0.1 | 0.2 | GO:0070889 | platelet alpha granule organization(GO:0070889) |
0.1 | 0.9 | GO:0051489 | regulation of filopodium assembly(GO:0051489) |
0.1 | 0.4 | GO:0042760 | very long-chain fatty acid catabolic process(GO:0042760) |
0.1 | 0.1 | GO:0035990 | tendon cell differentiation(GO:0035990) tendon formation(GO:0035992) |
0.1 | 0.2 | GO:0000056 | ribosomal small subunit export from nucleus(GO:0000056) |
0.1 | 0.1 | GO:0042939 | glutathione transport(GO:0034635) tripeptide transport(GO:0042939) |
0.1 | 0.3 | GO:0007220 | Notch receptor processing(GO:0007220) |
0.1 | 0.2 | GO:0044828 | negative regulation by host of viral genome replication(GO:0044828) |
0.1 | 0.3 | GO:0030953 | astral microtubule organization(GO:0030953) |
0.1 | 0.1 | GO:1902730 | regulation of heparan sulfate proteoglycan biosynthetic process(GO:0010908) positive regulation of heparan sulfate proteoglycan biosynthetic process(GO:0010909) positive regulation of proteoglycan biosynthetic process(GO:1902730) |
0.1 | 0.2 | GO:0048387 | negative regulation of retinoic acid receptor signaling pathway(GO:0048387) |
0.1 | 0.2 | GO:0018094 | protein polyglycylation(GO:0018094) |
0.1 | 0.7 | GO:0032401 | establishment of melanosome localization(GO:0032401) |
0.0 | 0.3 | GO:0002063 | chondrocyte development(GO:0002063) |
0.0 | 0.1 | GO:0051386 | regulation of neurotrophin TRK receptor signaling pathway(GO:0051386) |
0.0 | 0.2 | GO:0035814 | negative regulation of renal sodium excretion(GO:0035814) |
0.0 | 0.9 | GO:0086010 | membrane depolarization during action potential(GO:0086010) |
0.0 | 0.3 | GO:1901881 | positive regulation of protein depolymerization(GO:1901881) |
0.0 | 0.1 | GO:0060830 | ciliary receptor clustering involved in smoothened signaling pathway(GO:0060830) |
0.0 | 0.1 | GO:0070947 | neutrophil mediated killing of fungus(GO:0070947) |
0.0 | 0.0 | GO:0010637 | negative regulation of mitochondrial fusion(GO:0010637) |
0.0 | 0.2 | GO:1903012 | positive regulation of bone development(GO:1903012) |
0.0 | 0.2 | GO:0070837 | dehydroascorbic acid transport(GO:0070837) |
0.0 | 0.5 | GO:0061157 | mRNA destabilization(GO:0061157) |
0.0 | 0.1 | GO:0018364 | peptidyl-glutamine methylation(GO:0018364) |
0.0 | 0.1 | GO:1901097 | negative regulation of autophagosome maturation(GO:1901097) |
0.0 | 0.2 | GO:0009181 | purine nucleoside diphosphate catabolic process(GO:0009137) purine ribonucleoside diphosphate catabolic process(GO:0009181) |
0.0 | 0.1 | GO:1902534 | single-organism membrane invagination(GO:1902534) |
0.0 | 0.9 | GO:0043044 | ATP-dependent chromatin remodeling(GO:0043044) |
0.0 | 0.1 | GO:0006363 | termination of RNA polymerase I transcription(GO:0006363) |
0.0 | 0.3 | GO:0010603 | regulation of cytoplasmic mRNA processing body assembly(GO:0010603) |
0.0 | 0.2 | GO:0043328 | late endosome to vacuole transport via multivesicular body sorting pathway(GO:0032511) protein targeting to vacuole involved in ubiquitin-dependent protein catabolic process via the multivesicular body sorting pathway(GO:0043328) |
0.0 | 0.1 | GO:0043584 | nose development(GO:0043584) |
0.0 | 0.2 | GO:0003348 | cardiac endothelial cell differentiation(GO:0003348) |
0.0 | 0.0 | GO:0070640 | alveolar secondary septum development(GO:0061144) vitamin D3 metabolic process(GO:0070640) regulation of parathyroid hormone secretion(GO:2000828) |
0.0 | 0.1 | GO:0006553 | lysine metabolic process(GO:0006553) |
0.0 | 0.1 | GO:0061083 | regulation of protein refolding(GO:0061083) negative regulation of protein refolding(GO:0061084) |
0.0 | 0.1 | GO:0048713 | regulation of oligodendrocyte differentiation(GO:0048713) |
0.0 | 0.0 | GO:0061525 | hindgut development(GO:0061525) |
0.0 | 0.1 | GO:0014046 | dopamine secretion(GO:0014046) regulation of dopamine secretion(GO:0014059) |
0.0 | 0.1 | GO:0034316 | negative regulation of Arp2/3 complex-mediated actin nucleation(GO:0034316) |
0.0 | 0.1 | GO:2000118 | regulation of sodium-dependent phosphate transport(GO:2000118) |
0.0 | 0.4 | GO:0006044 | N-acetylglucosamine metabolic process(GO:0006044) |
0.0 | 0.2 | GO:0006012 | galactose metabolic process(GO:0006012) |
0.0 | 0.1 | GO:0060017 | parathyroid gland development(GO:0060017) |
0.0 | 0.1 | GO:0042276 | error-prone translesion synthesis(GO:0042276) |
0.0 | 0.3 | GO:0018095 | protein polyglutamylation(GO:0018095) |
0.0 | 0.1 | GO:0048625 | myoblast fate commitment(GO:0048625) |
0.0 | 0.0 | GO:0038026 | reelin-mediated signaling pathway(GO:0038026) |
0.0 | 0.2 | GO:0007288 | sperm axoneme assembly(GO:0007288) |
0.0 | 0.7 | GO:0071242 | cellular response to ammonium ion(GO:0071242) |
0.0 | 0.0 | GO:0048861 | leukemia inhibitory factor signaling pathway(GO:0048861) |
0.0 | 0.0 | GO:0071787 | endoplasmic reticulum tubular network assembly(GO:0071787) |
0.0 | 0.0 | GO:0071599 | otic vesicle development(GO:0071599) otic vesicle morphogenesis(GO:0071600) |
0.0 | 0.3 | GO:1990126 | retrograde transport, endosome to plasma membrane(GO:1990126) |
0.0 | 0.0 | GO:0015870 | acetylcholine transport(GO:0015870) acetate ester transport(GO:1901374) |
0.0 | 0.1 | GO:0006681 | galactosylceramide metabolic process(GO:0006681) |
0.0 | 0.2 | GO:1903964 | monounsaturated fatty acid metabolic process(GO:1903964) monounsaturated fatty acid biosynthetic process(GO:1903966) |
0.0 | 0.2 | GO:0045631 | regulation of auditory receptor cell differentiation(GO:0045607) regulation of mechanoreceptor differentiation(GO:0045631) regulation of inner ear receptor cell differentiation(GO:2000980) |
0.0 | 0.2 | GO:0070125 | mitochondrial translational elongation(GO:0070125) |
0.0 | 0.1 | GO:0002430 | complement receptor mediated signaling pathway(GO:0002430) |
0.0 | 0.1 | GO:0010387 | COP9 signalosome assembly(GO:0010387) |
0.0 | 0.2 | GO:0006432 | phenylalanyl-tRNA aminoacylation(GO:0006432) |
0.0 | 0.1 | GO:1903071 | positive regulation of ER-associated ubiquitin-dependent protein catabolic process(GO:1903071) |
0.0 | 0.0 | GO:0046100 | hypoxanthine metabolic process(GO:0046100) hypoxanthine biosynthetic process(GO:0046101) |
0.0 | 0.1 | GO:0001757 | somite specification(GO:0001757) |
0.0 | 0.2 | GO:0010640 | regulation of platelet-derived growth factor receptor signaling pathway(GO:0010640) |
0.0 | 0.0 | GO:0006987 | activation of signaling protein activity involved in unfolded protein response(GO:0006987) |
0.0 | 0.1 | GO:0015889 | cobalamin transport(GO:0015889) |
0.0 | 0.1 | GO:1903232 | melanosome assembly(GO:1903232) |
0.0 | 0.2 | GO:0006268 | DNA unwinding involved in DNA replication(GO:0006268) |
0.0 | 0.1 | GO:0007066 | female meiosis sister chromatid cohesion(GO:0007066) |
0.0 | 0.1 | GO:1902373 | negative regulation of mRNA catabolic process(GO:1902373) |
0.0 | 0.1 | GO:0060696 | regulation of phospholipid catabolic process(GO:0060696) |
0.0 | 0.4 | GO:0009312 | oligosaccharide biosynthetic process(GO:0009312) |
0.0 | 0.1 | GO:2000765 | regulation of cytoplasmic translation(GO:2000765) |
0.0 | 0.0 | GO:2001180 | negative regulation of interleukin-10 secretion(GO:2001180) |
0.0 | 0.1 | GO:0002317 | plasma cell differentiation(GO:0002317) |
0.0 | 0.2 | GO:0016557 | peroxisome membrane biogenesis(GO:0016557) |
0.0 | 0.1 | GO:0009957 | epidermal cell fate specification(GO:0009957) |
0.0 | 0.9 | GO:0043252 | sodium-independent organic anion transport(GO:0043252) |
0.0 | 0.2 | GO:0072674 | multinuclear osteoclast differentiation(GO:0072674) |
0.0 | 0.1 | GO:0000491 | small nucleolar ribonucleoprotein complex assembly(GO:0000491) box C/D snoRNP assembly(GO:0000492) |
0.0 | 0.2 | GO:0030007 | cellular potassium ion homeostasis(GO:0030007) |
0.0 | 0.1 | GO:0042421 | norepinephrine biosynthetic process(GO:0042421) |
0.0 | 0.3 | GO:1900037 | regulation of cellular response to hypoxia(GO:1900037) |
0.0 | 0.0 | GO:0090191 | negative regulation of branching involved in ureteric bud morphogenesis(GO:0090191) |
0.0 | 0.2 | GO:0016255 | attachment of GPI anchor to protein(GO:0016255) |
0.0 | 0.1 | GO:0033015 | porphyrin-containing compound catabolic process(GO:0006787) tetrapyrrole catabolic process(GO:0033015) |
0.0 | 0.2 | GO:0007616 | long-term memory(GO:0007616) |
0.0 | 0.1 | GO:0060480 | lung goblet cell differentiation(GO:0060480) |
0.0 | 0.2 | GO:0046838 | phosphorylated carbohydrate dephosphorylation(GO:0046838) |
0.0 | 0.2 | GO:1901678 | iron coordination entity transport(GO:1901678) |
0.0 | 0.1 | GO:0002017 | regulation of blood volume by renal aldosterone(GO:0002017) |
0.0 | 0.1 | GO:0045792 | negative regulation of cell size(GO:0045792) |
0.0 | 0.1 | GO:0031293 | membrane protein intracellular domain proteolysis(GO:0031293) |
0.0 | 0.0 | GO:0060423 | foregut regionalization(GO:0060423) lung field specification(GO:0060424) lung induction(GO:0060492) |
0.0 | 0.1 | GO:0015812 | gamma-aminobutyric acid transport(GO:0015812) |
0.0 | 0.3 | GO:0032119 | sequestering of zinc ion(GO:0032119) regulation of sequestering of zinc ion(GO:0061088) |
0.0 | 0.2 | GO:0040037 | negative regulation of fibroblast growth factor receptor signaling pathway(GO:0040037) |
0.0 | 0.1 | GO:0006598 | polyamine catabolic process(GO:0006598) |
0.0 | 0.1 | GO:0009240 | isopentenyl diphosphate biosynthetic process(GO:0009240) isopentenyl diphosphate biosynthetic process, mevalonate pathway(GO:0019287) |
0.0 | 0.3 | GO:1990118 | sodium ion import across plasma membrane(GO:0098719) sodium ion import into cell(GO:1990118) |
0.0 | 0.1 | GO:0042474 | middle ear morphogenesis(GO:0042474) |
0.0 | 0.1 | GO:0060351 | cartilage development involved in endochondral bone morphogenesis(GO:0060351) |
0.0 | 0.3 | GO:0000463 | maturation of LSU-rRNA from tricistronic rRNA transcript (SSU-rRNA, 5.8S rRNA, LSU-rRNA)(GO:0000463) |
0.0 | 0.3 | GO:0030517 | negative regulation of axon extension(GO:0030517) |
0.0 | 0.1 | GO:0003128 | heart field specification(GO:0003128) |
0.0 | 0.1 | GO:0042759 | long-chain fatty acid biosynthetic process(GO:0042759) |
0.0 | 0.1 | GO:0036265 | RNA (guanine-N7)-methylation(GO:0036265) |
0.0 | 0.4 | GO:0098868 | endochondral bone growth(GO:0003416) bone growth(GO:0098868) |
0.0 | 0.1 | GO:0061146 | Peyer's patch morphogenesis(GO:0061146) |
0.0 | 0.0 | GO:1903546 | protein localization to photoreceptor outer segment(GO:1903546) |
0.0 | 0.1 | GO:0045041 | protein import into mitochondrial intermembrane space(GO:0045041) |
0.0 | 0.1 | GO:1901387 | positive regulation of voltage-gated calcium channel activity(GO:1901387) |
0.0 | 0.4 | GO:1902043 | positive regulation of extrinsic apoptotic signaling pathway via death domain receptors(GO:1902043) |
0.0 | 0.0 | GO:0035627 | ceramide transport(GO:0035627) |
0.0 | 0.1 | GO:0070601 | centromeric sister chromatid cohesion(GO:0070601) |
0.0 | 0.1 | GO:0006651 | diacylglycerol biosynthetic process(GO:0006651) |
0.0 | 0.1 | GO:0044860 | protein localization to plasma membrane raft(GO:0044860) |
0.0 | 0.0 | GO:0010918 | positive regulation of mitochondrial membrane potential(GO:0010918) |
0.0 | 0.0 | GO:0060620 | regulation of cholesterol import(GO:0060620) regulation of sterol import(GO:2000909) |
0.0 | 0.0 | GO:0035989 | tendon development(GO:0035989) |
0.0 | 0.2 | GO:2000480 | negative regulation of cAMP-dependent protein kinase activity(GO:2000480) |
0.0 | 0.7 | GO:0008542 | visual learning(GO:0008542) |
0.0 | 0.3 | GO:0046847 | filopodium assembly(GO:0046847) |
0.0 | 0.0 | GO:0060988 | lipid tube assembly(GO:0060988) |
0.0 | 0.0 | GO:2000686 | regulation of rubidium ion transmembrane transporter activity(GO:2000686) |
0.0 | 0.1 | GO:1903862 | positive regulation of oxidative phosphorylation(GO:1903862) |
0.0 | 0.1 | GO:1902459 | positive regulation of stem cell population maintenance(GO:1902459) |
0.0 | 0.1 | GO:0051350 | negative regulation of lyase activity(GO:0051350) |
0.0 | 0.2 | GO:0006122 | mitochondrial electron transport, ubiquinol to cytochrome c(GO:0006122) |
0.0 | 0.2 | GO:0043615 | astrocyte cell migration(GO:0043615) |
0.0 | 0.0 | GO:0001927 | exocyst assembly(GO:0001927) |
0.0 | 0.1 | GO:0061051 | positive regulation of cell growth involved in cardiac muscle cell development(GO:0061051) |
0.0 | 0.0 | GO:0018992 | germ-line sex determination(GO:0018992) |
0.0 | 0.1 | GO:0046880 | regulation of follicle-stimulating hormone secretion(GO:0046880) negative regulation of follicle-stimulating hormone secretion(GO:0046882) |
0.0 | 0.1 | GO:0032227 | negative regulation of synaptic transmission, dopaminergic(GO:0032227) |
0.0 | 1.8 | GO:0010923 | negative regulation of phosphatase activity(GO:0010923) |
0.0 | 0.3 | GO:1901741 | positive regulation of myoblast fusion(GO:1901741) |
0.0 | 0.2 | GO:0000291 | nuclear-transcribed mRNA catabolic process, exonucleolytic(GO:0000291) |
0.0 | 0.1 | GO:0070268 | cornification(GO:0070268) |
0.0 | 0.3 | GO:0036065 | fucosylation(GO:0036065) |
0.0 | 0.1 | GO:0035694 | mitochondrial protein catabolic process(GO:0035694) |
0.0 | 0.4 | GO:0021549 | cerebellum development(GO:0021549) |
0.0 | 0.0 | GO:1904714 | regulation of chaperone-mediated autophagy(GO:1904714) |
0.0 | 0.1 | GO:1901529 | positive regulation of anion channel activity(GO:1901529) |
0.0 | 0.7 | GO:0006890 | retrograde vesicle-mediated transport, Golgi to ER(GO:0006890) |
0.0 | 0.0 | GO:2000019 | negative regulation of male gonad development(GO:2000019) |
0.0 | 0.2 | GO:0006228 | UTP biosynthetic process(GO:0006228) |
0.0 | 0.1 | GO:1900273 | positive regulation of long-term synaptic potentiation(GO:1900273) |
0.0 | 0.1 | GO:0010820 | positive regulation of T cell chemotaxis(GO:0010820) |
0.0 | 0.0 | GO:0014832 | urinary bladder smooth muscle contraction(GO:0014832) urinary tract smooth muscle contraction(GO:0014848) micturition(GO:0060073) smooth muscle contraction involved in micturition(GO:0060083) |
0.0 | 0.1 | GO:0060011 | Sertoli cell proliferation(GO:0060011) |
0.0 | 0.1 | GO:0044341 | sodium-dependent phosphate transport(GO:0044341) |
0.0 | 0.1 | GO:0009235 | cobalamin metabolic process(GO:0009235) |
0.0 | 0.1 | GO:0035962 | response to interleukin-13(GO:0035962) cellular response to interleukin-13(GO:0035963) |
0.0 | 0.1 | GO:0043654 | recognition of apoptotic cell(GO:0043654) |
0.0 | 0.2 | GO:0033572 | transferrin transport(GO:0033572) |
0.0 | 0.1 | GO:1902626 | assembly of large subunit precursor of preribosome(GO:1902626) |
0.0 | 0.1 | GO:1904177 | regulation of adipose tissue development(GO:1904177) |
0.0 | 0.3 | GO:0007020 | microtubule nucleation(GO:0007020) |
0.0 | 0.2 | GO:0015074 | DNA integration(GO:0015074) |
0.0 | 0.1 | GO:0044252 | negative regulation of multicellular organismal metabolic process(GO:0044252) |
0.0 | 0.3 | GO:0006379 | mRNA cleavage(GO:0006379) |
0.0 | 0.1 | GO:0014072 | response to isoquinoline alkaloid(GO:0014072) response to morphine(GO:0043278) |
0.0 | 0.1 | GO:0060158 | phospholipase C-activating dopamine receptor signaling pathway(GO:0060158) |
0.0 | 0.1 | GO:0050965 | detection of temperature stimulus involved in sensory perception(GO:0050961) detection of temperature stimulus involved in sensory perception of pain(GO:0050965) |
0.0 | 0.1 | GO:0016480 | negative regulation of transcription from RNA polymerase III promoter(GO:0016480) |
0.0 | 0.1 | GO:0045085 | negative regulation of interleukin-2 biosynthetic process(GO:0045085) |
0.0 | 0.0 | GO:0035964 | COPI-coated vesicle budding(GO:0035964) |
0.0 | 0.1 | GO:0006048 | UDP-N-acetylglucosamine biosynthetic process(GO:0006048) |
0.0 | 0.1 | GO:0045113 | regulation of integrin biosynthetic process(GO:0045113) |
0.0 | 0.1 | GO:0002254 | kinin cascade(GO:0002254) |
0.0 | 0.0 | GO:0006930 | substrate-dependent cell migration, cell extension(GO:0006930) |
0.0 | 1.9 | GO:0006813 | potassium ion transport(GO:0006813) |
0.0 | 0.1 | GO:0090656 | t-circle formation(GO:0090656) |
0.0 | 0.0 | GO:0071280 | cellular response to copper ion(GO:0071280) cellular response to mercury ion(GO:0071288) |
0.0 | 0.5 | GO:0071300 | cellular response to retinoic acid(GO:0071300) |
0.0 | 0.7 | GO:0000245 | spliceosomal complex assembly(GO:0000245) |
0.0 | 0.1 | GO:0071442 | positive regulation of histone H3-K14 acetylation(GO:0071442) |
0.0 | 0.1 | GO:0035745 | T-helper 2 cell cytokine production(GO:0035745) |
0.0 | 0.0 | GO:0009078 | alanine metabolic process(GO:0006522) pyruvate family amino acid metabolic process(GO:0009078) |
0.0 | 0.0 | GO:0043084 | penile erection(GO:0043084) |
0.0 | 0.1 | GO:0043568 | positive regulation of insulin-like growth factor receptor signaling pathway(GO:0043568) |
0.0 | 0.7 | GO:0008333 | endosome to lysosome transport(GO:0008333) |
0.0 | 0.1 | GO:1902093 | positive regulation of sperm motility(GO:1902093) |
0.0 | 0.1 | GO:0040023 | nuclear migration(GO:0007097) establishment of nucleus localization(GO:0040023) |
0.0 | 0.0 | GO:1903069 | regulation of ER-associated ubiquitin-dependent protein catabolic process(GO:1903069) |
0.0 | 0.0 | GO:0090245 | axis elongation involved in somitogenesis(GO:0090245) |
0.0 | 0.0 | GO:1902445 | regulation of mitochondrial membrane permeability involved in programmed necrotic cell death(GO:1902445) |
0.0 | 0.1 | GO:0036151 | phosphatidylcholine acyl-chain remodeling(GO:0036151) |
0.0 | 0.2 | GO:0050802 | circadian sleep/wake cycle process(GO:0022410) circadian sleep/wake cycle, sleep(GO:0050802) |
0.0 | 0.0 | GO:0051957 | positive regulation of amino acid transport(GO:0051957) |
0.0 | 0.3 | GO:0006085 | acetyl-CoA biosynthetic process(GO:0006085) |
0.0 | 0.2 | GO:0048011 | neurotrophin TRK receptor signaling pathway(GO:0048011) |
0.0 | 0.0 | GO:0072584 | caveolin-mediated endocytosis(GO:0072584) |
0.0 | 0.1 | GO:0060178 | regulation of exocyst localization(GO:0060178) |
0.0 | 0.1 | GO:0090385 | phagosome-lysosome fusion(GO:0090385) |
0.0 | 0.2 | GO:0042407 | cristae formation(GO:0042407) |
0.0 | 0.4 | GO:0034605 | cellular response to heat(GO:0034605) |
0.0 | 0.0 | GO:0001963 | synaptic transmission, dopaminergic(GO:0001963) |
0.0 | 0.1 | GO:0046950 | cellular ketone body metabolic process(GO:0046950) ketone body catabolic process(GO:0046952) |
0.0 | 0.1 | GO:0046541 | saliva secretion(GO:0046541) |
0.0 | 0.0 | GO:0033566 | gamma-tubulin complex localization(GO:0033566) |
0.0 | 0.0 | GO:2000152 | regulation of ubiquitin-specific protease activity(GO:2000152) |
0.0 | 0.0 | GO:0009233 | menaquinone metabolic process(GO:0009233) |
0.0 | 0.1 | GO:0035977 | protein deglycosylation involved in glycoprotein catabolic process(GO:0035977) protein demannosylation(GO:0036507) protein alpha-1,2-demannosylation(GO:0036508) mannose trimming involved in glycoprotein ERAD pathway(GO:1904382) |
0.0 | 0.0 | GO:1903999 | negative regulation of eating behavior(GO:1903999) |
0.0 | 0.0 | GO:0006183 | GTP biosynthetic process(GO:0006183) |
0.0 | 0.2 | GO:0070816 | phosphorylation of RNA polymerase II C-terminal domain(GO:0070816) |
0.0 | 0.0 | GO:0030538 | embryonic genitalia morphogenesis(GO:0030538) |
0.0 | 0.1 | GO:2000318 | positive regulation of T-helper 17 type immune response(GO:2000318) |
0.0 | 0.1 | GO:0060600 | dichotomous subdivision of an epithelial terminal unit(GO:0060600) |
0.0 | 0.4 | GO:0007340 | acrosome reaction(GO:0007340) |
0.0 | 0.0 | GO:0035425 | autocrine signaling(GO:0035425) |
0.0 | 0.0 | GO:1904742 | regulation of telomeric DNA binding(GO:1904742) |
0.0 | 0.0 | GO:0009750 | response to fructose(GO:0009750) |
0.0 | 0.0 | GO:0038091 | cell migration involved in vasculogenesis(GO:0035441) VEGF-activated platelet-derived growth factor receptor signaling pathway(GO:0038086) positive regulation of cell proliferation by VEGF-activated platelet derived growth factor receptor signaling pathway(GO:0038091) |
0.0 | 0.0 | GO:0009794 | regulation of mitotic cell cycle, embryonic(GO:0009794) mitotic cell cycle, embryonic(GO:0045448) |
0.0 | 0.0 | GO:1902630 | regulation of membrane hyperpolarization(GO:1902630) |
0.0 | 0.1 | GO:0070934 | CRD-mediated mRNA stabilization(GO:0070934) |
0.0 | 0.0 | GO:0061484 | hematopoietic stem cell homeostasis(GO:0061484) |
0.0 | 0.0 | GO:0070973 | protein localization to endoplasmic reticulum exit site(GO:0070973) |
0.0 | 0.0 | GO:0048850 | hypophysis morphogenesis(GO:0048850) |
0.0 | 0.0 | GO:2000651 | positive regulation of sodium ion transmembrane transporter activity(GO:2000651) |
0.0 | 0.2 | GO:0002098 | tRNA wobble uridine modification(GO:0002098) |
0.0 | 0.1 | GO:0030803 | negative regulation of cyclic nucleotide biosynthetic process(GO:0030803) |
0.0 | 0.0 | GO:0046655 | folic acid metabolic process(GO:0046655) |
0.0 | 0.1 | GO:0034975 | protein folding in endoplasmic reticulum(GO:0034975) |
0.0 | 0.0 | GO:0032380 | regulation of intracellular lipid transport(GO:0032377) regulation of intracellular sterol transport(GO:0032380) regulation of intracellular cholesterol transport(GO:0032383) |
0.0 | 0.0 | GO:0043652 | engulfment of apoptotic cell(GO:0043652) |
0.0 | 0.0 | GO:0033326 | cerebrospinal fluid secretion(GO:0033326) |
0.0 | 0.0 | GO:0035743 | CD4-positive, alpha-beta T cell cytokine production(GO:0035743) |
0.0 | 0.1 | GO:0070131 | positive regulation of mitochondrial translation(GO:0070131) |
0.0 | 0.1 | GO:0018344 | protein geranylgeranylation(GO:0018344) |
0.0 | 0.0 | GO:1900378 | positive regulation of melanin biosynthetic process(GO:0048023) positive regulation of secondary metabolite biosynthetic process(GO:1900378) |
0.0 | 0.1 | GO:1903265 | positive regulation of tumor necrosis factor-mediated signaling pathway(GO:1903265) |
0.0 | 0.1 | GO:0009624 | response to nematode(GO:0009624) |
0.0 | 0.0 | GO:0042424 | catechol-containing compound catabolic process(GO:0019614) catecholamine catabolic process(GO:0042424) |
0.0 | 0.0 | GO:0051956 | negative regulation of amino acid transport(GO:0051956) |
0.0 | 0.1 | GO:0042136 | neurotransmitter biosynthetic process(GO:0042136) |
0.0 | 0.8 | GO:0042147 | retrograde transport, endosome to Golgi(GO:0042147) |
0.0 | 0.1 | GO:0006685 | sphingomyelin catabolic process(GO:0006685) |
0.0 | 0.1 | GO:0050686 | negative regulation of mRNA processing(GO:0050686) |
0.0 | 0.0 | GO:0060054 | positive regulation of epithelial cell proliferation involved in wound healing(GO:0060054) |
0.0 | 0.0 | GO:0002314 | germinal center B cell differentiation(GO:0002314) |
0.0 | 0.1 | GO:0042637 | catagen(GO:0042637) |
0.0 | 0.0 | GO:0097211 | response to gonadotropin-releasing hormone(GO:0097210) cellular response to gonadotropin-releasing hormone(GO:0097211) |
0.0 | 0.1 | GO:0035721 | intraciliary retrograde transport(GO:0035721) |
0.0 | 0.1 | GO:0006646 | phosphatidylethanolamine biosynthetic process(GO:0006646) |
0.0 | 0.1 | GO:0051966 | regulation of synaptic transmission, glutamatergic(GO:0051966) |
0.0 | 0.0 | GO:1902896 | terminal web assembly(GO:1902896) |
0.0 | 0.0 | GO:2000048 | negative regulation of cell-cell adhesion mediated by cadherin(GO:2000048) |
0.0 | 0.1 | GO:1903020 | positive regulation of glycoprotein metabolic process(GO:1903020) |
0.0 | 0.0 | GO:0045760 | positive regulation of action potential(GO:0045760) |
0.0 | 0.0 | GO:0043497 | regulation of protein heterodimerization activity(GO:0043497) |
0.0 | 0.1 | GO:1900262 | regulation of DNA-directed DNA polymerase activity(GO:1900262) positive regulation of DNA-directed DNA polymerase activity(GO:1900264) |
0.0 | 0.0 | GO:0002905 | mature B cell apoptotic process(GO:0002901) regulation of mature B cell apoptotic process(GO:0002905) negative regulation of mature B cell apoptotic process(GO:0002906) |
0.0 | 0.2 | GO:0031639 | plasminogen activation(GO:0031639) |
0.0 | 0.0 | GO:0044065 | regulation of respiratory system process(GO:0044065) |
0.0 | 0.1 | GO:0043651 | linoleic acid metabolic process(GO:0043651) |
0.0 | 0.0 | GO:0002949 | tRNA threonylcarbamoyladenosine modification(GO:0002949) |
0.0 | 0.0 | GO:0045161 | neuronal ion channel clustering(GO:0045161) |
0.0 | 0.0 | GO:0097466 | glycoprotein ERAD pathway(GO:0097466) response to glycoprotein(GO:1904587) |
0.0 | 0.1 | GO:0030259 | lipid glycosylation(GO:0030259) |
0.0 | 0.2 | GO:0048791 | calcium ion-regulated exocytosis of neurotransmitter(GO:0048791) |
0.0 | 0.0 | GO:0006361 | transcription initiation from RNA polymerase I promoter(GO:0006361) |
0.0 | 0.0 | GO:1904694 | negative regulation of vascular smooth muscle contraction(GO:1904694) |
0.0 | 0.2 | GO:0006491 | N-glycan processing(GO:0006491) |
0.0 | 0.1 | GO:0030238 | male sex determination(GO:0030238) |
0.0 | 0.3 | GO:0031146 | SCF-dependent proteasomal ubiquitin-dependent protein catabolic process(GO:0031146) |
0.0 | 0.1 | GO:0070197 | meiotic telomere tethering at nuclear periphery(GO:0044821) meiotic attachment of telomere to nuclear envelope(GO:0070197) chromosome attachment to the nuclear envelope(GO:0097240) |
0.0 | 0.0 | GO:0045039 | protein import into mitochondrial inner membrane(GO:0045039) |
0.0 | 0.1 | GO:0071786 | endoplasmic reticulum tubular network organization(GO:0071786) |
0.0 | 0.0 | GO:0034755 | iron ion transmembrane transport(GO:0034755) |
0.0 | 0.0 | GO:0035188 | blastocyst hatching(GO:0001835) hatching(GO:0035188) organism emergence from protective structure(GO:0071684) |
0.0 | 0.0 | GO:0048024 | regulation of mRNA splicing, via spliceosome(GO:0048024) |
0.0 | 0.0 | GO:0010871 | negative regulation of receptor biosynthetic process(GO:0010871) |
0.0 | 0.0 | GO:0035092 | sperm chromatin condensation(GO:0035092) |
0.0 | 0.0 | GO:1900747 | negative regulation of vascular endothelial growth factor signaling pathway(GO:1900747) |
0.0 | 0.1 | GO:0006750 | glutathione biosynthetic process(GO:0006750) |
0.0 | 0.0 | GO:0015014 | heparan sulfate proteoglycan biosynthetic process, polysaccharide chain biosynthetic process(GO:0015014) |
0.0 | 0.0 | GO:0007084 | mitotic nuclear envelope reassembly(GO:0007084) |
0.0 | 0.1 | GO:0098734 | protein depalmitoylation(GO:0002084) macromolecule depalmitoylation(GO:0098734) |
0.0 | 0.1 | GO:0046485 | ether lipid metabolic process(GO:0046485) |
0.0 | 0.2 | GO:0034587 | piRNA metabolic process(GO:0034587) |
0.0 | 0.0 | GO:0050955 | thermoception(GO:0050955) |
0.0 | 0.0 | GO:0034116 | positive regulation of heterotypic cell-cell adhesion(GO:0034116) |
0.0 | 0.0 | GO:0002581 | negative regulation of antigen processing and presentation of peptide or polysaccharide antigen via MHC class II(GO:0002581) |
0.0 | 0.1 | GO:0008089 | anterograde axonal transport(GO:0008089) |
0.0 | 0.0 | GO:0022007 | neural plate elongation(GO:0014022) convergent extension involved in neural plate elongation(GO:0022007) |
0.0 | 0.1 | GO:0043461 | proton-transporting ATP synthase complex assembly(GO:0043461) proton-transporting ATP synthase complex biogenesis(GO:0070272) |
0.0 | 0.0 | GO:0090237 | regulation of arachidonic acid secretion(GO:0090237) |
0.0 | 0.1 | GO:0009128 | purine nucleoside monophosphate catabolic process(GO:0009128) |
0.0 | 0.0 | GO:0071799 | response to prostaglandin D(GO:0071798) cellular response to prostaglandin D stimulus(GO:0071799) |
0.0 | 0.0 | GO:0032328 | alanine transport(GO:0032328) |
0.0 | 0.0 | GO:0006667 | sphinganine metabolic process(GO:0006667) |
0.0 | 0.0 | GO:0046668 | regulation of retinal cell programmed cell death(GO:0046668) |
0.0 | 0.0 | GO:0033121 | regulation of purine nucleotide catabolic process(GO:0033121) |
0.0 | 0.0 | GO:0045988 | negative regulation of striated muscle contraction(GO:0045988) |
0.0 | 0.0 | GO:0035697 | CD8-positive, alpha-beta T cell extravasation(GO:0035697) regulation of CD8-positive, alpha-beta T cell extravasation(GO:2000449) |
0.0 | 0.0 | GO:0034650 | cortisol metabolic process(GO:0034650) |
0.0 | 0.1 | GO:0051014 | actin filament severing(GO:0051014) |
0.0 | 0.0 | GO:0050771 | negative regulation of axonogenesis(GO:0050771) |
0.0 | 0.3 | GO:0045600 | positive regulation of fat cell differentiation(GO:0045600) |
0.0 | 0.1 | GO:0006904 | vesicle docking involved in exocytosis(GO:0006904) |
0.0 | 0.0 | GO:0097084 | vascular smooth muscle cell development(GO:0097084) |
0.0 | 0.4 | GO:0006284 | base-excision repair(GO:0006284) |
0.0 | 0.1 | GO:0009143 | nucleoside triphosphate catabolic process(GO:0009143) |
0.0 | 0.1 | GO:0042989 | sequestering of actin monomers(GO:0042989) |
0.0 | 0.0 | GO:0051026 | chiasma assembly(GO:0051026) |
0.0 | 0.1 | GO:0090503 | RNA phosphodiester bond hydrolysis, exonucleolytic(GO:0090503) |
0.0 | 0.0 | GO:0010996 | response to auditory stimulus(GO:0010996) |
0.0 | 0.2 | GO:0000387 | spliceosomal snRNP assembly(GO:0000387) |
0.0 | 0.0 | GO:0060049 | regulation of protein glycosylation(GO:0060049) |
0.0 | 0.0 | GO:0010578 | regulation of adenylate cyclase activity involved in G-protein coupled receptor signaling pathway(GO:0010578) positive regulation of adenylate cyclase activity involved in G-protein coupled receptor signaling pathway(GO:0010579) |
0.0 | 0.0 | GO:1903715 | regulation of aerobic respiration(GO:1903715) |
0.0 | 0.0 | GO:0002678 | positive regulation of chronic inflammatory response(GO:0002678) |
0.0 | 0.0 | GO:1901857 | positive regulation of cellular respiration(GO:1901857) |
0.0 | 0.0 | GO:0072383 | plus-end-directed vesicle transport along microtubule(GO:0072383) plus-end-directed organelle transport along microtubule(GO:0072386) |
0.0 | 0.0 | GO:0051660 | establishment of centrosome localization(GO:0051660) |
Log-likelihood per target | Total log-likelihood | Term | Description |
---|---|---|---|
1.0 | 3.1 | GO:0038037 | G-protein coupled receptor dimeric complex(GO:0038037) G-protein coupled receptor complex(GO:0097648) |
0.7 | 2.1 | GO:0044393 | microspike(GO:0044393) |
0.7 | 1.3 | GO:0097454 | Schwann cell microvillus(GO:0097454) |
0.6 | 12.3 | GO:0060077 | inhibitory synapse(GO:0060077) |
0.4 | 4.4 | GO:0044224 | juxtaparanode region of axon(GO:0044224) |
0.4 | 1.1 | GO:0005594 | collagen type IX trimer(GO:0005594) |
0.4 | 1.1 | GO:0016533 | cyclin-dependent protein kinase 5 holoenzyme complex(GO:0016533) |
0.3 | 3.1 | GO:0032045 | guanyl-nucleotide exchange factor complex(GO:0032045) |
0.3 | 4.1 | GO:0017146 | NMDA selective glutamate receptor complex(GO:0017146) |
0.3 | 0.3 | GO:0097418 | neurofibrillary tangle(GO:0097418) |
0.3 | 4.3 | GO:0030877 | beta-catenin destruction complex(GO:0030877) |
0.3 | 11.8 | GO:0008328 | ionotropic glutamate receptor complex(GO:0008328) neurotransmitter receptor complex(GO:0098878) |
0.3 | 2.9 | GO:0002116 | semaphorin receptor complex(GO:0002116) |
0.3 | 1.5 | GO:0044326 | dendritic spine neck(GO:0044326) |
0.3 | 2.8 | GO:0000137 | Golgi cis cisterna(GO:0000137) |
0.3 | 1.5 | GO:0043083 | synaptic cleft(GO:0043083) |
0.3 | 2.1 | GO:0032584 | growth cone membrane(GO:0032584) |
0.3 | 0.8 | GO:0072534 | perineuronal net(GO:0072534) |
0.3 | 0.8 | GO:0070033 | synaptobrevin 2-SNAP-25-syntaxin-1a-complexin II complex(GO:0070033) |
0.3 | 2.4 | GO:0005869 | dynactin complex(GO:0005869) |
0.3 | 12.0 | GO:0042734 | presynaptic membrane(GO:0042734) |
0.3 | 3.1 | GO:0001518 | voltage-gated sodium channel complex(GO:0001518) |
0.3 | 4.0 | GO:0032839 | dendrite cytoplasm(GO:0032839) |
0.2 | 0.7 | GO:0030289 | protein phosphatase 4 complex(GO:0030289) |
0.2 | 1.2 | GO:0044300 | cerebellar mossy fiber(GO:0044300) |
0.2 | 2.1 | GO:0033268 | node of Ranvier(GO:0033268) |
0.2 | 0.4 | GO:0044316 | cone cell pedicle(GO:0044316) |
0.2 | 2.6 | GO:0032433 | filopodium tip(GO:0032433) |
0.2 | 0.6 | GO:0097427 | microtubule bundle(GO:0097427) |
0.2 | 2.2 | GO:0035102 | PRC1 complex(GO:0035102) |
0.2 | 0.7 | GO:0032591 | dendritic spine membrane(GO:0032591) |
0.2 | 0.4 | GO:1990635 | proximal dendrite(GO:1990635) |
0.2 | 1.7 | GO:0036156 | inner dynein arm(GO:0036156) |
0.2 | 0.2 | GO:0031595 | nuclear proteasome complex(GO:0031595) |
0.2 | 0.5 | GO:0033596 | TSC1-TSC2 complex(GO:0033596) |
0.2 | 2.3 | GO:0043196 | varicosity(GO:0043196) |
0.2 | 0.5 | GO:0032280 | symmetric synapse(GO:0032280) |
0.2 | 0.5 | GO:0071818 | BAT3 complex(GO:0071818) ER membrane insertion complex(GO:0072379) |
0.2 | 1.3 | GO:0042788 | polysomal ribosome(GO:0042788) |
0.2 | 1.5 | GO:0000813 | ESCRT I complex(GO:0000813) |
0.2 | 5.3 | GO:0099501 | synaptic vesicle membrane(GO:0030672) exocytic vesicle membrane(GO:0099501) |
0.2 | 2.3 | GO:0071565 | nBAF complex(GO:0071565) |
0.2 | 0.5 | GO:0070110 | ciliary neurotrophic factor receptor complex(GO:0070110) |
0.2 | 5.8 | GO:0043198 | dendritic shaft(GO:0043198) |
0.2 | 0.9 | GO:0001674 | female germ cell nucleus(GO:0001674) |
0.2 | 0.5 | GO:0005967 | mitochondrial pyruvate dehydrogenase complex(GO:0005967) |
0.2 | 2.9 | GO:0090545 | NuRD complex(GO:0016581) CHD-type complex(GO:0090545) |
0.1 | 0.6 | GO:0071953 | elastic fiber(GO:0071953) |
0.1 | 3.0 | GO:0032809 | neuronal cell body membrane(GO:0032809) |
0.1 | 0.8 | GO:0005851 | eukaryotic translation initiation factor 2B complex(GO:0005851) |
0.1 | 0.4 | GO:0008091 | spectrin(GO:0008091) |
0.1 | 0.1 | GO:1990812 | growth cone filopodium(GO:1990812) |
0.1 | 0.5 | GO:0048237 | rough endoplasmic reticulum lumen(GO:0048237) |
0.1 | 0.4 | GO:0014701 | junctional sarcoplasmic reticulum membrane(GO:0014701) |
0.1 | 0.4 | GO:0035748 | myelin sheath abaxonal region(GO:0035748) |
0.1 | 0.5 | GO:0043194 | axon initial segment(GO:0043194) |
0.1 | 1.6 | GO:1902710 | GABA receptor complex(GO:1902710) GABA-A receptor complex(GO:1902711) |
0.1 | 0.4 | GO:0043527 | tRNA methyltransferase complex(GO:0043527) |
0.1 | 2.7 | GO:0044295 | axonal growth cone(GO:0044295) |
0.1 | 0.9 | GO:0005677 | chromatin silencing complex(GO:0005677) |
0.1 | 0.7 | GO:0019907 | cyclin-dependent protein kinase activating kinase holoenzyme complex(GO:0019907) |
0.1 | 10.0 | GO:0030426 | growth cone(GO:0030426) |
0.1 | 0.2 | GO:0044299 | C-fiber(GO:0044299) |
0.1 | 0.7 | GO:0036057 | filtration diaphragm(GO:0036056) slit diaphragm(GO:0036057) |
0.1 | 0.6 | GO:0005952 | cAMP-dependent protein kinase complex(GO:0005952) |
0.1 | 0.5 | GO:0097255 | R2TP complex(GO:0097255) |
0.1 | 7.4 | GO:0043204 | perikaryon(GO:0043204) |
0.1 | 0.3 | GO:0097149 | centralspindlin complex(GO:0097149) |
0.1 | 0.5 | GO:0005638 | lamin filament(GO:0005638) |
0.1 | 1.5 | GO:0071004 | U2-type prespliceosome(GO:0071004) |
0.1 | 1.2 | GO:0032580 | Golgi cisterna membrane(GO:0032580) |
0.1 | 0.1 | GO:0032279 | asymmetric synapse(GO:0032279) |
0.1 | 0.4 | GO:0071797 | LUBAC complex(GO:0071797) |
0.1 | 0.4 | GO:0016589 | NURF complex(GO:0016589) |
0.1 | 0.3 | GO:0000110 | nucleotide-excision repair factor 1 complex(GO:0000110) |
0.1 | 0.4 | GO:0044530 | supraspliceosomal complex(GO:0044530) |
0.1 | 0.3 | GO:0030427 | site of polarized growth(GO:0030427) |
0.1 | 0.2 | GO:0070552 | BRISC complex(GO:0070552) |
0.1 | 0.2 | GO:0005956 | protein kinase CK2 complex(GO:0005956) |
0.1 | 0.3 | GO:0042567 | insulin-like growth factor binding protein complex(GO:0016942) growth factor complex(GO:0036454) insulin-like growth factor ternary complex(GO:0042567) |
0.1 | 3.7 | GO:0008076 | voltage-gated potassium channel complex(GO:0008076) |
0.1 | 0.2 | GO:0020018 | ciliary pocket(GO:0020016) ciliary pocket membrane(GO:0020018) |
0.1 | 4.5 | GO:0035097 | histone methyltransferase complex(GO:0035097) |
0.1 | 0.4 | GO:0048476 | Holliday junction resolvase complex(GO:0048476) |
0.1 | 3.4 | GO:0043195 | terminal bouton(GO:0043195) |
0.1 | 1.1 | GO:0005892 | acetylcholine-gated channel complex(GO:0005892) |
0.1 | 0.4 | GO:0031428 | box C/D snoRNP complex(GO:0031428) |
0.1 | 0.5 | GO:0030673 | axolemma(GO:0030673) |
0.1 | 0.8 | GO:0005583 | fibrillar collagen trimer(GO:0005583) banded collagen fibril(GO:0098643) |
0.1 | 0.1 | GO:0070820 | tertiary granule(GO:0070820) |
0.1 | 0.4 | GO:0016593 | Cdc73/Paf1 complex(GO:0016593) |
0.1 | 0.1 | GO:0032437 | cuticular plate(GO:0032437) |
0.1 | 1.0 | GO:0030134 | ER to Golgi transport vesicle(GO:0030134) |
0.1 | 0.1 | GO:0071598 | neuronal ribonucleoprotein granule(GO:0071598) |
0.1 | 0.4 | GO:0001940 | male pronucleus(GO:0001940) |
0.1 | 0.2 | GO:1990393 | 3M complex(GO:1990393) |
0.1 | 0.3 | GO:0031315 | extrinsic component of mitochondrial outer membrane(GO:0031315) |
0.1 | 0.2 | GO:1990851 | Wnt-Frizzled-LRP5/6 complex(GO:1990851) |
0.1 | 0.3 | GO:0033588 | Elongator holoenzyme complex(GO:0033588) |
0.1 | 0.2 | GO:0016222 | procollagen-proline 4-dioxygenase complex(GO:0016222) |
0.1 | 2.1 | GO:0043197 | dendritic spine(GO:0043197) |
0.1 | 0.5 | GO:0097539 | ciliary transition fiber(GO:0097539) |
0.1 | 0.3 | GO:0016011 | dystroglycan complex(GO:0016011) sarcoglycan complex(GO:0016012) |
0.1 | 1.3 | GO:0005891 | voltage-gated calcium channel complex(GO:0005891) |
0.1 | 0.3 | GO:0071439 | clathrin complex(GO:0071439) |
0.1 | 0.2 | GO:0031233 | intrinsic component of external side of plasma membrane(GO:0031233) |
0.1 | 0.3 | GO:0030061 | mitochondrial crista(GO:0030061) |
0.1 | 0.4 | GO:0097038 | perinuclear endoplasmic reticulum(GO:0097038) |
0.1 | 0.3 | GO:0070578 | RISC-loading complex(GO:0070578) |
0.1 | 0.2 | GO:0097543 | ciliary inversin compartment(GO:0097543) |
0.1 | 7.0 | GO:0031225 | anchored component of membrane(GO:0031225) |
0.1 | 0.2 | GO:0032777 | Piccolo NuA4 histone acetyltransferase complex(GO:0032777) |
0.1 | 0.2 | GO:0032937 | SREBP-SCAP-Insig complex(GO:0032937) |
0.1 | 0.6 | GO:0034704 | calcium channel complex(GO:0034704) |
0.1 | 0.8 | GO:0005719 | nuclear euchromatin(GO:0005719) |
0.0 | 0.3 | GO:0044232 | organelle membrane contact site(GO:0044232) |
0.0 | 0.1 | GO:0070761 | pre-snoRNP complex(GO:0070761) |
0.0 | 5.9 | GO:0097060 | synaptic membrane(GO:0097060) |
0.0 | 0.1 | GO:0072357 | PTW/PP1 phosphatase complex(GO:0072357) |
0.0 | 1.1 | GO:0016235 | aggresome(GO:0016235) |
0.0 | 0.2 | GO:0061617 | MICOS complex(GO:0061617) |
0.0 | 0.1 | GO:0000836 | ER ubiquitin ligase complex(GO:0000835) Hrd1p ubiquitin ligase complex(GO:0000836) |
0.0 | 0.2 | GO:0061689 | tricellular tight junction(GO:0061689) |
0.0 | 0.1 | GO:1990907 | beta-catenin-TCF complex(GO:1990907) |
0.0 | 1.6 | GO:0005834 | heterotrimeric G-protein complex(GO:0005834) |
0.0 | 0.4 | GO:0034709 | methylosome(GO:0034709) |
0.0 | 0.3 | GO:0005766 | primary lysosome(GO:0005766) azurophil granule(GO:0042582) |
0.0 | 0.5 | GO:0030126 | COPI vesicle coat(GO:0030126) |
0.0 | 0.2 | GO:0045261 | mitochondrial proton-transporting ATP synthase complex, catalytic core F(1)(GO:0000275) proton-transporting ATP synthase complex, catalytic core F(1)(GO:0045261) |
0.0 | 0.1 | GO:0000802 | transverse filament(GO:0000802) |
0.0 | 0.1 | GO:0005608 | laminin-3 complex(GO:0005608) |
0.0 | 0.4 | GO:0005639 | integral component of nuclear inner membrane(GO:0005639) intrinsic component of nuclear inner membrane(GO:0031229) |
0.0 | 0.0 | GO:0044298 | cell body membrane(GO:0044298) |
0.0 | 2.0 | GO:0008021 | synaptic vesicle(GO:0008021) |
0.0 | 0.5 | GO:0005736 | DNA-directed RNA polymerase I complex(GO:0005736) |
0.0 | 0.6 | GO:0032588 | trans-Golgi network membrane(GO:0032588) |
0.0 | 0.1 | GO:0000814 | ESCRT II complex(GO:0000814) |
0.0 | 0.1 | GO:0031417 | NatC complex(GO:0031417) |
0.0 | 0.2 | GO:1990712 | HFE-transferrin receptor complex(GO:1990712) |
0.0 | 0.2 | GO:0071986 | Ragulator complex(GO:0071986) |
0.0 | 0.1 | GO:0045298 | tubulin complex(GO:0045298) |
0.0 | 2.2 | GO:0031463 | Cul3-RING ubiquitin ligase complex(GO:0031463) |
0.0 | 0.2 | GO:0042765 | GPI-anchor transamidase complex(GO:0042765) |
0.0 | 0.9 | GO:0015030 | Cajal body(GO:0015030) |
0.0 | 0.1 | GO:0000235 | astral microtubule(GO:0000235) |
0.0 | 0.4 | GO:0042555 | MCM complex(GO:0042555) |
0.0 | 0.1 | GO:1990604 | IRE1-TRAF2-ASK1 complex(GO:1990604) |
0.0 | 0.2 | GO:0033256 | I-kappaB/NF-kappaB complex(GO:0033256) |
0.0 | 0.1 | GO:0061574 | ASAP complex(GO:0061574) |
0.0 | 0.0 | GO:0044462 | cell outer membrane(GO:0009279) cell envelope(GO:0030313) external encapsulating structure part(GO:0044462) |
0.0 | 0.1 | GO:0005745 | m-AAA complex(GO:0005745) |
0.0 | 0.3 | GO:0005858 | axonemal dynein complex(GO:0005858) outer dynein arm(GO:0036157) |
0.0 | 0.3 | GO:0000815 | ESCRT III complex(GO:0000815) |
0.0 | 0.1 | GO:1990716 | axonemal central apparatus(GO:1990716) |
0.0 | 0.0 | GO:0097512 | cardiac myofibril(GO:0097512) |
0.0 | 0.5 | GO:0005852 | eukaryotic translation initiation factor 3 complex(GO:0005852) |
0.0 | 0.2 | GO:1904115 | axon cytoplasm(GO:1904115) |
0.0 | 0.2 | GO:0000788 | nuclear nucleosome(GO:0000788) |
0.0 | 0.1 | GO:0097433 | dense body(GO:0097433) |
0.0 | 4.9 | GO:0030425 | dendrite(GO:0030425) |
0.0 | 0.1 | GO:0070545 | PeBoW complex(GO:0070545) |
0.0 | 0.7 | GO:0034451 | centriolar satellite(GO:0034451) |
0.0 | 0.6 | GO:0031307 | integral component of mitochondrial outer membrane(GO:0031307) |
0.0 | 0.1 | GO:1990124 | messenger ribonucleoprotein complex(GO:1990124) |
0.0 | 0.2 | GO:0034362 | low-density lipoprotein particle(GO:0034362) |
0.0 | 0.1 | GO:0090498 | extrinsic component of Golgi membrane(GO:0090498) |
0.0 | 0.1 | GO:1990745 | EARP complex(GO:1990745) |
0.0 | 1.6 | GO:0097014 | axoneme(GO:0005930) ciliary plasm(GO:0097014) |
0.0 | 0.1 | GO:0070852 | cell body fiber(GO:0070852) |
0.0 | 0.0 | GO:0070765 | gamma-secretase complex(GO:0070765) |
0.0 | 0.1 | GO:0036396 | MIS complex(GO:0036396) |
0.0 | 0.2 | GO:0032300 | mismatch repair complex(GO:0032300) |
0.0 | 0.1 | GO:0030137 | COPI-coated vesicle(GO:0030137) |
0.0 | 0.1 | GO:0097524 | sperm plasma membrane(GO:0097524) |
0.0 | 0.2 | GO:0016272 | prefoldin complex(GO:0016272) |
0.0 | 0.0 | GO:1990909 | Wnt signalosome(GO:1990909) |
0.0 | 0.1 | GO:0072487 | MSL complex(GO:0072487) |
0.0 | 0.0 | GO:0036195 | muscle cell projection(GO:0036194) muscle cell projection membrane(GO:0036195) |
0.0 | 0.1 | GO:0032444 | activin responsive factor complex(GO:0032444) |
0.0 | 0.0 | GO:0005827 | polar microtubule(GO:0005827) |
0.0 | 0.1 | GO:0002177 | manchette(GO:0002177) |
0.0 | 0.1 | GO:0005853 | eukaryotic translation elongation factor 1 complex(GO:0005853) |
0.0 | 0.1 | GO:0031314 | extrinsic component of mitochondrial inner membrane(GO:0031314) |
0.0 | 0.0 | GO:0055087 | Ski complex(GO:0055087) |
0.0 | 0.0 | GO:0005593 | FACIT collagen trimer(GO:0005593) |
0.0 | 0.1 | GO:0089717 | spanning component of plasma membrane(GO:0044214) spanning component of membrane(GO:0089717) |
0.0 | 0.2 | GO:0097225 | sperm midpiece(GO:0097225) |
0.0 | 0.1 | GO:0097169 | AIM2 inflammasome complex(GO:0097169) |
0.0 | 0.0 | GO:0032590 | dendrite membrane(GO:0032590) |
0.0 | 0.1 | GO:0005750 | mitochondrial respiratory chain complex III(GO:0005750) respiratory chain complex III(GO:0045275) |
0.0 | 0.2 | GO:0031011 | Ino80 complex(GO:0031011) |
0.0 | 0.1 | GO:0000923 | equatorial microtubule organizing center(GO:0000923) |
0.0 | 0.1 | GO:0044322 | endoplasmic reticulum quality control compartment(GO:0044322) |
0.0 | 0.0 | GO:0032127 | dense core granule membrane(GO:0032127) |
0.0 | 0.1 | GO:0032299 | ribonuclease H2 complex(GO:0032299) |
0.0 | 0.1 | GO:0020005 | symbiont-containing vacuole membrane(GO:0020005) |
0.0 | 0.1 | GO:0031390 | Ctf18 RFC-like complex(GO:0031390) |
0.0 | 0.1 | GO:0070876 | SOSS complex(GO:0070876) |
0.0 | 0.1 | GO:0008250 | oligosaccharyltransferase complex(GO:0008250) |
0.0 | 0.1 | GO:0030689 | Noc complex(GO:0030689) |
0.0 | 0.1 | GO:0000801 | central element(GO:0000801) |
0.0 | 0.0 | GO:1903349 | omegasome membrane(GO:1903349) |
0.0 | 0.1 | GO:0090568 | nuclear transcriptional repressor complex(GO:0090568) |
0.0 | 0.6 | GO:0042645 | nucleoid(GO:0009295) mitochondrial nucleoid(GO:0042645) |
0.0 | 0.0 | GO:0044194 | cytolytic granule(GO:0044194) |
0.0 | 1.3 | GO:0035068 | micro-ribonucleoprotein complex(GO:0035068) |
0.0 | 0.3 | GO:0005801 | cis-Golgi network(GO:0005801) |
0.0 | 0.2 | GO:0030286 | dynein complex(GO:0030286) |
0.0 | 0.1 | GO:0000127 | transcription factor TFIIIC complex(GO:0000127) |
0.0 | 0.1 | GO:0000783 | telomere cap complex(GO:0000782) nuclear telomere cap complex(GO:0000783) |
0.0 | 2.0 | GO:0045202 | synapse(GO:0045202) |
0.0 | 0.0 | GO:0072558 | NLRP1 inflammasome complex(GO:0072558) |
0.0 | 0.2 | GO:0005838 | proteasome regulatory particle(GO:0005838) |
0.0 | 0.4 | GO:0005762 | organellar large ribosomal subunit(GO:0000315) mitochondrial large ribosomal subunit(GO:0005762) |
0.0 | 0.1 | GO:0031083 | BLOC-1 complex(GO:0031083) |
0.0 | 0.1 | GO:0032426 | stereocilium tip(GO:0032426) |
0.0 | 0.1 | GO:0034045 | pre-autophagosomal structure membrane(GO:0034045) |
0.0 | 0.1 | GO:0017119 | Golgi transport complex(GO:0017119) |
0.0 | 0.0 | GO:0034363 | intermediate-density lipoprotein particle(GO:0034363) |
Log-likelihood per target | Total log-likelihood | Term | Description |
---|---|---|---|
1.2 | 3.5 | GO:0097109 | neuroligin family protein binding(GO:0097109) |
1.2 | 5.8 | GO:0044323 | retinoic acid-responsive element binding(GO:0044323) |
0.7 | 2.2 | GO:0004965 | G-protein coupled GABA receptor activity(GO:0004965) |
0.7 | 2.1 | GO:0030297 | transmembrane receptor protein tyrosine kinase activator activity(GO:0030297) |
0.7 | 2.0 | GO:0000702 | oxidized base lesion DNA N-glycosylase activity(GO:0000702) |
0.7 | 2.0 | GO:0004351 | glutamate decarboxylase activity(GO:0004351) |
0.6 | 1.9 | GO:0005519 | cytoskeletal regulatory protein binding(GO:0005519) |
0.6 | 5.5 | GO:0098988 | G-protein coupled glutamate receptor activity(GO:0098988) |
0.5 | 1.6 | GO:0030144 | alpha-1,6-mannosylglycoprotein 6-beta-N-acetylglucosaminyltransferase activity(GO:0030144) |
0.5 | 1.6 | GO:0003941 | L-serine ammonia-lyase activity(GO:0003941) |
0.5 | 1.5 | GO:0008401 | retinoic acid 4-hydroxylase activity(GO:0008401) |
0.5 | 2.4 | GO:0005095 | GTPase inhibitor activity(GO:0005095) |
0.5 | 2.8 | GO:0016933 | extracellular-glycine-gated ion channel activity(GO:0016933) extracellular-glycine-gated chloride channel activity(GO:0016934) |
0.5 | 3.8 | GO:0008599 | protein phosphatase type 1 regulator activity(GO:0008599) |
0.5 | 1.9 | GO:0004966 | galanin receptor activity(GO:0004966) |
0.4 | 2.2 | GO:0003828 | alpha-N-acetylneuraminate alpha-2,8-sialyltransferase activity(GO:0003828) |
0.4 | 2.5 | GO:0004385 | guanylate kinase activity(GO:0004385) |
0.4 | 0.8 | GO:0035373 | chondroitin sulfate proteoglycan binding(GO:0035373) |
0.4 | 4.3 | GO:0042043 | neurexin family protein binding(GO:0042043) |
0.4 | 1.5 | GO:0015375 | glycine:sodium symporter activity(GO:0015375) |
0.4 | 1.1 | GO:0035851 | Krueppel-associated box domain binding(GO:0035851) |
0.4 | 1.1 | GO:0030160 | GKAP/Homer scaffold activity(GO:0030160) |
0.4 | 2.5 | GO:0005004 | GPI-linked ephrin receptor activity(GO:0005004) |
0.4 | 1.8 | GO:0004985 | opioid receptor activity(GO:0004985) |
0.4 | 2.8 | GO:0004972 | NMDA glutamate receptor activity(GO:0004972) |
0.3 | 2.2 | GO:0003680 | AT DNA binding(GO:0003680) |
0.3 | 1.6 | GO:0086006 | voltage-gated sodium channel activity involved in cardiac muscle cell action potential(GO:0086006) |
0.3 | 0.9 | GO:0015018 | galactosylgalactosylxylosylprotein 3-beta-glucuronosyltransferase activity(GO:0015018) |
0.3 | 1.5 | GO:0000155 | phosphorelay sensor kinase activity(GO:0000155) |
0.3 | 3.5 | GO:0005313 | L-glutamate transmembrane transporter activity(GO:0005313) |
0.3 | 0.9 | GO:0004949 | cannabinoid receptor activity(GO:0004949) |
0.3 | 0.8 | GO:0001075 | transcription factor activity, RNA polymerase II core promoter sequence-specific binding involved in preinitiation complex assembly(GO:0001075) |
0.3 | 1.3 | GO:0015185 | gamma-aminobutyric acid transmembrane transporter activity(GO:0015185) |
0.3 | 1.1 | GO:0004528 | phosphodiesterase I activity(GO:0004528) |
0.3 | 2.9 | GO:0017154 | semaphorin receptor activity(GO:0017154) |
0.3 | 0.5 | GO:0050816 | phosphothreonine binding(GO:0050816) |
0.3 | 0.5 | GO:0038191 | neuropilin binding(GO:0038191) |
0.3 | 1.5 | GO:0008046 | axon guidance receptor activity(GO:0008046) |
0.3 | 0.8 | GO:0005146 | leukemia inhibitory factor receptor binding(GO:0005146) |
0.3 | 6.3 | GO:0045499 | chemorepellent activity(GO:0045499) |
0.2 | 1.2 | GO:0003847 | 1-alkyl-2-acetylglycerophosphocholine esterase activity(GO:0003847) |
0.2 | 0.7 | GO:0031749 | D2 dopamine receptor binding(GO:0031749) |
0.2 | 1.7 | GO:0098632 | protein binding involved in cell-cell adhesion(GO:0098632) |
0.2 | 0.7 | GO:0030519 | snoRNP binding(GO:0030519) |
0.2 | 0.5 | GO:0004886 | 9-cis retinoic acid receptor activity(GO:0004886) |
0.2 | 1.1 | GO:0004111 | creatine kinase activity(GO:0004111) |
0.2 | 3.0 | GO:0070016 | armadillo repeat domain binding(GO:0070016) |
0.2 | 2.7 | GO:0031005 | filamin binding(GO:0031005) |
0.2 | 4.7 | GO:0071837 | HMG box domain binding(GO:0071837) |
0.2 | 0.7 | GO:0097108 | hedgehog family protein binding(GO:0097108) |
0.2 | 0.8 | GO:0031750 | D3 dopamine receptor binding(GO:0031750) |
0.2 | 0.8 | GO:0015467 | G-protein activated inward rectifier potassium channel activity(GO:0015467) |
0.2 | 0.8 | GO:0097001 | ceramide binding(GO:0097001) |
0.2 | 1.4 | GO:0015280 | ligand-gated sodium channel activity(GO:0015280) |
0.2 | 1.2 | GO:0005225 | volume-sensitive anion channel activity(GO:0005225) |
0.2 | 0.6 | GO:0004517 | nitric-oxide synthase activity(GO:0004517) |
0.2 | 0.6 | GO:1990829 | C-rich single-stranded DNA binding(GO:1990829) |
0.2 | 1.8 | GO:0103116 | alpha-D-galactofuranose transporter activity(GO:0103116) |
0.2 | 0.8 | GO:0001602 | pancreatic polypeptide receptor activity(GO:0001602) |
0.2 | 0.6 | GO:0019797 | procollagen-proline 3-dioxygenase activity(GO:0019797) |
0.2 | 5.0 | GO:0046875 | ephrin receptor binding(GO:0046875) |
0.2 | 3.8 | GO:0016917 | GABA receptor activity(GO:0016917) |
0.2 | 1.9 | GO:0050811 | GABA receptor binding(GO:0050811) |
0.2 | 1.0 | GO:0005432 | calcium:sodium antiporter activity(GO:0005432) |
0.2 | 0.9 | GO:0003958 | NADPH-hemoprotein reductase activity(GO:0003958) |
0.2 | 0.6 | GO:0051870 | methotrexate binding(GO:0051870) |
0.2 | 0.7 | GO:0005042 | netrin receptor activity(GO:0005042) |
0.2 | 1.6 | GO:0001972 | retinoic acid binding(GO:0001972) |
0.2 | 1.7 | GO:0000983 | transcription factor activity, RNA polymerase II core promoter sequence-specific(GO:0000983) |
0.2 | 0.7 | GO:0070052 | collagen V binding(GO:0070052) |
0.2 | 1.8 | GO:0048018 | receptor agonist activity(GO:0048018) |
0.2 | 1.1 | GO:0030306 | ADP-ribosylation factor binding(GO:0030306) |
0.2 | 1.1 | GO:0001094 | TFIID-class transcription factor binding(GO:0001094) |
0.2 | 0.8 | GO:0005007 | fibroblast growth factor-activated receptor activity(GO:0005007) |
0.2 | 0.6 | GO:0038064 | collagen receptor activity(GO:0038064) |
0.2 | 0.3 | GO:0001091 | RNA polymerase II basal transcription factor binding(GO:0001091) |
0.2 | 1.4 | GO:0009931 | calcium-dependent protein serine/threonine kinase activity(GO:0009931) |
0.2 | 1.2 | GO:0008889 | glycerophosphodiester phosphodiesterase activity(GO:0008889) |
0.2 | 0.2 | GO:0034056 | estrogen response element binding(GO:0034056) |
0.2 | 0.2 | GO:0005283 | sodium:amino acid symporter activity(GO:0005283) |
0.1 | 3.3 | GO:0001106 | RNA polymerase II transcription corepressor activity(GO:0001106) |
0.1 | 0.1 | GO:0001962 | alpha-1,3-galactosyltransferase activity(GO:0001962) |
0.1 | 0.7 | GO:0030550 | acetylcholine receptor inhibitor activity(GO:0030550) |
0.1 | 0.7 | GO:0019871 | sodium channel inhibitor activity(GO:0019871) |
0.1 | 0.7 | GO:0015562 | efflux transmembrane transporter activity(GO:0015562) |
0.1 | 0.6 | GO:0004897 | ciliary neurotrophic factor receptor activity(GO:0004897) |
0.1 | 1.1 | GO:0004767 | sphingomyelin phosphodiesterase activity(GO:0004767) |
0.1 | 0.4 | GO:0033829 | O-fucosylpeptide 3-beta-N-acetylglucosaminyltransferase activity(GO:0033829) |
0.1 | 1.2 | GO:0004708 | MAP kinase kinase activity(GO:0004708) |
0.1 | 0.7 | GO:0048403 | brain-derived neurotrophic factor binding(GO:0048403) |
0.1 | 1.4 | GO:0050321 | tau-protein kinase activity(GO:0050321) |
0.1 | 0.4 | GO:1990188 | euchromatin binding(GO:1990188) |
0.1 | 0.7 | GO:0015349 | thyroid hormone transmembrane transporter activity(GO:0015349) |
0.1 | 0.7 | GO:0008467 | [heparan sulfate]-glucosamine 3-sulfotransferase 1 activity(GO:0008467) |
0.1 | 0.9 | GO:0019992 | diacylglycerol binding(GO:0019992) |
0.1 | 0.4 | GO:0032767 | copper-dependent protein binding(GO:0032767) |
0.1 | 0.4 | GO:0004471 | malic enzyme activity(GO:0004470) malate dehydrogenase (decarboxylating) (NAD+) activity(GO:0004471) |
0.1 | 0.4 | GO:0004967 | glucagon receptor activity(GO:0004967) |
0.1 | 0.6 | GO:0015379 | potassium:chloride symporter activity(GO:0015379) potassium ion symporter activity(GO:0022820) |
0.1 | 0.5 | GO:0008517 | folic acid transporter activity(GO:0008517) |
0.1 | 1.4 | GO:0004705 | JUN kinase activity(GO:0004705) SAP kinase activity(GO:0016909) |
0.1 | 3.3 | GO:0005246 | calcium channel regulator activity(GO:0005246) |
0.1 | 2.1 | GO:0005229 | intracellular calcium activated chloride channel activity(GO:0005229) |
0.1 | 0.6 | GO:0031489 | myosin V binding(GO:0031489) |
0.1 | 0.2 | GO:0032357 | oxidized DNA binding(GO:0032356) oxidized purine DNA binding(GO:0032357) |
0.1 | 0.7 | GO:0004952 | dopamine neurotransmitter receptor activity(GO:0004952) |
0.1 | 0.1 | GO:0045340 | mercury ion binding(GO:0045340) |
0.1 | 2.2 | GO:0017075 | syntaxin-1 binding(GO:0017075) |
0.1 | 0.4 | GO:0004832 | valine-tRNA ligase activity(GO:0004832) |
0.1 | 0.5 | GO:0031493 | nucleosomal histone binding(GO:0031493) |
0.1 | 1.7 | GO:0030275 | LRR domain binding(GO:0030275) |
0.1 | 1.2 | GO:0051378 | serotonin binding(GO:0051378) |
0.1 | 0.4 | GO:0016647 | oxidoreductase activity, acting on the CH-NH group of donors, oxygen as acceptor(GO:0016647) |
0.1 | 0.2 | GO:0042030 | ATPase inhibitor activity(GO:0042030) |
0.1 | 0.5 | GO:0032051 | clathrin light chain binding(GO:0032051) |
0.1 | 0.5 | GO:0004740 | pyruvate dehydrogenase (acetyl-transferring) kinase activity(GO:0004740) |
0.1 | 1.5 | GO:0035255 | ionotropic glutamate receptor binding(GO:0035255) |
0.1 | 1.6 | GO:0005248 | voltage-gated sodium channel activity(GO:0005248) voltage-gated ion channel activity involved in regulation of postsynaptic membrane potential(GO:1905030) |
0.1 | 0.1 | GO:0031893 | vasopressin receptor binding(GO:0031893) |
0.1 | 1.7 | GO:0015026 | coreceptor activity(GO:0015026) |
0.1 | 0.4 | GO:0035727 | lysophosphatidic acid binding(GO:0035727) |
0.1 | 0.4 | GO:0016286 | small conductance calcium-activated potassium channel activity(GO:0016286) |
0.1 | 1.7 | GO:0032794 | GTPase activating protein binding(GO:0032794) |
0.1 | 1.4 | GO:0035198 | miRNA binding(GO:0035198) |
0.1 | 0.3 | GO:0008332 | low voltage-gated calcium channel activity(GO:0008332) |
0.1 | 0.5 | GO:0004791 | thioredoxin-disulfide reductase activity(GO:0004791) |
0.1 | 0.3 | GO:0005167 | neurotrophin TRK receptor binding(GO:0005167) |
0.1 | 0.3 | GO:0004814 | arginine-tRNA ligase activity(GO:0004814) |
0.1 | 1.0 | GO:0070679 | inositol 1,4,5 trisphosphate binding(GO:0070679) |
0.1 | 0.3 | GO:0048101 | calcium- and calmodulin-regulated 3',5'-cyclic-GMP phosphodiesterase activity(GO:0048101) |
0.1 | 1.5 | GO:0034185 | apolipoprotein binding(GO:0034185) |
0.1 | 0.5 | GO:0071558 | histone demethylase activity (H3-K27 specific)(GO:0071558) |
0.1 | 0.3 | GO:0008073 | ornithine decarboxylase inhibitor activity(GO:0008073) |
0.1 | 0.7 | GO:0005272 | sodium channel activity(GO:0005272) |
0.1 | 0.2 | GO:0001030 | RNA polymerase III type 1 promoter DNA binding(GO:0001030) RNA polymerase III type 2 promoter DNA binding(GO:0001031) RNA polymerase III type 3 promoter DNA binding(GO:0001032) 5S rDNA binding(GO:0080084) |
0.1 | 0.7 | GO:0070181 | small ribosomal subunit rRNA binding(GO:0070181) |
0.1 | 0.3 | GO:0004980 | melanocyte-stimulating hormone receptor activity(GO:0004980) |
0.1 | 0.7 | GO:0050291 | sphingosine N-acyltransferase activity(GO:0050291) |
0.1 | 1.3 | GO:0051183 | vitamin transporter activity(GO:0051183) |
0.1 | 0.6 | GO:0004983 | neuropeptide Y receptor activity(GO:0004983) |
0.1 | 0.3 | GO:0070051 | fibrinogen binding(GO:0070051) |
0.1 | 0.6 | GO:0046974 | histone methyltransferase activity (H3-K9 specific)(GO:0046974) |
0.1 | 0.4 | GO:0043237 | laminin-1 binding(GO:0043237) |
0.1 | 0.3 | GO:0004691 | cAMP-dependent protein kinase activity(GO:0004691) |
0.1 | 0.4 | GO:0015277 | kainate selective glutamate receptor activity(GO:0015277) |
0.1 | 0.9 | GO:0008239 | dipeptidyl-peptidase activity(GO:0008239) |
0.1 | 1.1 | GO:0008191 | metalloendopeptidase inhibitor activity(GO:0008191) |
0.1 | 1.2 | GO:0015643 | toxic substance binding(GO:0015643) |
0.1 | 1.2 | GO:0070567 | cytidylyltransferase activity(GO:0070567) |
0.1 | 0.4 | GO:0003840 | gamma-glutamyltransferase activity(GO:0003840) glutathione hydrolase activity(GO:0036374) |
0.1 | 0.2 | GO:0005005 | transmembrane-ephrin receptor activity(GO:0005005) |
0.1 | 0.3 | GO:0004461 | lactose synthase activity(GO:0004461) |
0.1 | 0.3 | GO:0042296 | ISG15 transferase activity(GO:0042296) |
0.1 | 0.2 | GO:0071532 | ankyrin repeat binding(GO:0071532) |
0.1 | 0.8 | GO:0008504 | monoamine transmembrane transporter activity(GO:0008504) |
0.1 | 0.3 | GO:0004558 | alpha-1,4-glucosidase activity(GO:0004558) |
0.1 | 0.1 | GO:0008158 | hedgehog receptor activity(GO:0008158) |
0.1 | 1.5 | GO:0043395 | heparan sulfate proteoglycan binding(GO:0043395) |
0.1 | 0.3 | GO:0042895 | antibiotic transporter activity(GO:0042895) |
0.1 | 1.1 | GO:0022841 | potassium ion leak channel activity(GO:0022841) |
0.1 | 2.5 | GO:0005251 | delayed rectifier potassium channel activity(GO:0005251) |
0.1 | 0.2 | GO:0036042 | long-chain fatty acyl-CoA binding(GO:0036042) |
0.1 | 0.1 | GO:0046976 | histone methyltransferase activity (H3-K27 specific)(GO:0046976) |
0.1 | 2.3 | GO:0015459 | potassium channel regulator activity(GO:0015459) |
0.1 | 0.4 | GO:0004993 | G-protein coupled serotonin receptor activity(GO:0004993) serotonin receptor activity(GO:0099589) |
0.1 | 0.3 | GO:0070579 | methylcytosine dioxygenase activity(GO:0070579) |
0.1 | 0.7 | GO:0097027 | ubiquitin-protein transferase activator activity(GO:0097027) |
0.1 | 0.2 | GO:1901702 | urate transmembrane transporter activity(GO:0015143) salt transmembrane transporter activity(GO:1901702) |
0.1 | 0.3 | GO:0004332 | fructose-bisphosphate aldolase activity(GO:0004332) |
0.1 | 0.4 | GO:0046912 | transferase activity, transferring acyl groups, acyl groups converted into alkyl on transfer(GO:0046912) |
0.1 | 1.3 | GO:0003777 | microtubule motor activity(GO:0003777) |
0.1 | 0.6 | GO:0001055 | RNA polymerase II activity(GO:0001055) |
0.1 | 0.2 | GO:0043533 | inositol 1,3,4,5 tetrakisphosphate binding(GO:0043533) |
0.1 | 2.2 | GO:0005184 | neuropeptide hormone activity(GO:0005184) |
0.1 | 0.1 | GO:0022858 | L-alanine transmembrane transporter activity(GO:0015180) alanine transmembrane transporter activity(GO:0022858) |
0.1 | 2.0 | GO:0017147 | Wnt-protein binding(GO:0017147) |
0.1 | 0.1 | GO:0001016 | RNA polymerase III regulatory region DNA binding(GO:0001016) |
0.1 | 2.4 | GO:0005245 | voltage-gated calcium channel activity(GO:0005245) |
0.1 | 0.1 | GO:0030215 | semaphorin receptor binding(GO:0030215) |
0.1 | 0.2 | GO:0019976 | interleukin-2 binding(GO:0019976) |
0.1 | 0.2 | GO:0042392 | sphingosine-1-phosphate phosphatase activity(GO:0042392) |
0.1 | 0.5 | GO:0004970 | ionotropic glutamate receptor activity(GO:0004970) |
0.1 | 0.5 | GO:0030957 | Tat protein binding(GO:0030957) |
0.1 | 1.0 | GO:0042800 | histone methyltransferase activity (H3-K4 specific)(GO:0042800) |
0.1 | 0.4 | GO:0004634 | phosphopyruvate hydratase activity(GO:0004634) |
0.1 | 2.0 | GO:0008188 | neuropeptide receptor activity(GO:0008188) |
0.1 | 0.2 | GO:0015556 | succinate transmembrane transporter activity(GO:0015141) C4-dicarboxylate transmembrane transporter activity(GO:0015556) |
0.1 | 0.1 | GO:0003696 | satellite DNA binding(GO:0003696) |
0.1 | 0.1 | GO:1990430 | extracellular matrix protein binding(GO:1990430) |
0.1 | 2.0 | GO:0001540 | beta-amyloid binding(GO:0001540) |
0.1 | 1.4 | GO:0042165 | neurotransmitter binding(GO:0042165) |
0.1 | 0.4 | GO:0004563 | beta-N-acetylhexosaminidase activity(GO:0004563) |
0.1 | 0.2 | GO:0019153 | protein-disulfide reductase (glutathione) activity(GO:0019153) |
0.1 | 0.6 | GO:0039706 | co-receptor binding(GO:0039706) |
0.1 | 0.5 | GO:0008093 | cytoskeletal adaptor activity(GO:0008093) |
0.1 | 0.7 | GO:0001730 | 2'-5'-oligoadenylate synthetase activity(GO:0001730) |
0.1 | 0.1 | GO:0051380 | norepinephrine binding(GO:0051380) |
0.1 | 0.2 | GO:0016716 | oxidoreductase activity, acting on paired donors, with incorporation or reduction of molecular oxygen, another compound as one donor, and incorporation of one atom of oxygen(GO:0016716) |
0.1 | 0.3 | GO:0008526 | phosphatidylinositol transporter activity(GO:0008526) |
0.1 | 0.1 | GO:0098531 | RNA polymerase II transcription factor activity, ligand-activated sequence-specific DNA binding(GO:0004879) transcription factor activity, direct ligand regulated sequence-specific DNA binding(GO:0098531) |
0.1 | 0.2 | GO:0005483 | soluble NSF attachment protein activity(GO:0005483) |
0.1 | 0.3 | GO:0098518 | polynucleotide phosphatase activity(GO:0098518) |
0.1 | 0.1 | GO:1990715 | mRNA CDS binding(GO:1990715) |
0.1 | 0.3 | GO:0008499 | UDP-galactose:beta-N-acetylglucosamine beta-1,3-galactosyltransferase activity(GO:0008499) |
0.1 | 0.2 | GO:0008597 | calcium-dependent protein serine/threonine phosphatase regulator activity(GO:0008597) |
0.1 | 0.2 | GO:1990226 | histone methyltransferase binding(GO:1990226) |
0.1 | 0.6 | GO:0001077 | transcriptional activator activity, RNA polymerase II core promoter proximal region sequence-specific binding(GO:0001077) |
0.1 | 0.4 | GO:0008821 | crossover junction endodeoxyribonuclease activity(GO:0008821) |
0.1 | 0.2 | GO:0000403 | Y-form DNA binding(GO:0000403) |
0.1 | 0.7 | GO:0003707 | steroid hormone receptor activity(GO:0003707) |
0.1 | 1.3 | GO:0005540 | hyaluronic acid binding(GO:0005540) |
0.1 | 1.1 | GO:0031492 | nucleosomal DNA binding(GO:0031492) |
0.1 | 0.1 | GO:0005094 | Rho GDP-dissociation inhibitor activity(GO:0005094) |
0.1 | 2.2 | GO:0030276 | clathrin binding(GO:0030276) |
0.1 | 0.4 | GO:0031995 | insulin-like growth factor II binding(GO:0031995) |
0.1 | 0.7 | GO:0031210 | phosphatidylcholine binding(GO:0031210) |
0.1 | 1.4 | GO:0005104 | fibroblast growth factor receptor binding(GO:0005104) |
0.1 | 0.3 | GO:0097157 | pre-mRNA intronic binding(GO:0097157) |
0.1 | 1.2 | GO:0043014 | alpha-tubulin binding(GO:0043014) |
0.1 | 0.1 | GO:0034739 | histone deacetylase activity (H4-K16 specific)(GO:0034739) |
0.1 | 0.1 | GO:0030619 | U1 snRNA binding(GO:0030619) |
0.1 | 0.1 | GO:0010857 | calcium-dependent protein kinase activity(GO:0010857) |
0.1 | 0.3 | GO:0017099 | very-long-chain-acyl-CoA dehydrogenase activity(GO:0017099) |
0.1 | 0.2 | GO:0008147 | structural constituent of bone(GO:0008147) |
0.1 | 1.7 | GO:0019894 | kinesin binding(GO:0019894) |
0.1 | 0.2 | GO:0034511 | U3 snoRNA binding(GO:0034511) |
0.1 | 1.3 | GO:0004864 | protein phosphatase inhibitor activity(GO:0004864) |
0.1 | 0.3 | GO:0030250 | cyclase activator activity(GO:0010853) guanylate cyclase activator activity(GO:0030250) |
0.1 | 0.5 | GO:0016215 | acyl-CoA desaturase activity(GO:0016215) |
0.1 | 0.2 | GO:0004942 | anaphylatoxin receptor activity(GO:0004942) |
0.1 | 0.4 | GO:0050786 | RAGE receptor binding(GO:0050786) |
0.1 | 0.1 | GO:0017089 | glycolipid transporter activity(GO:0017089) |
0.1 | 0.2 | GO:0070699 | type II activin receptor binding(GO:0070699) |
0.1 | 0.1 | GO:0038132 | neuregulin binding(GO:0038132) |
0.1 | 0.2 | GO:0019166 | trans-2-enoyl-CoA reductase (NADPH) activity(GO:0019166) |
0.1 | 0.4 | GO:0070742 | C2H2 zinc finger domain binding(GO:0070742) |
0.1 | 0.4 | GO:0038036 | sphingosine-1-phosphate receptor activity(GO:0038036) |
0.1 | 0.6 | GO:0004535 | poly(A)-specific ribonuclease activity(GO:0004535) |
0.1 | 0.2 | GO:0046624 | sphingolipid transporter activity(GO:0046624) |
0.1 | 0.4 | GO:0016308 | 1-phosphatidylinositol-4-phosphate 5-kinase activity(GO:0016308) |
0.0 | 42.7 | GO:0043565 | sequence-specific DNA binding(GO:0043565) |
0.0 | 0.1 | GO:0008900 | hydrogen:potassium-exchanging ATPase activity(GO:0008900) |
0.0 | 0.1 | GO:1990825 | sequence-specific mRNA binding(GO:1990825) |
0.0 | 0.1 | GO:0015271 | outward rectifier potassium channel activity(GO:0015271) |
0.0 | 0.3 | GO:0033691 | sialic acid binding(GO:0033691) |
0.0 | 1.2 | GO:0019706 | protein-cysteine S-palmitoyltransferase activity(GO:0019706) |
0.0 | 0.2 | GO:0031694 | alpha-2A adrenergic receptor binding(GO:0031694) |
0.0 | 0.0 | GO:0016532 | superoxide dismutase copper chaperone activity(GO:0016532) |
0.0 | 0.2 | GO:0034235 | GPI anchor binding(GO:0034235) |
0.0 | 0.5 | GO:0045295 | gamma-catenin binding(GO:0045295) |
0.0 | 0.2 | GO:0048156 | tau protein binding(GO:0048156) |
0.0 | 1.2 | GO:0045543 | sulfonate dioxygenase activity(GO:0000907) 2,4-dichlorophenoxyacetate alpha-ketoglutarate dioxygenase activity(GO:0018602) hypophosphite dioxygenase activity(GO:0034792) gibberellin 2-beta-dioxygenase activity(GO:0045543) C-19 gibberellin 2-beta-dioxygenase activity(GO:0052634) C-20 gibberellin 2-beta-dioxygenase activity(GO:0052635) |
0.0 | 0.1 | GO:0004611 | phosphoenolpyruvate carboxykinase activity(GO:0004611) |
0.0 | 0.2 | GO:0004656 | procollagen-proline 4-dioxygenase activity(GO:0004656) |
0.0 | 0.8 | GO:0001965 | G-protein alpha-subunit binding(GO:0001965) |
0.0 | 0.4 | GO:0016922 | ligand-dependent nuclear receptor binding(GO:0016922) |
0.0 | 0.1 | GO:0016015 | morphogen activity(GO:0016015) |
0.0 | 0.2 | GO:0031545 | peptidyl-proline 4-dioxygenase activity(GO:0031545) |
0.0 | 0.3 | GO:0016920 | pyroglutamyl-peptidase activity(GO:0016920) |
0.0 | 0.3 | GO:0016443 | bidentate ribonuclease III activity(GO:0016443) |
0.0 | 0.1 | GO:0004103 | choline kinase activity(GO:0004103) |
0.0 | 0.3 | GO:0071933 | Arp2/3 complex binding(GO:0071933) |
0.0 | 0.2 | GO:0019145 | aminobutyraldehyde dehydrogenase activity(GO:0019145) 4-trimethylammoniobutyraldehyde dehydrogenase activity(GO:0047105) |
0.0 | 0.3 | GO:0031386 | protein tag(GO:0031386) |
0.0 | 0.5 | GO:0005520 | insulin-like growth factor binding(GO:0005520) |
0.0 | 0.1 | GO:0016520 | growth hormone-releasing hormone receptor activity(GO:0016520) |
0.0 | 0.1 | GO:0030350 | iron-responsive element binding(GO:0030350) |
0.0 | 0.1 | GO:0008454 | alpha-1,3-mannosylglycoprotein 4-beta-N-acetylglucosaminyltransferase activity(GO:0008454) |
0.0 | 0.2 | GO:0015193 | L-proline transmembrane transporter activity(GO:0015193) |
0.0 | 0.1 | GO:0030158 | protein xylosyltransferase activity(GO:0030158) |
0.0 | 0.1 | GO:0042731 | PH domain binding(GO:0042731) |
0.0 | 0.2 | GO:0005131 | growth hormone receptor binding(GO:0005131) |
0.0 | 0.1 | GO:0004337 | geranyltranstransferase activity(GO:0004337) |
0.0 | 0.1 | GO:0004594 | pantothenate kinase activity(GO:0004594) |
0.0 | 0.0 | GO:0004690 | cyclic nucleotide-dependent protein kinase activity(GO:0004690) |
0.0 | 0.2 | GO:0048027 | mRNA 5'-UTR binding(GO:0048027) |
0.0 | 0.2 | GO:0033130 | acetylcholine receptor binding(GO:0033130) |
0.0 | 0.1 | GO:0003846 | 2-acylglycerol O-acyltransferase activity(GO:0003846) |
0.0 | 0.0 | GO:0044020 | histone methyltransferase activity (H4-R3 specific)(GO:0044020) |
0.0 | 0.1 | GO:1990254 | keratin filament binding(GO:1990254) |
0.0 | 0.1 | GO:0050220 | prostaglandin-E synthase activity(GO:0050220) |
0.0 | 0.1 | GO:0016833 | oxo-acid-lyase activity(GO:0016833) |
0.0 | 0.3 | GO:0005522 | profilin binding(GO:0005522) |
0.0 | 0.1 | GO:0031730 | CCR5 chemokine receptor binding(GO:0031730) |
0.0 | 0.1 | GO:0017150 | tRNA dihydrouridine synthase activity(GO:0017150) |
0.0 | 0.1 | GO:0008970 | phosphatidylcholine 1-acylhydrolase activity(GO:0008970) |
0.0 | 0.3 | GO:0047555 | 3',5'-cyclic-GMP phosphodiesterase activity(GO:0047555) |
0.0 | 0.2 | GO:0008097 | 5S rRNA binding(GO:0008097) |
0.0 | 0.2 | GO:0042301 | phosphate ion binding(GO:0042301) |
0.0 | 0.1 | GO:0032564 | dATP binding(GO:0032564) |
0.0 | 0.1 | GO:0004719 | protein-L-isoaspartate (D-aspartate) O-methyltransferase activity(GO:0004719) |
0.0 | 0.6 | GO:0050699 | WW domain binding(GO:0050699) |
0.0 | 0.1 | GO:0008427 | calcium-dependent protein kinase inhibitor activity(GO:0008427) |
0.0 | 0.3 | GO:0017091 | AU-rich element binding(GO:0017091) |
0.0 | 0.1 | GO:0031490 | chromatin DNA binding(GO:0031490) |
0.0 | 0.2 | GO:0043495 | protein anchor(GO:0043495) |
0.0 | 0.1 | GO:1901612 | cardiolipin binding(GO:1901612) |
0.0 | 0.3 | GO:0015385 | sodium:proton antiporter activity(GO:0015385) potassium:proton antiporter activity(GO:0015386) |
0.0 | 0.2 | GO:0036310 | annealing helicase activity(GO:0036310) |
0.0 | 0.1 | GO:0017108 | 5'-flap endonuclease activity(GO:0017108) |
0.0 | 0.7 | GO:0045502 | dynein binding(GO:0045502) |
0.0 | 0.1 | GO:0043546 | molybdopterin cofactor binding(GO:0043546) |
0.0 | 0.2 | GO:0042577 | lipid phosphatase activity(GO:0042577) |
0.0 | 0.0 | GO:0016775 | phosphotransferase activity, nitrogenous group as acceptor(GO:0016775) |
0.0 | 2.4 | GO:0004725 | protein tyrosine phosphatase activity(GO:0004725) |
0.0 | 1.5 | GO:0008146 | sulfotransferase activity(GO:0008146) |
0.0 | 0.2 | GO:0046933 | proton-transporting ATP synthase activity, rotational mechanism(GO:0046933) |
0.0 | 0.4 | GO:0005521 | lamin binding(GO:0005521) |
0.0 | 0.1 | GO:0016743 | carboxyl- or carbamoyltransferase activity(GO:0016743) |
0.0 | 1.9 | GO:0008376 | acetylgalactosaminyltransferase activity(GO:0008376) |
0.0 | 0.2 | GO:0004908 | interleukin-1 receptor activity(GO:0004908) |
0.0 | 0.0 | GO:0097603 | temperature-gated ion channel activity(GO:0097603) |
0.0 | 0.1 | GO:0070548 | L-glutamine aminotransferase activity(GO:0070548) |
0.0 | 0.0 | GO:0070697 | activin receptor binding(GO:0070697) |
0.0 | 0.0 | GO:0008532 | N-acetyllactosaminide beta-1,3-N-acetylglucosaminyltransferase activity(GO:0008532) |
0.0 | 0.4 | GO:0070628 | proteasome binding(GO:0070628) |
0.0 | 0.1 | GO:0004416 | hydroxyacylglutathione hydrolase activity(GO:0004416) |
0.0 | 0.1 | GO:0050815 | phosphoserine binding(GO:0050815) |
0.0 | 0.1 | GO:0005165 | neurotrophin receptor binding(GO:0005165) |
0.0 | 2.5 | GO:0042393 | histone binding(GO:0042393) |
0.0 | 0.0 | GO:0046921 | alpha-(1->6)-fucosyltransferase activity(GO:0046921) |
0.0 | 0.1 | GO:0003726 | double-stranded RNA adenosine deaminase activity(GO:0003726) |
0.0 | 0.0 | GO:0005119 | smoothened binding(GO:0005119) |
0.0 | 0.2 | GO:0031681 | G-protein beta-subunit binding(GO:0031681) |
0.0 | 0.2 | GO:0015651 | quaternary ammonium group transmembrane transporter activity(GO:0015651) |
0.0 | 0.1 | GO:0033265 | choline binding(GO:0033265) |
0.0 | 0.0 | GO:0051429 | corticotropin-releasing hormone receptor binding(GO:0051429) corticotropin-releasing hormone receptor 2 binding(GO:0051431) |
0.0 | 0.1 | GO:0004035 | alkaline phosphatase activity(GO:0004035) |
0.0 | 0.2 | GO:0036312 | phosphatidylinositol 3-kinase regulatory subunit binding(GO:0036312) |
0.0 | 0.4 | GO:0036002 | pre-mRNA binding(GO:0036002) |
0.0 | 0.1 | GO:0070815 | procollagen-lysine 5-dioxygenase activity(GO:0008475) peptidyl-lysine 5-dioxygenase activity(GO:0070815) |
0.0 | 0.0 | GO:0043125 | ErbB-3 class receptor binding(GO:0043125) |
0.0 | 0.2 | GO:0043008 | ATP-dependent protein binding(GO:0043008) |
0.0 | 0.2 | GO:0016176 | superoxide-generating NADPH oxidase activator activity(GO:0016176) |
0.0 | 0.1 | GO:0004724 | magnesium-dependent protein serine/threonine phosphatase activity(GO:0004724) |
0.0 | 0.9 | GO:0008907 | integrase activity(GO:0008907) T/G mismatch-specific endonuclease activity(GO:0043765) retroviral integrase activity(GO:0044823) retroviral 3' processing activity(GO:0044824) |
0.0 | 0.0 | GO:0016889 | endodeoxyribonuclease activity, producing 3'-phosphomonoesters(GO:0016889) |
0.0 | 0.0 | GO:0019002 | GMP binding(GO:0019002) |
0.0 | 0.0 | GO:0030621 | U4 snRNA binding(GO:0030621) |
0.0 | 0.1 | GO:0023029 | MHC class Ib protein binding(GO:0023029) |
0.0 | 0.0 | GO:0008948 | oxaloacetate decarboxylase activity(GO:0008948) |
0.0 | 0.0 | GO:0070840 | dynein complex binding(GO:0070840) |
0.0 | 0.0 | GO:0002094 | polyprenyltransferase activity(GO:0002094) |
0.0 | 0.3 | GO:0004467 | long-chain fatty acid-CoA ligase activity(GO:0004467) |
0.0 | 0.2 | GO:0051011 | microtubule minus-end binding(GO:0051011) |
0.0 | 0.0 | GO:0016717 | oxidoreductase activity, acting on paired donors, with oxidation of a pair of donors resulting in the reduction of molecular oxygen to two molecules of water(GO:0016717) |
0.0 | 0.1 | GO:0004127 | cytidylate kinase activity(GO:0004127) |
0.0 | 0.4 | GO:0030507 | spectrin binding(GO:0030507) |
0.0 | 0.2 | GO:0030296 | protein tyrosine kinase activator activity(GO:0030296) |
0.0 | 0.1 | GO:0035259 | glucocorticoid receptor binding(GO:0035259) |
0.0 | 0.1 | GO:0016715 | oxidoreductase activity, acting on paired donors, with incorporation or reduction of molecular oxygen, reduced ascorbate as one donor, and incorporation of one atom of oxygen(GO:0016715) |
0.0 | 0.2 | GO:0034236 | protein kinase A catalytic subunit binding(GO:0034236) |
0.0 | 0.1 | GO:0016174 | NAD(P)H oxidase activity(GO:0016174) |
0.0 | 0.1 | GO:0070569 | uridylyltransferase activity(GO:0070569) |
0.0 | 0.1 | GO:0008260 | 3-oxoacid CoA-transferase activity(GO:0008260) |
0.0 | 0.1 | GO:0034584 | piRNA binding(GO:0034584) |
0.0 | 0.1 | GO:0046870 | cadmium ion binding(GO:0046870) |
0.0 | 0.0 | GO:0016937 | short-branched-chain-acyl-CoA dehydrogenase activity(GO:0016937) |
0.0 | 0.1 | GO:0004826 | phenylalanine-tRNA ligase activity(GO:0004826) |
0.0 | 0.1 | GO:0017070 | U6 snRNA binding(GO:0017070) |
0.0 | 0.2 | GO:0016886 | ligase activity, forming phosphoric ester bonds(GO:0016886) |
0.0 | 0.1 | GO:0031127 | galactoside 2-alpha-L-fucosyltransferase activity(GO:0008107) alpha-(1,2)-fucosyltransferase activity(GO:0031127) |
0.0 | 0.1 | GO:0002162 | dystroglycan binding(GO:0002162) |
0.0 | 0.4 | GO:0052771 | coenzyme F390-A hydrolase activity(GO:0052770) coenzyme F390-G hydrolase activity(GO:0052771) |
0.0 | 1.0 | GO:0044325 | ion channel binding(GO:0044325) |
0.0 | 0.1 | GO:0051428 | peptide hormone receptor binding(GO:0051428) |
0.0 | 0.1 | GO:0017128 | phospholipid scramblase activity(GO:0017128) |
0.0 | 0.1 | GO:0008559 | xenobiotic-transporting ATPase activity(GO:0008559) xenobiotic transporter activity(GO:0042910) |
0.0 | 0.3 | GO:0016493 | C-C chemokine receptor activity(GO:0016493) |
0.0 | 0.5 | GO:0005249 | voltage-gated potassium channel activity(GO:0005249) |
0.0 | 0.2 | GO:0016813 | hydrolase activity, acting on carbon-nitrogen (but not peptide) bonds, in linear amidines(GO:0016813) |
0.0 | 0.1 | GO:0034955 | 2,3-dihydroxy DDT 1,2-dioxygenase activity(GO:0018542) phenanthrene dioxygenase activity(GO:0018555) 2,2',3-trihydroxybiphenyl dioxygenase activity(GO:0018556) 1,2-dihydroxyfluorene 1,1-alpha-dioxygenase activity(GO:0018557) 5,6-dihydroxy-3-methyl-2-oxo-1,2-dihydroquinoline dioxygenase activity(GO:0018558) 1,1-dichloro-2-(dihydroxy-4-chlorophenyl)-(4-chlorophenyl)ethene 1,2-dioxygenase activity(GO:0018559) protocatechuate 3,4-dioxygenase type II activity(GO:0018560) 2'-aminobiphenyl-2,3-diol 1,2-dioxygenase activity(GO:0018561) 3,4-dihydroxyfluorene 4,4-alpha-dioxygenase activity(GO:0018562) 2,3-dihydroxy-ethylbenzene 1,2-dioxygenase activity(GO:0018563) carbazole 1,9a-dioxygenase activity(GO:0018564) dihydroxydibenzothiophene dioxygenase activity(GO:0018565) 1,2-dihydroxynaphthalene-6-sulfonate 1,8a-dioxygenase activity(GO:0018566) styrene dioxygenase activity(GO:0018567) 3,4-dihydroxyphenanthrene dioxygenase activity(GO:0018568) hydroquinone 1,2-dioxygenase activity(GO:0018569) p-cumate 2,3-dioxygenase activity(GO:0018570) 2,3-dihydroxy-p-cumate dioxygenase activity(GO:0018571) 3,5-dichlorocatechol 1,2-dioxygenase activity(GO:0018572) 2-aminophenol 1,6-dioxygenase activity(GO:0018573) 2,6-dichloro-p-hydroquinone 1,2-dioxygenase activity(GO:0018574) chlorocatechol 1,2-dioxygenase activity(GO:0018575) catechol dioxygenase activity(GO:0019114) dihydroxyfluorene dioxygenase activity(GO:0019117) 5-aminosalicylate dioxygenase activity(GO:0034543) 3-hydroxy-2-naphthoate 2,3-dioxygenase activity(GO:0034803) benzo(a)pyrene 11,12-dioxygenase activity(GO:0034806) benzo(a)pyrene 4,5-dioxygenase activity(GO:0034808) 4,5-dihydroxybenzo(a)pyrene dioxygenase activity(GO:0034810) benzo(a)pyrene 9,10-dioxygenase activity(GO:0034811) 9,10-dihydroxybenzo(a)pyrene dioxygenase activity(GO:0034812) benzo(a)pyrene 7,8-dioxygenase activity(GO:0034813) 7,8-dihydroxy benzo(a)pyrene dioxygenase activity(GO:0034814) 1,2-dihydroxy-5,6,7,8-tetrahydronaphthalene extradiol dioxygenase activity(GO:0034827) 2-mercaptobenzothiazole dioxygenase activity(GO:0034834) pyridine-3,4-diol dioxygenase activity(GO:0034895) pyrene dioxygenase activity(GO:0034920) 4,5-dihydroxypyrene dioxygenase activity(GO:0034922) phenanthrene-4-carboxylate dioxygenase activity(GO:0034934) tetrachlorobenzene dioxygenase activity(GO:0034935) 4,6-dichloro-3-methylcatechol 1,2-dioxygenase activity(GO:0034936) 2,3-dihydroxydiphenyl ether dioxygenase activity(GO:0034955) diphenyl ether 1,2-dioxygenase activity(GO:0034956) arachidonate 8(S)-lipoxygenase activity(GO:0036403) 4-hydroxycatechol 1,2-dioxygenase activity(GO:0047074) |
0.0 | 0.0 | GO:0031711 | bradykinin receptor binding(GO:0031711) |
0.0 | 0.1 | GO:0070137 | ubiquitin-like protein-specific endopeptidase activity(GO:0070137) SUMO-specific endopeptidase activity(GO:0070139) |
0.0 | 0.2 | GO:0051721 | protein phosphatase 2A binding(GO:0051721) |
0.0 | 0.0 | GO:2001070 | starch binding(GO:2001070) |
0.0 | 2.0 | GO:0003729 | mRNA binding(GO:0003729) |
0.0 | 0.2 | GO:0016805 | dipeptidase activity(GO:0016805) |
0.0 | 0.2 | GO:0030881 | beta-2-microglobulin binding(GO:0030881) |
0.0 | 0.1 | GO:0008474 | palmitoyl-(protein) hydrolase activity(GO:0008474) palmitoyl hydrolase activity(GO:0098599) |
0.0 | 0.1 | GO:0015194 | L-serine transmembrane transporter activity(GO:0015194) serine transmembrane transporter activity(GO:0022889) |
0.0 | 0.1 | GO:1990247 | N6-methyladenosine-containing RNA binding(GO:1990247) |
0.0 | 0.2 | GO:0003746 | translation elongation factor activity(GO:0003746) |
0.0 | 0.1 | GO:0004969 | histamine receptor activity(GO:0004969) |
0.0 | 0.0 | GO:0003829 | beta-1,3-galactosyl-O-glycosyl-glycoprotein beta-1,6-N-acetylglucosaminyltransferase activity(GO:0003829) |
0.0 | 0.0 | GO:0016615 | malate dehydrogenase activity(GO:0016615) |
0.0 | 0.0 | GO:0005113 | patched binding(GO:0005113) |
0.0 | 0.0 | GO:0050508 | glucuronosyl-N-acetylglucosaminyl-proteoglycan 4-alpha-N-acetylglucosaminyltransferase activity(GO:0050508) |
0.0 | 0.0 | GO:1990932 | 5.8S rRNA binding(GO:1990932) |
0.0 | 0.0 | GO:0043398 | HLH domain binding(GO:0043398) |
0.0 | 0.1 | GO:0003689 | DNA clamp loader activity(GO:0003689) protein-DNA loading ATPase activity(GO:0033170) |
0.0 | 2.2 | GO:0015631 | tubulin binding(GO:0015631) |
0.0 | 0.0 | GO:0061629 | RNA polymerase II sequence-specific DNA binding transcription factor binding(GO:0061629) |
0.0 | 0.0 | GO:0043891 | glyceraldehyde-3-phosphate dehydrogenase (NAD+) (phosphorylating) activity(GO:0004365) glyceraldehyde-3-phosphate dehydrogenase (NAD(P)+) (phosphorylating) activity(GO:0043891) |
0.0 | 0.1 | GO:0043262 | adenosine-diphosphatase activity(GO:0043262) |
0.0 | 0.1 | GO:0004579 | dolichyl-diphosphooligosaccharide-protein glycotransferase activity(GO:0004579) |
0.0 | 0.1 | GO:0015093 | ferrous iron transmembrane transporter activity(GO:0015093) |
0.0 | 0.0 | GO:0002046 | opsin binding(GO:0002046) |
0.0 | 0.0 | GO:0016595 | glutamate binding(GO:0016595) |
0.0 | 0.3 | GO:0015347 | sodium-independent organic anion transmembrane transporter activity(GO:0015347) |
0.0 | 0.0 | GO:0030942 | endoplasmic reticulum signal peptide binding(GO:0030942) |
0.0 | 0.1 | GO:0070180 | large ribosomal subunit rRNA binding(GO:0070180) |
0.0 | 0.1 | GO:0016494 | C-X-C chemokine receptor activity(GO:0016494) |
0.0 | 0.0 | GO:0004126 | cytidine deaminase activity(GO:0004126) |
0.0 | 0.2 | GO:0019003 | GDP binding(GO:0019003) |
0.0 | 1.5 | GO:0003924 | GTPase activity(GO:0003924) |
0.0 | 0.1 | GO:1990380 | Lys48-specific deubiquitinase activity(GO:1990380) |
0.0 | 0.0 | GO:0070653 | high-density lipoprotein particle receptor binding(GO:0070653) |
Log-likelihood per target | Total log-likelihood | Term | Description |
---|---|---|---|
0.4 | 1.7 | PID CDC42 PATHWAY | CDC42 signaling events |
0.4 | 0.4 | PID REELIN PATHWAY | Reelin signaling pathway |
0.4 | 0.4 | PID ARF6 DOWNSTREAM PATHWAY | Arf6 downstream pathway |
0.2 | 0.7 | PID EPHB FWD PATHWAY | EPHB forward signaling |
0.2 | 2.9 | PID SYNDECAN 3 PATHWAY | Syndecan-3-mediated signaling events |
0.2 | 6.7 | PID NETRIN PATHWAY | Netrin-mediated signaling events |
0.2 | 3.4 | PID BETA CATENIN DEG PATHWAY | Degradation of beta catenin |
0.2 | 4.6 | PID LIS1 PATHWAY | Lissencephaly gene (LIS1) in neuronal migration and development |
0.1 | 3.0 | PID WNT SIGNALING PATHWAY | Wnt signaling network |
0.1 | 0.3 | PID INTEGRIN A4B1 PATHWAY | Alpha4 beta1 integrin signaling events |
0.1 | 0.5 | PID CXCR4 PATHWAY | CXCR4-mediated signaling events |
0.1 | 0.2 | PID MET PATHWAY | Signaling events mediated by Hepatocyte Growth Factor Receptor (c-Met) |
0.1 | 1.5 | PID WNT NONCANONICAL PATHWAY | Noncanonical Wnt signaling pathway |
0.1 | 2.6 | SIG REGULATION OF THE ACTIN CYTOSKELETON BY RHO GTPASES | Genes related to regulation of the actin cytoskeleton |
0.1 | 0.3 | PID RHOA PATHWAY | RhoA signaling pathway |
0.1 | 0.1 | PID INTEGRIN4 PATHWAY | Alpha6 beta4 integrin-ligand interactions |
0.1 | 0.9 | PID ANTHRAX PATHWAY | Cellular roles of Anthrax toxin |
0.1 | 0.1 | PID IFNG PATHWAY | IFN-gamma pathway |
0.1 | 1.1 | PID HEDGEHOG 2PATHWAY | Signaling events mediated by the Hedgehog family |
0.1 | 1.0 | PID AR TF PATHWAY | Regulation of Androgen receptor activity |
0.1 | 0.2 | PID ERBB NETWORK PATHWAY | ErbB receptor signaling network |
0.1 | 2.0 | NABA PROTEOGLYCANS | Genes encoding proteoglycans |
0.1 | 8.0 | NABA ECM AFFILIATED | Genes encoding proteins affiliated structurally or functionally to extracellular matrix proteins |
0.0 | 0.9 | PID ARF 3PATHWAY | Arf1 pathway |
0.0 | 0.2 | SIG CHEMOTAXIS | Genes related to chemotaxis |
0.0 | 0.2 | PID PI3K PLC TRK PATHWAY | Trk receptor signaling mediated by PI3K and PLC-gamma |
0.0 | 1.3 | PID ERBB4 PATHWAY | ErbB4 signaling events |
0.0 | 1.1 | PID AURORA B PATHWAY | Aurora B signaling |
0.0 | 2.0 | PID P75 NTR PATHWAY | p75(NTR)-mediated signaling |
0.0 | 0.2 | PID LYMPH ANGIOGENESIS PATHWAY | VEGFR3 signaling in lymphatic endothelium |
0.0 | 1.3 | PID CASPASE PATHWAY | Caspase cascade in apoptosis |
0.0 | 0.1 | PID IL3 PATHWAY | IL3-mediated signaling events |
0.0 | 0.1 | PID NFKAPPAB ATYPICAL PATHWAY | Atypical NF-kappaB pathway |
0.0 | 0.7 | PID EPHA FWDPATHWAY | EPHA forward signaling |
0.0 | 0.3 | PID GLYPICAN 1PATHWAY | Glypican 1 network |
0.0 | 1.2 | ST FAS SIGNALING PATHWAY | Fas Signaling Pathway |
0.0 | 0.6 | PID HDAC CLASSIII PATHWAY | Signaling events mediated by HDAC Class III |
0.0 | 0.6 | ST WNT BETA CATENIN PATHWAY | Wnt/beta-catenin Pathway |
0.0 | 0.7 | PID RET PATHWAY | Signaling events regulated by Ret tyrosine kinase |
0.0 | 0.7 | PID ATM PATHWAY | ATM pathway |
0.0 | 0.8 | PID ATR PATHWAY | ATR signaling pathway |
0.0 | 0.1 | PID S1P S1P4 PATHWAY | S1P4 pathway |
0.0 | 0.7 | PID TRKR PATHWAY | Neurotrophic factor-mediated Trk receptor signaling |
0.0 | 0.1 | PID TCR RAS PATHWAY | Ras signaling in the CD4+ TCR pathway |
0.0 | 0.1 | PID EPHA2 FWD PATHWAY | EPHA2 forward signaling |
0.0 | 0.3 | PID DNA PK PATHWAY | DNA-PK pathway in nonhomologous end joining |
0.0 | 0.5 | PID AURORA A PATHWAY | Aurora A signaling |
0.0 | 0.2 | PID ECADHERIN KERATINOCYTE PATHWAY | E-cadherin signaling in keratinocytes |
0.0 | 0.7 | PID ER NONGENOMIC PATHWAY | Plasma membrane estrogen receptor signaling |
0.0 | 0.1 | PID IL2 STAT5 PATHWAY | IL2 signaling events mediated by STAT5 |
0.0 | 1.1 | PID NOTCH PATHWAY | Notch signaling pathway |
0.0 | 0.1 | PID IL8 CXCR1 PATHWAY | IL8- and CXCR1-mediated signaling events |
0.0 | 0.4 | PID ARF6 PATHWAY | Arf6 signaling events |
0.0 | 0.4 | PID FGF PATHWAY | FGF signaling pathway |
0.0 | 0.0 | ST INTERLEUKIN 4 PATHWAY | Interleukin 4 (IL-4) Pathway |
0.0 | 0.7 | PID LKB1 PATHWAY | LKB1 signaling events |
0.0 | 0.7 | PID ARF6 TRAFFICKING PATHWAY | Arf6 trafficking events |
0.0 | 0.0 | PID CXCR3 PATHWAY | CXCR3-mediated signaling events |
0.0 | 0.2 | PID NFAT 3PATHWAY | Role of Calcineurin-dependent NFAT signaling in lymphocytes |
0.0 | 0.3 | PID CERAMIDE PATHWAY | Ceramide signaling pathway |
0.0 | 3.8 | NABA SECRETED FACTORS | Genes encoding secreted soluble factors |
0.0 | 0.0 | ST JAK STAT PATHWAY | Jak-STAT Pathway |
0.0 | 0.1 | ST IL 13 PATHWAY | Interleukin 13 (IL-13) Pathway |
0.0 | 0.1 | PID AMB2 NEUTROPHILS PATHWAY | amb2 Integrin signaling |
0.0 | 0.1 | PID TCR CALCIUM PATHWAY | Calcium signaling in the CD4+ TCR pathway |
0.0 | 0.1 | PID MAPK TRK PATHWAY | Trk receptor signaling mediated by the MAPK pathway |
0.0 | 0.1 | PID EPHRINB REV PATHWAY | Ephrin B reverse signaling |
0.0 | 0.2 | PID CONE PATHWAY | Visual signal transduction: Cones |
Log-likelihood per target | Total log-likelihood | Term | Description |
---|---|---|---|
0.5 | 6.4 | REACTOME CRMPS IN SEMA3A SIGNALING | Genes involved in CRMPs in Sema3A signaling |
0.4 | 5.5 | REACTOME CLASS C 3 METABOTROPIC GLUTAMATE PHEROMONE RECEPTORS | Genes involved in Class C/3 (Metabotropic glutamate/pheromone receptors) |
0.3 | 5.1 | REACTOME UNBLOCKING OF NMDA RECEPTOR GLUTAMATE BINDING AND ACTIVATION | Genes involved in Unblocking of NMDA receptor, glutamate binding and activation |
0.3 | 6.7 | REACTOME LIGAND GATED ION CHANNEL TRANSPORT | Genes involved in Ligand-gated ion channel transport |
0.3 | 0.3 | REACTOME SIGNALING BY FGFR3 MUTANTS | Genes involved in Signaling by FGFR3 mutants |
0.3 | 4.9 | REACTOME GABA SYNTHESIS RELEASE REUPTAKE AND DEGRADATION | Genes involved in GABA synthesis, release, reuptake and degradation |
0.2 | 2.7 | REACTOME IONOTROPIC ACTIVITY OF KAINATE RECEPTORS | Genes involved in Ionotropic activity of Kainate Receptors |
0.2 | 3.2 | REACTOME POST CHAPERONIN TUBULIN FOLDING PATHWAY | Genes involved in Post-chaperonin tubulin folding pathway |
0.2 | 2.6 | REACTOME OTHER SEMAPHORIN INTERACTIONS | Genes involved in Other semaphorin interactions |
0.2 | 2.0 | REACTOME BASE FREE SUGAR PHOSPHATE REMOVAL VIA THE SINGLE NUCLEOTIDE REPLACEMENT PATHWAY | Genes involved in Base-free sugar-phosphate removal via the single-nucleotide replacement pathway |
0.2 | 1.7 | REACTOME ROLE OF SECOND MESSENGERS IN NETRIN1 SIGNALING | Genes involved in Role of second messengers in netrin-1 signaling |
0.2 | 3.8 | REACTOME INTERACTION BETWEEN L1 AND ANKYRINS | Genes involved in Interaction between L1 and Ankyrins |
0.2 | 0.5 | REACTOME KERATAN SULFATE BIOSYNTHESIS | Genes involved in Keratan sulfate biosynthesis |
0.2 | 2.1 | REACTOME CS DS DEGRADATION | Genes involved in CS/DS degradation |
0.2 | 1.5 | REACTOME MEMBRANE BINDING AND TARGETTING OF GAG PROTEINS | Genes involved in Membrane binding and targetting of GAG proteins |
0.2 | 1.9 | REACTOME NA CL DEPENDENT NEUROTRANSMITTER TRANSPORTERS | Genes involved in Na+/Cl- dependent neurotransmitter transporters |
0.2 | 0.5 | REACTOME ACETYLCHOLINE NEUROTRANSMITTER RELEASE CYCLE | Genes involved in Acetylcholine Neurotransmitter Release Cycle |
0.2 | 0.6 | REACTOME DOPAMINE NEUROTRANSMITTER RELEASE CYCLE | Genes involved in Dopamine Neurotransmitter Release Cycle |
0.1 | 1.6 | REACTOME SEROTONIN RECEPTORS | Genes involved in Serotonin receptors |
0.1 | 1.5 | REACTOME ACTIVATION OF THE AP1 FAMILY OF TRANSCRIPTION FACTORS | Genes involved in Activation of the AP-1 family of transcription factors |
0.1 | 1.9 | REACTOME N GLYCAN ANTENNAE ELONGATION | Genes involved in N-Glycan antennae elongation |
0.1 | 3.5 | REACTOME NETRIN1 SIGNALING | Genes involved in Netrin-1 signaling |
0.1 | 5.4 | REACTOME VOLTAGE GATED POTASSIUM CHANNELS | Genes involved in Voltage gated Potassium channels |
0.1 | 2.7 | REACTOME MYOGENESIS | Genes involved in Myogenesis |
0.1 | 0.2 | REACTOME SEMA3A PLEXIN REPULSION SIGNALING BY INHIBITING INTEGRIN ADHESION | Genes involved in SEMA3A-Plexin repulsion signaling by inhibiting Integrin adhesion |
0.1 | 0.2 | REACTOME NGF SIGNALLING VIA TRKA FROM THE PLASMA MEMBRANE | Genes involved in NGF signalling via TRKA from the plasma membrane |
0.1 | 0.3 | REACTOME OLFACTORY SIGNALING PATHWAY | Genes involved in Olfactory Signaling Pathway |
0.1 | 0.3 | REACTOME PHOSPHOLIPASE C MEDIATED CASCADE | Genes involved in Phospholipase C-mediated cascade |
0.1 | 1.3 | REACTOME NEPHRIN INTERACTIONS | Genes involved in Nephrin interactions |
0.1 | 1.1 | REACTOME TANDEM PORE DOMAIN POTASSIUM CHANNELS | Genes involved in Tandem pore domain potassium channels |
0.1 | 1.5 | REACTOME INSULIN SYNTHESIS AND PROCESSING | Genes involved in Insulin Synthesis and Processing |
0.1 | 3.4 | REACTOME NCAM1 INTERACTIONS | Genes involved in NCAM1 interactions |
0.1 | 1.2 | REACTOME RETROGRADE NEUROTROPHIN SIGNALLING | Genes involved in Retrograde neurotrophin signalling |
0.1 | 0.1 | REACTOME PROSTACYCLIN SIGNALLING THROUGH PROSTACYCLIN RECEPTOR | Genes involved in Prostacyclin signalling through prostacyclin receptor |
0.1 | 0.6 | REACTOME ROLE OF DCC IN REGULATING APOPTOSIS | Genes involved in Role of DCC in regulating apoptosis |
0.1 | 1.0 | REACTOME HIGHLY CALCIUM PERMEABLE POSTSYNAPTIC NICOTINIC ACETYLCHOLINE RECEPTORS | Genes involved in Highly calcium permeable postsynaptic nicotinic acetylcholine receptors |
0.1 | 1.9 | REACTOME INHIBITION OF VOLTAGE GATED CA2 CHANNELS VIA GBETA GAMMA SUBUNITS | Genes involved in Inhibition of voltage gated Ca2+ channels via Gbeta/gamma subunits |
0.1 | 0.3 | REACTOME ADP SIGNALLING THROUGH P2RY12 | Genes involved in ADP signalling through P2Y purinoceptor 12 |
0.1 | 1.2 | REACTOME TRAFFICKING OF AMPA RECEPTORS | Genes involved in Trafficking of AMPA receptors |
0.1 | 0.2 | REACTOME DSCAM INTERACTIONS | Genes involved in DSCAM interactions |
0.1 | 1.3 | REACTOME ACTIVATED POINT MUTANTS OF FGFR2 | Genes involved in Activated point mutants of FGFR2 |
0.1 | 0.6 | REACTOME TRANSPORT OF ORGANIC ANIONS | Genes involved in Transport of organic anions |
0.1 | 0.6 | REACTOME ACTIVATION OF RAC | Genes involved in Activation of Rac |
0.1 | 1.0 | REACTOME SYNTHESIS SECRETION AND INACTIVATION OF GLP1 | Genes involved in Synthesis, Secretion, and Inactivation of Glucagon-like Peptide-1 (GLP-1) |
0.1 | 0.6 | REACTOME TRANSCRIPTIONAL REGULATION OF WHITE ADIPOCYTE DIFFERENTIATION | Genes involved in Transcriptional Regulation of White Adipocyte Differentiation |
0.1 | 0.8 | REACTOME SIGNALING BY NOTCH4 | Genes involved in Signaling by NOTCH4 |
0.1 | 1.8 | REACTOME CYTOCHROME P450 ARRANGED BY SUBSTRATE TYPE | Genes involved in Cytochrome P450 - arranged by substrate type |
0.1 | 0.3 | REACTOME SEMA3A PAK DEPENDENT AXON REPULSION | Genes involved in Sema3A PAK dependent Axon repulsion |
0.1 | 0.4 | REACTOME AKT PHOSPHORYLATES TARGETS IN THE CYTOSOL | Genes involved in AKT phosphorylates targets in the cytosol |
0.1 | 1.0 | REACTOME THE ROLE OF NEF IN HIV1 REPLICATION AND DISEASE PATHOGENESIS | Genes involved in The role of Nef in HIV-1 replication and disease pathogenesis |
0.1 | 0.5 | REACTOME COPI MEDIATED TRANSPORT | Genes involved in COPI Mediated Transport |
0.1 | 0.6 | REACTOME PLATELET CALCIUM HOMEOSTASIS | Genes involved in Platelet calcium homeostasis |
0.1 | 1.0 | REACTOME ADHERENS JUNCTIONS INTERACTIONS | Genes involved in Adherens junctions interactions |
0.1 | 0.5 | REACTOME ADVANCED GLYCOSYLATION ENDPRODUCT RECEPTOR SIGNALING | Genes involved in Advanced glycosylation endproduct receptor signaling |
0.1 | 1.0 | REACTOME CHOLESTEROL BIOSYNTHESIS | Genes involved in Cholesterol biosynthesis |
0.1 | 0.2 | REACTOME REGULATED PROTEOLYSIS OF P75NTR | Genes involved in Regulated proteolysis of p75NTR |
0.1 | 0.1 | REACTOME PROCESSING OF CAPPED INTRON CONTAINING PRE MRNA | Genes involved in Processing of Capped Intron-Containing Pre-mRNA |
0.1 | 0.7 | REACTOME SIGNALING BY ROBO RECEPTOR | Genes involved in Signaling by Robo receptor |
0.0 | 0.5 | REACTOME VITAMIN B5 PANTOTHENATE METABOLISM | Genes involved in Vitamin B5 (pantothenate) metabolism |
0.0 | 0.1 | REACTOME GLUTAMATE NEUROTRANSMITTER RELEASE CYCLE | Genes involved in Glutamate Neurotransmitter Release Cycle |
0.0 | 2.0 | REACTOME AMINO ACID AND OLIGOPEPTIDE SLC TRANSPORTERS | Genes involved in Amino acid and oligopeptide SLC transporters |
0.0 | 0.2 | REACTOME DOWNREGULATION OF ERBB2 ERBB3 SIGNALING | Genes involved in Downregulation of ERBB2:ERBB3 signaling |
0.0 | 0.5 | REACTOME ERKS ARE INACTIVATED | Genes involved in ERKs are inactivated |
0.0 | 0.7 | REACTOME DARPP 32 EVENTS | Genes involved in DARPP-32 events |
0.0 | 0.9 | REACTOME SIGNALING BY HIPPO | Genes involved in Signaling by Hippo |
0.0 | 0.0 | REACTOME FGFR4 LIGAND BINDING AND ACTIVATION | Genes involved in FGFR4 ligand binding and activation |
0.0 | 6.8 | REACTOME PEPTIDE LIGAND BINDING RECEPTORS | Genes involved in Peptide ligand-binding receptors |
0.0 | 3.0 | REACTOME CLASS B 2 SECRETIN FAMILY RECEPTORS | Genes involved in Class B/2 (Secretin family receptors) |
0.0 | 0.0 | REACTOME SIGNALING BY NOTCH3 | Genes involved in Signaling by NOTCH3 |
0.0 | 0.3 | REACTOME ABACAVIR TRANSPORT AND METABOLISM | Genes involved in Abacavir transport and metabolism |
0.0 | 0.6 | REACTOME VIRAL MESSENGER RNA SYNTHESIS | Genes involved in Viral Messenger RNA Synthesis |
0.0 | 0.5 | REACTOME REGULATION OF PYRUVATE DEHYDROGENASE PDH COMPLEX | Genes involved in Regulation of pyruvate dehydrogenase (PDH) complex |
0.0 | 0.3 | REACTOME HORMONE LIGAND BINDING RECEPTORS | Genes involved in Hormone ligand-binding receptors |
0.0 | 0.2 | REACTOME NOTCH HLH TRANSCRIPTION PATHWAY | Genes involved in Notch-HLH transcription pathway |
0.0 | 0.0 | REACTOME INFLUENZA LIFE CYCLE | Genes involved in Influenza Life Cycle |
0.0 | 0.4 | REACTOME MITOCHONDRIAL FATTY ACID BETA OXIDATION | Genes involved in Mitochondrial Fatty Acid Beta-Oxidation |
0.0 | 0.2 | REACTOME ETHANOL OXIDATION | Genes involved in Ethanol oxidation |
0.0 | 0.2 | REACTOME ORGANIC CATION ANION ZWITTERION TRANSPORT | Genes involved in Organic cation/anion/zwitterion transport |
0.0 | 0.1 | REACTOME BETA DEFENSINS | Genes involved in Beta defensins |
0.0 | 0.1 | REACTOME REGULATION OF THE FANCONI ANEMIA PATHWAY | Genes involved in Regulation of the Fanconi anemia pathway |
0.0 | 0.3 | REACTOME PRE NOTCH PROCESSING IN GOLGI | Genes involved in Pre-NOTCH Processing in Golgi |
0.0 | 1.0 | REACTOME HEPARAN SULFATE HEPARIN HS GAG METABOLISM | Genes involved in Heparan sulfate/heparin (HS-GAG) metabolism |
0.0 | 0.6 | REACTOME RNA POL III TRANSCRIPTION | Genes involved in RNA Polymerase III Transcription |
0.0 | 0.2 | REACTOME TETRAHYDROBIOPTERIN BH4 SYNTHESIS RECYCLING SALVAGE AND REGULATION | Genes involved in Tetrahydrobiopterin (BH4) synthesis, recycling, salvage and regulation |
0.0 | 0.2 | REACTOME ALPHA LINOLENIC ACID ALA METABOLISM | Genes involved in alpha-linolenic acid (ALA) metabolism |
0.0 | 0.0 | REACTOME TAK1 ACTIVATES NFKB BY PHOSPHORYLATION AND ACTIVATION OF IKKS COMPLEX | Genes involved in TAK1 activates NFkB by phosphorylation and activation of IKKs complex |
0.0 | 1.1 | REACTOME RECRUITMENT OF MITOTIC CENTROSOME PROTEINS AND COMPLEXES | Genes involved in Recruitment of mitotic centrosome proteins and complexes |
0.0 | 0.0 | REACTOME ACYL CHAIN REMODELLING OF PS | Genes involved in Acyl chain remodelling of PS |
0.0 | 0.0 | REACTOME JNK C JUN KINASES PHOSPHORYLATION AND ACTIVATION MEDIATED BY ACTIVATED HUMAN TAK1 | Genes involved in JNK (c-Jun kinases) phosphorylation and activation mediated by activated human TAK1 |
0.0 | 0.3 | REACTOME ACYL CHAIN REMODELLING OF PG | Genes involved in Acyl chain remodelling of PG |
0.0 | 0.4 | REACTOME CYTOSOLIC TRNA AMINOACYLATION | Genes involved in Cytosolic tRNA aminoacylation |
0.0 | 0.1 | REACTOME MTORC1 MEDIATED SIGNALLING | Genes involved in mTORC1-mediated signalling |
0.0 | 0.1 | REACTOME KERATAN SULFATE DEGRADATION | Genes involved in Keratan sulfate degradation |
0.0 | 0.9 | REACTOME PEPTIDE CHAIN ELONGATION | Genes involved in Peptide chain elongation |
0.0 | 0.1 | REACTOME CROSS PRESENTATION OF SOLUBLE EXOGENOUS ANTIGENS ENDOSOMES | Genes involved in Cross-presentation of soluble exogenous antigens (endosomes) |
0.0 | 0.5 | REACTOME GLYCOSPHINGOLIPID METABOLISM | Genes involved in Glycosphingolipid metabolism |
0.0 | 0.1 | REACTOME SIGNALLING TO RAS | Genes involved in Signalling to RAS |
0.0 | 0.6 | REACTOME FORMATION OF THE TERNARY COMPLEX AND SUBSEQUENTLY THE 43S COMPLEX | Genes involved in Formation of the ternary complex, and subsequently, the 43S complex |
0.0 | 0.3 | REACTOME EFFECTS OF PIP2 HYDROLYSIS | Genes involved in Effects of PIP2 hydrolysis |
0.0 | 0.1 | REACTOME APOPTOSIS INDUCED DNA FRAGMENTATION | Genes involved in Apoptosis induced DNA fragmentation |
0.0 | 0.2 | REACTOME POTASSIUM CHANNELS | Genes involved in Potassium Channels |
0.0 | 0.1 | REACTOME UNWINDING OF DNA | Genes involved in Unwinding of DNA |
0.0 | 0.1 | REACTOME FANCONI ANEMIA PATHWAY | Genes involved in Fanconi Anemia pathway |
0.0 | 0.1 | REACTOME EARLY PHASE OF HIV LIFE CYCLE | Genes involved in Early Phase of HIV Life Cycle |